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Abstract 
Grazing cattle can be infected with a variety of gastrointestinal nematode species.  In 
temperate regions, the most common of these species are considered to be the abomasal 
parasite, Ostertagia ostertagi, and the small intestinal dwelling nematode, Cooperia 
oncophora.  Control of these nematodes is largely reliant upon the use of three anthelmintic 
classes: the benzimidazoles, imidazothiazoles and the macrocyclic lactones (ML).  
Worldwide, reports of anthelmintic resistance in cattle nematodes have increased in recent 
years; however, little information is available regarding this issue in farmed cattle in the UK.  
Knowledge is also lacking regarding anthelmintic usage practices, and whether or not the 
current methods used to detect anthelmintic resistance in cattle nematodes are robust and 
accurate.   
In this thesis, a number of approaches were taken to investigate these issues.  A 
questionnaire study was conducted to evaluate anthelmintic usage and nematode control 
practices on a cohort of UK cattle farms.  Descriptive analysis of the responses revealed that 
first season grazing calves were administered with anthelmintics, on average, twice per year 
(ranging between once and four times per year).  It was also found that farmers depended 
heavily on ML products, with 80% of respondents administering a ML product in the 
previous 12 months and only 55% of respondents employing a quarantine treatment for cattle 
brought onto their farm.   
Faecal egg count reduction tests (FECRT) were then performed on 20 of the respondents’ 
farms, using injectable ivermectin (IVM).  Two types of faecal egg count (FEC) 
methodology (a double centrifugation salt flotation method sensitive to one egg per gram and 
a McMaster method sensitive to 50 eggs per gram) were compared to investigate their utility 
in determining anthelmintic sensitivity of the derived nematode populations.  A number of 
different statistical analyses were also performed to determine the optimum method of 
analysis for determining anthelmintic efficacy taking into account the effect of using 
arithmetic or geometric means, sensitivity of the FEC method and the effect of parametric 
bootstrapping.  Of the 20 farms tested, 13 showed indications of inefficacy of IVM.  Genus 
identification analysis of larvae derived from faecal samples obtained from the FECRT 
cohort indicated a minimum of 95% Cooperia spp. larvae in the post-treatment samples.  
Logistic regression analysis was also used to determine associations between management 
strategy on beef and dairy cattle enterprises and risk factors for IVM resistance.  Farmers 
with dairy cattle were significantly less likely to use FEC (P = 0.013) or isolate new animals 
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at quarantine (P = 0.013) compared to beef cattle farmers.  Farmers who routinely monitored 
FEC were significantly less likely to use anthelmintics than those who did not monitor FEC 
(P = 0.042) and farmers who sought advice from their veterinary surgeons were less likely to 
administer anthelmintics according to the average weight of the herd (P = 0.02).   
Nematodes from two of the farms on which IVM resistance was indicated by the field 
FECRT were then further passaged and both isolates subjected to a controlled efficacy test 
(CET).  Results from the CET confirmed the presence of IVM resistant C. oncophora (using 
two different application methods: injectable and pour-on administration), as well as the 
presence of moxidectin-resistant C. oncophora, the first confirmation in the UK.  Analysis of 
phenotypic parameters was conducted on 679 female C. oncophora recovered at necropsy 
from all treatment groups.  For both isolates, nematodes recovered from calves administered 
with moxidectin (MOX) pour-on anthelmintic were found to be significantly shorter than 
nematodes surviving IVM administration and nematodes from untreated control calves.  
Oviposition was also examined; with no eggs in utero found in any of the nematodes 
surviving MOX administration.  Differences in the numbers of eggs in utero surviving IVM 
application were observed between the two isolates and also between application methods.  
Subsequently, analysis of a small section of a glutamate-gated chloride channel (glc-6) gene 
was conducted to investigate the presence of a single nucleotide polymorphism (SNP) in the 
glc-6 gene that had been previously proposed to be associated with ML resistance.  This was 
achieved by comparing sequences derived from male and female C. oncophora (from both 
isolates) obtained from untreated calves with sequences from nematodes that had survived 
IVM administration.  The SNP was not identified in any of the parasites analysed.   
Due to time and labour costs for conducting FECRTs for detecting anthelmintic resistance, a 
migration inhibition test was examined for its utility in assessing IVM sensitivity of third 
stage larvae (L3) derived from populations that had been demonstrated to have varying IVM 
sensitivity in vivo.  Following optimisation, dose response curves and effective concentration 
(EC50) estimates were generated for all populations, including single species laboratory 
isolates of O. ostertagi and C. oncophora and mixed species isolates derived from the field 
studies above.  The data failed to correlate with the previously obtained in vivo anthelmintic 
sensitivity classification for each isolate.  Overall, O. ostertagi appeared to be less sensitive 
to IVM in the LMIT compared to C. oncophora, regardless of the ML sensitivity status of 
the isolate under study.  Thus, these experiments indicated that the LMIT may have limited 
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utility for assessing ML sensitivity of mixed species nematode isolates generated from field 
samples.   
In summary, the work in this thesis has found that UK cattle farmers heavily rely upon ML 
anthelmintics and there are clear differences in parasite control practices between farmers in 
the dairy and beef sectors, which may influence the development of anthelmintic resistance.  
As it is unclear when new classes of anthelmintics will become available for cattle, it is 
imperative to prolong the effectiveness of the current effective classes and to detect 
anthelmintic resistance as it emerges.  This thesis has explored some currently available tools 
for the detection of ML resistance, with a view to improving them with appropriate best 
practice advice to help protect the health and welfare of cattle. 
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Chapter 1: General Introduction 
1.1 Nematodes that infect cattle and their economic 
importance 
Grazing cattle can be infected with a variety of gastrointestinal nematodes (GIN), 
with more than 20 trichostrongylid species reported in the UK (Morgan and Soulsby, 
1956).  The most common genera of GIN cited as infecting cattle globally are 
Ostertagia, Cooperia, Nematodirus, Trichostrongylus and Haemonchus, together 
with the bovine lungworm, Dictyocaulus viviparus (Armour, 1989).  Within Western 
Europe, the most prevalent GIN species are the abomasal nematode Ostertagia 
ostertagi and small intestinal-dwelling species, Cooperia oncophora (Parkins et al., 
1990).  The GIN species can be host specific, such as O. ostertagi, or infect a variety 
of ruminants, for example, C. oncophora (Stoll, 1936), or Trichostrongylus axei 
(Kates, 1965).  The life cycles of all these nematodes are similar, regardless of host 
specificity or parasite predilection site (Kates, 1965). 
 
1.1.1 General life cycle of trichostrongylid nematodes 
Female adult nematodes produce eggs, which are passed out in faeces of infected 
hosts onto pasture.  Trichostrongyle eggs are comprised of three layers: a thick outer 
layer, which is comprised of remnant material from the lining of the uterus; a 
chitinous layer, which is strong and responsible for the ability of nematode eggs to 
survive in challenging environments; and a vitelline layer, containing lipoprotein, 
believed to have the ability to exclude harmful substances from the inner part of the 
egg, thus protecting the developing larva (Anya, 1976; Patel, 1997).  First stage 
larvae (L1) develop within the egg, and are thus protected from environmental 
  Chapter 1 
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stresses.  Under temperate conditions, L1 develop and hatch within 24 to 48 h, 
although this can occur more slowly under cooler conditions.  The L1 feed on 
bacteria and protozoa contained in the faecal pat (Soulsby, 1982) and moult to second 
stage larvae (L2), which moult to third stage larvae (L3), the infective stage.  
Development from egg to L3 can occur within 10-14 days of the eggs being passed in 
faeces in temperate regions (Armour, 1970). The L3 retain the cuticle of the L2 as a 
sheath to provide protection against dehydration and UV radiation and migrate out of 
the faecal pat (Armour, 1970).  Once on pasture, L3 require a film of water to survive 
in the environment (Anya, 1976).  They migrate up grass blades, where they are 
available to be ingested by grazing cattle.  Following ingestion, L3 shed the sheath.  
Exsheathment sites are species-specific, for example, O. ostertagi larvae exsheath in 
the rumen (Frankena, 1987), whereas C. oncophora have been shown to exsheath in 
the abomasum (Frankena, 1987).  Once exsheathed, larvae move through the 
alimentary tract to the predilection site.  The predilection site varies between species, 
with O. ostertagi, H. placei and T. axei (amongst other species) in the abomasum and 
other species, for example, C. oncophora, in the small intestine (Anderson et al., 
1965a).  Exsheathed O. ostertagi L3 enter gastric glands of the abomasum, where 
they undergo two moults, before fifth stage larvae (L5) emerge onto the surface of the 
mucosa.  Alternatively, in the abomasal glands, larvae enter a period of inhibition,  
known as hypobiosis (Gordon, 1970), where early fourth stage larvae (EL4) slow 
development for up to six months before the life cycle continues as described above 
(Armour, 1970).  The exact factors involved in hypobiosis and re-emergence to 
development are unknown and have been postulated to be due to a combination of 
environmental and host-mediated factors (Ritchie et al., 1966).  Exsheathed C. 
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oncophora L3 do not enter the crypts of the small intestine, but instead, coil around 
villi of the small intestine, and are also thought to undergo inhibited development at 
the EL4 stage (Armour, 1980).  The larvae then moult to fifth-stage larvae (L5) 
followed by a final moult to adult nematodes, which mate and the females produce 
eggs (Soulsby, 1982).  Under experimental conditions, the pre-patent period for O. 
ostertagi has been reported to be between 18 and 23 days, with the pre-patent period 
for C. oncophora to be between 11 and 14 days (Wood et al., 1995).  
1.1.2 Pathogenesis of GIN in cattle  
Parasitic gastroenteritis (PGE) is one of the most important causes of production loss 
in livestock worldwide, particularly in calves in their first grazing season (Eysker and 
Ploeger, 2000).  This can be the result of clinical symptoms such as diarrhoea, 
oedema, anaemia and anorexia, or may due to subclinical effects, with reduced daily 
weight gain and ill-thrift (Eysker and Ploeger, 2000).  Infections in older cattle may 
result in reduced milk yields or fertility losses (Gross et al., 1999).  Multi-species 
infections are common, particularly with O. ostertagi and C. oncophora and the 
pathogenicity of O. ostertagi is considered a more serious threat to health than the 
more prolific species, C. oncophora (Michel, 1963; Anderson et al., 1965b; Michel, 
1968; Armour et al., 1969a, b; Michel, 1969d, c; Michel and Lancaster, 1970; Michel 
et al., 1970b; Armour, 1974; Michel et al., 1978a; Armour and Duncan, 1987; 
Armour, 1989; Taylor et al., 1989; Parkins et al., 1990).    
  1.1.3 Infection with Ostertagia ostertagi (Ostertagiosis) 
As indicated above, the most economically important GIN in temperate regions is O. 
ostertagi, and is most commonly associated with the symptoms of PGE, although all 
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GIN species contribute to this syndrome and its associated production losses 
(Bairden and Armour, 1981).  Clinically, ostertagiosis is characterised by diarrhoea, 
oedema, weight loss, and hypoalbuminaemia, which can result in mortality (Armour, 
1970).  Epidemiologically, the disease can manifest in one of two ways; this was first 
described in 1965 after examination of a number of PGE cases in Scottish cattle 
where O. ostertagi was observed at post mortem (Anderson et al., 1965a).  First, 
Type I ostertagiosis is an acute, relatively high morbidity syndrome observed in 
summer, usually from mid-July onwards, in first season-grazing calves (FSG) as a 
result of ingestion of substantial numbers of L3.  It is characterised by green, profuse 
and watery diarrhoea, and is often, but not always, accompanied by high faecal egg 
counts (for example, in excess of 1,000 eggs per gram of faeces), thirst, weight loss 
and anorexia (Anderson et al., 1965a).  Type II disease occurs in older calves, in the 
late winter or early spring following their first grazing season.  Disease is seen due to 
the maturation and emergence of hypobiotic larvae from the abomasal gastric gland, 
with higher levels of hypoalbuminaemia than observed in Type I disease (Armour, 
1970).  Type II disease typically has a lower prevalence of disease; however, it has 
been shown that pathophysiological changes can be seen in calves at post mortem 
without evidence of acute clinical disease occurring (Taylor et al., 1989).  Both 
forms of the disease are associated with weight loss and poor productivity, partially 
attributable to the damage to the abomasal surface due, described morphologically as 
a ‘morocco leather” effect due to the distinctive surface nodules induced in response 
to the larvae and their re-emergence (Ritchie et al., 1966) (Figure 1)   
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Figure 1: Distinctive nodules observed in Ostertagia ostertagi infections (28 days post-infection) 
associated with larval re-emergence from the gastric glands.  (Photo provided courtesy of Dr 
David Bartley, MRI) 
Growth in, and emergence from, the gastric glands results in damage to parietal cells, 
responsible for the production of hydrochloric acid (Simpson, 2000; Mihi et al., 
2013).  The resultant reduction in acidity in the abomasum, and associated increase 
in pH (to above 7), results in a failure to convert pepsinogen to pepsin, and greater 
numbers of bacteria in the abomasum (Murray and Jennings, 1970).  Physical 
damage, due to worm movement also leads to the abomasal mucosa becoming more 
permeable, resulting in increased pepsinogen levels in plasma, plasma proteins 
leaking into the abomasum (leading to a protein-losing gastropathy) and the onset of 
the clinical symptoms (Armour, 1970).     
1.1.4 Infection with Cooperia species  
In comparison to the pathogenicity observed with ostertagiosis, pathology associated 
with intestinal species such as Cooperia, is considered to be relatively low (Keymer, 
1982).  Cooperia spp. do not encyst in glands but coil around intestinal villi.  This 
can cause widespread villous atrophy in heavy infections and a subsequent loss of 
brush border enzymes and digestive disturbance (Armour et al., 1987).  The 
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Cooperia spp. which infect cattle include Cooperia punctata, Cooperia pectinata, 
Cooperia oncophora and Cooperia  surnabada, of which C. pectinata is believed to 
be the most pathogenic as it has been found to enter the small intestinal mucosa 
(Herlich, 1965b).  Cattle infected with Cooperia spp. have a catarrhal enteritis and 
thickening of the gut mucosa (Bailey, 1949).  In other studies, although not generally 
associated with anaemia, a mucosal pallor has also been reported (Herlich, 1965a).  
Although C. oncophora has been presumed to be largely non-pathogenic (Coop et 
al., 1979), it has been demonstrated that co-infection of this species with O. ostertagi 
can augment poor productivity, inappetence, and has been considered a contributory 
factor to the effects of PGE in the field (Rose, 1968; Hawkins, 1993; Ploeger and 
Kloosterman, 1993).  Production losses have been recorded in a number of studies 
when cattle have been infected monospecifically with Cooperia spp.  For example, a 
13.5% reduction in live weight gain was observed over a period of 20 weeks when 
non-infected calves were compared to calves infected with C. oncophora, despite no 
obvious signs of pathology or clinical symptoms (Coop et al., 1979).    
1.1.5 Epidemiology of GIN infection in cattle 
Over the course of a typical grazing season, C. oncophora has been reported as being 
responsible for contributing up to 80% of the nematode eggs contaminating pasture 
and as immunity develops, the majority of adult C. oncophora have been shown to 
be expelled from the host (Albers, 1981).  In contrast, O. ostertagi has been shown to 
exhibit a lower peak in egg output and this is usually observed later in the grazing 
season than C. oncophora (Michel et al., 1970b).  The longevity of infective L3 on 
pasture is a contributing factor to the severity of GIN infections (Michel, 1969a).  
Larvae can migrate down into soil to avoid adverse environmental conditions and 
  Chapter 1 
  16 
have been detected at depths of 12.5 cm (Fincher and Stewart, 1979).  Whilst a high 
degree of mortality is thought to occur over winter, given a suitably moist 
environment, viable L3 have been recovered from herbage up to two years on rested 
pastures following grazing by infected calves (Rose, 1961).  Studies in Canada 
demonstrated that O. ostertagi and C. oncophora L3 can survive under snow cover in 
sufficient numbers to cause clinical parasitism in the following grazing season 
(Smith and Archibald, 1969; Slocombe, 1974).  The time taken for infective L3 to 
develop from eggs has been shown to be longer over winter months, taking up to 20 
weeks to develop, in comparison to approximately 3 weeks observed during the UK 
grazing season, from April to October (Rose, 1961, 1962).  It has been hypothesised 
that faeces on pasture can act as a reservoir for L3 and L3 levels peak when the faeces 
disintegrate, which is speeded by rainfall and physical disturbance (Michel and 
Lancaster, 1970).  This means that eggs passed out in the previous grazing season 
can still provide sufficient contamination for susceptible calves to be infected when 
turned out onto pasture the following season.  Such susceptible calves show a peak in 
faecal egg counts from 3 weeks onwards, providing greater pasture contamination 
later in the grazing season which is usually associated with the signs of clinical 
disease in affected animals (Michel, 1963). 
Given the perceived differences in pathogenicity between O. ostertagi and C. 
oncophora, it would be expected that reports of PGE would identify the prevalence 
of species present in each case.  However, reporting of PGE in surveillance reports 
rarely identifies the species of GIN involved.  As can be seen from the data reported 
in Figure 2, the majority of cases referred for pathological examination were not 
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attributed to one species, indicative that a mixed infection may be present.  
Approximately 10% of referred cases were attributable to infection with O. ostertagi, 
with the highest percentage recorded in 1996 (26% of submitted cases) and the 
lowest recorded in 2001 (2%).  
 
 
Figure 2: Percentage data of bovine PGE cases attributed specifically to ostertagiosis reported 




2014).   
1.1.6 Development of immunity 
In GIN infections, immunity was shown to be induced in a dose-dependent manner 
(Armour, 1970). It has been stated that, in the field, natural immunity develops over 
the course of two grazing seasons.  Immunity to C. oncophora has been reported to 
develop within the course of a grazing season, and if exposure to C. oncophora is 
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removed, for example, by housing over the winter months, immunity is quickly re-
established upon re-exposure in the next grazing season (Kanobana et al., 2004).  
Immunity to infection with O. ostertagi develops slowly in the field and is generally 
accepted to develop by the end of the second grazing season (Armour and Duncan, 
1987).  This delay and the potential for reinfection during this period has been 
established O. ostertagi as the most economically important cattle nematode 
(Sonstegard and Gasbarre, 2001). Immunity against GIN can manifest in a variety of 
ways.  First, there is a reduction in parasite fecundity, with fewer eggs produced from 
female worms and passed out to pasture (Michel, 1963).  The reduction in eggs 
produced seems to be a successive downward trend, with each generation of 
nematodes producing fewer eggs than nematodes in the previous generation (Michel, 
1963).  This is important epidemiologically as pasture contamination will reduce 
from a given animal over time following exposure, and is important in clinical 
assessment, as low faecal egg counts may be observed in animals that still have 
substantial adult worm burdens (Kanobana et al., 2004).  Stunting of nematode 
length also occurs (Kanobana et al., 2004) as well as direct expulsion of nematodes 
and reductions in establishment of newly acquired infections (Armour, 1980; 
Vercruysse and Claerebout, 1997).  
 
1.1.7 Economic effects of GIN infection 
It is difficult to ascertain precise figures for economic losses attribute able to GIN 
infection alone, particularly in the case of sub-clinical disease, where veterinary 
intervention is often not sought, but losses in production occur (Hawkins, 1993).  
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Attempts to survey farmers to estimate losses per annum have had limited success; in 
a US survey, less than half the respondents were willing to place a figure on the cost 
of parasite infection per head of cattle, with over a third feeling they were unable to 
accurately judge the extent of infection on their farm (Gasbarre et al., 2001). Those 
that did, estimated the cost to be $1 - $200 per cow per annum, with the majority of 
respondents estimating a loss of between $5 and $20 per cow each year (Gasbarre et 
al., 2001).  This figure did not take into account the cost of anthelmintic applications, 
nor any additional feed rations required to ensure that target weight gain was 
achieved (Gasbarre et al., 2001).  To provide any sort of meaningful figure for the 
producer, individual farm conditions should be considered, together with factors such 
as carcass price, reproductive performance and feed conversion rates (Hawkins, 
1993).  Production losses are not limited to losses observed with sub-optimal 
slaughter weights.  Within the EU, nematode infections have been associated with 
reduced conception rates in second season grazing calves, longer intervals between 
calving and conception in adult cattle, both of which can impinge on the profitability 
of farming (Forbes, 2008). Also, infection with nematodes has been shown to 
significantly reduce milk yields in adult dairy cattle, by 0.63 kg per day, in 
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1.2 Treatment of parasitic nematodes in cattle 
1.2.1 Anthelmintic products prior to 1960 
 
Prior to the development of broad spectrum anthelmintics in the latter half of the 20
th
 
Century, control of GIN relied upon a variety of chemicals such as arsenic 
derivatives, nicotine sulphate, copper sulphate and carbon tetrachloride; however, 
issues with efficacy, toxicity and spectrum of activity were inherent with each of 
these (McKellar and Jackson, 2004).  Advances were made with the development of 
phenothiazine, where doses of 50 to 80 grams were observed to be 100% effective 
against Haemonchus spp., and 80 to 97% effective against O. ostertagi (Swanson et 
al., 1940).  However, limited efficacy was observed against C. oncophora, and when 
the dose was increased, toxicity (in the form of blindness and corneal ulceration) was 
observed, and little reduction in C. oncophora faecal egg count was found (Riek, 
1951).  An organophosphate compound “Neguvon” (Dipterex, Bayer Ltd) was 
reported to be highly successful in reducing numbers of adult O. ostertagi and in 
controlling an outbreak of ostertagiosis in cattle in Western Australia; however, 
atropine had to be administered to several animals to combat the symptoms 
associated with toxicity with this chemical (Banks and Mitton, 1960).   
   
1.2.2 Development of broad spectrum anthelmintic classes 
 
1.2.2.1 Benzimidazoles 
The benzimidazoles (BZ) represented the first class of modern broad spectrum 
anthelmintics and were developed in the 1960s (Brown et al., 1961).  These products 
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showed considerably higher levels of efficacy, together with a wider spectrum of 
activity and high levels of safety in comparison to the previous anthelmintics 
(Barragry, 1984).  Efficacy is attributed to the selective ability of BZs to bind to 
nematode β-tubulin, which in turn, results in depolymerisation of microtubules and 
instability of the nematode cytoskeleton (Lacey, 1988; Lespine et al., 2012).  In 
addition to affecting adult and immature worms by interfering with tubulin binding 
in intestinal cells and preventing uptake of glucose, BZs possess ovicidal qualities 
(Martin, 1997; Winterrowd et al., 2003).  In the case of thiabendazole (TBZ), 
inhibition of fumerate reductase activity results in starvation of the nematode, due to 
the disruption of the parasite metabolic processes (Prichard, 1973).  Fenbendazole is 
the BZ product currently licensed for use in cattle in the UK in the form of oral 
drenches; an intra-ruminal bolus where an aluminium core is inserted per os and 
corrodes to release discs of anthelmintic over time or as an in-feed mix (NOAH, 
2014).  Boli provide anthelmintic coverage for periods of up to 140 days and are 
usually administered early in the year to provide protection throughout the grazing 
season (Coles, 2002).  
 
1.2.2.2 Imidazothiazoles  
Following the success of the BZ anthelmintics, the next group of broad spectrum 
anthelmintics to be developed was the imidazothiazoles/tetrahydropyrimadine group 
in the late 1960s (Turton, 1969).  Of these compounds, levamisole (LEV) was 
developed for use in sheep and cattle.  An injectable formulation of LEV was shown 
to exhibit high efficacy against adult O. ostertagi and all stages of C. oncophora 
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(Rubin and Hibler, 1968; Turton, 1969).  Unlike BZs, LEV is not ovicidal and acts 
on acetylcholine receptors within the nematode, resulting in a spastic paralysis 
(Martin and Le Jambre, 1979).  It is thought that receptor desensitization may occur 
when high concentrations of LEV are administered, and so increasing dose rates to 
achieve greater efficacy was not recommended, particularly as LEV also acts as a 
nicotinic agonist in mammals and so has a lower therapeutic safety index than BZs 
(McKellar and Jackson, 2004).  LEV is currently only available in the UK for use in  
cattle as an oral drench, and no products are currently licensed for use in cattle 
producing milk for human consumption (NOAH, 2014).  However, a dermal 
application method was developed in Australia as a topical pour-on solution, applied 
directly to the hair (Brooker and Goose, 1975), a method noted for its ease of use and 
convenience (Bogan and Armour, 1987).  The kinetics of LEV absorption through 
the skin are not well documented, but similar levels of efficacy were observed 
between oral, injectable and pour-on administration routes previously (Bogan and 
Armour, 1987). However, lower absorption and efficacy levels than expected have 
been observed when LEV pour-on preparation was administered in winter months 
(Forsyth et al., 1983).   
1.2.2.3 Macrocyclic lactones 
The third broad spectrum anthelmintic class to be developed is the most successful 
developed to date.  Avermectins (such as ivermectin, IVM, and eprinomectin) and 
milbemycins (such as moxidectin, MOX, doramectin) form the macrocyclic lactone 
(ML) class, the most used class worldwide, due to high potency, safety index and 
spectrum of activity against ectoparasites and endoparasites (Campbell, 1981; 
González Canga et al., 2009).  The chemicals, in particular MOX, are highly 
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lipophilic and have a persistent action (Campbell and Benz, 1984).  Both families 
contain a fused cyclohexene-tetrahydrofuran ring system, a bicyclic 6,6-membered 
spiroketal, and a cyclohexene ring fused to the 16-membered macrocyclic ring 
(Zulalian et al., 1994).  These compounds exert rapid flaccid paralysis and prevention 
of pharyngeal pumping within GIN (Wolstenholme and Rogers, 2005), and work 
conducted on filarial parasites indicates a further role in reducing reproductive 
activity (Wolstenholme and Rogers, 2005).  The paralysis is, in part, thought to be 
due to the action of MLs on glutamate gated chloride (GluCl) channels (Sutherland 
and Campbell, 1990; Martin, 1997).  MLs irreversibly bind to the GluCl channel, 
allowing an influx of chloride ions into nematode neuron cells, resulting in 
hyperpolarisation and paralysis of the parasite (Arena et al., 1991; Cully et al., 1994; 
Wolstenholme and Rogers, 2005).  In addition to the binding of GluCls, MLs have 
also been shown to act on nematode muscle cells, by enhancing the conductance of 
the neurotransmitter gamma amino butyric acid (GABA) (Afzal et al., 1994; 
Brownlee et al., 1997; Feng et al., 2002).  IVM has also been shown to be a substrate 
of P-glycoproteins (P-gp), transmembrane protein pumps in nematodes (Sangster et 
al, 1994).  This is thought to be the main reason why ML compounds are not toxic to 
most mammals because these pumps are important transmembrane transporters at the 
blood-brain barrier (Mealey et al., 2001). 
1.2.2.3.1 Ivermectin 
Avermectins, including IVM, are derived from the fermentation products of 
Streptomyces avermitilis.  This bacterium can generate four pairs of closely related 
compounds; avermectin A1a, A1b, A2a, A2b, B1a, .B1b, B2a and B2b (Campbell, 1989).  
Modification of the structure of avermectin products can affect the potency and 
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spectrum of efficacy of the resulting derivatives (Egerton et al., 1980): this has led to 
the further development of derivative B1a and B1b  (Burg et al., 1979) as the product 
IVM. Commercially available IVM contains at least 80% of 22,23-
dyhydroavermectin B1a and less than 20% of 22,23-dihydroavermectin B1b).  IVM 
was first registered for use as a broad spectrum anthelmintic in cattle in 1983 and has 
since become one of the most widely used animal health products worldwide 
(Prichard and Ranjan, 1993) and considered to be the pinnacle of anthelmintic 
development in the 20
th
 Century (Geary et al., 2004).    
 
1.2.2.3.2 Moxidectin 
Moxidectin is a semi-synthetic derivative milbemycin of another endectocide, 
nemadectin (Asato and France, 1990).  Milbemycin was originally derived from 
Streptomyces cyanogriseus in a sample of red sand in 1983 (Ranjan et al., 1992; 
Alvinerie et al., 1998) and was registered for use as an anthelmintic for cattle in the 
early 1990s (Prichard and Ranjan, 1993).  MOX is structurally different from IVM in 
three ways; it lacks a sugar moiety at the C-13 position, has a characteristic 
methoxime moiety at C-23 and has an unsaturated side chain at C-25 (Zulalian et al., 
1994), resulting in a product that is 100 times more lipophilic than IVM.  Due to this 
increased lipophilic nature, MOX has a longer half-life in host fat compared to IVM 
(Bassissi et al., 2004). 
1.2.2.3.3 Doramectin and eprinomectin 
In addition to IVM and MOX, eprinomectin was developed and is particularly used 
in dairy cattle in the UK, due to a zero day milk withdrawal period, a characteristic 
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unique within this class, due to the portioning between milk and plasma. It is only 
available as a pour-on formulation (Shoop et al., 1996).  Doramectin was developed 
around the same time as MOX, with the aim to control the dose-limiting Cooperia 
species, as the dose-limiting species for this compound was shown to be the 
relatively rare, Nematodirus helvatianus, in addition to the persistency of this 
compound in the host (Jones et al., 1993) 
1.2.2.3.4  Macrocyclic lactone application methods 
After initial development as oral suspensions, an oral boli and subcutaneous 
injectable formulations, MLs were developed as pour-on applications for cattle.  This 
application method is generally viewed as being the most practicable method of 
administering anthelmintics due to reduced animal handling time and reduced risk of 
injury to handlers (Bogan and Armour, 1987; González Canga et al., 2009).  The 
application method has the added benefit of avoiding ML metabolism by the liver 
and so allowing greater systemic bioavailability (Sallovitz et al., 2002).  Pour on 
anthelmintics are applied along the mid dorsal skin and are absorbed from there.  
Dose rates are higher than those of injectable and oral formulations to give 
equivalent levels of efficacy (Leathwick and Miller, 2013); however, a number of 
concerns have been raised about the use of pour-on applications, especially as a 
number of factors have been shown to affect efficacy.  These include animal breed 
differences (Sallovitz et al., 2002), hair coat length (Sargison et al., 2009), 
environmental and husbandry parameters, such as season of treatment (Forsyth et al., 
1983); rainfall (Rehbein et al., 1999; Skogerboe et al., 1999) and the action of 
animals licking each other after treatment (Bousquet-Mélou et al., 2011).  It has also 
been indicated that minor changes to ML disposition (for example, through changing 
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the  application vehicle or excipient used to deliver the anthelmintic) can affect 
efficacy (Lanusse et al., 1997). 
1.2.3 Anthelmintic efficacy at the time of product 
development  
1.2.3.1 Efficacy of benzimidazole products 
Thiabendazole efficacy against adult O. ostertagi was generally found to be greater 
than 99% effective in reducing adult worm burden in treated compared to untreated 
calves (Rubin et al., 1965).  However, efficacy of only 55% was reported against O. 
ostertagi L4 (Rubin et al 1965).  Conversely, greater efficacy was observed against C. 
oncophora L4 (92% reduction in worm burden) compared to adult C. oncophora 
(78% reduction) (Rubin et al., 1965).  It was concluded that, compared with the 
anthelmintic products that predated its release, thiabendazole was more effective at 
controlling most parasitic nematode species (Hotson, 1963; Rubin et al., 1965).  
However, a later study observed thiabendazole efficacy was 72.3% against O. 
ostertagi L4 compared to that of 100% efficacy with fenbendazole (FBZ) (Callinan 
and Cummins, 1979).  Further work looking at the effect of these compounds on 
inhibited stages of O. ostertagi revealed inconsistent efficacies of BZs: these 
differences have been attributed to small group sizes and different isolates of O. 
ostertagi used in the experimental studies (Duncan et al., 1976, 1977; Williams, 
1991) (Duncan et al., 1976, 1977; Duncan et al., 1978).  The general consensus 
regarding efficacy of FBZ against inhibited O. ostertagi is further confused by the 
information provided on product data sheets, with most currently available in the UK 
stating BZ products are “usually effective” with no further explanation of the level of 
efficacy (NOAH, 2014).  
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1.2.3.2 Efficacy of levamisole 
Pour-on applied LEV was shown to exert 100% efficacy against adult O. ostertagi 
and C. oncophora in one study (Brooker and Goose, 1975); however, later 
experiments found that efficacy varied between the nematode species, with 92–97% 
efficacy documented against O. ostertagi adults and 99-100% efficacy measured 
against C. oncophora adult worms (Guerrero et al., 1984).  No significant reduction 
in the numbers of O. ostertagi or C. oncophora L4 were observed in LEV treated 
calves compared to untreated control animals (Guerrero et al., 1984). These findings 
are similar to those documented in other studies (Callinan and Cummins, 1979; 
Williams, 1991).    
 
1.2.3.3 Efficacy of macrocyclic lactones 
1.2.3.3.1 Efficacy of ivermectin  
Levels of efficacy observed against O. ostertagi and C. oncophora exceeded 95% 
reduction in adult worm burdens in many studies in the development of IVM 
(Armour et al., 1980; Alva-Valdes et al., 1984; Alva-Valdes et al., 1986).  Despite 
these data, C. oncophora is considered the dose-limiting species for ML 
anthelmintics (Egerton et al., 1979; Egerton et al., 1981) and, generally, higher 
concentrations of anthelmintic are required to kill > 95% of all nematode stages, in 
comparison to other species (Ranjan et al., 1992; Scholl et al., 1992).  The persistent 
effect of ML products is shorter against Cooperia spp. compared with other genera 
(Williams et al., 1997).  In one study where an IVM pour-on formulation was studied 
on 15 farms in Australia with no previous use of IVM, the percentage reduction in 
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faecal egg count was variable against Cooperia spp. (Eagleson and Allerton, 1992).  
Reduction in FEC was greater than 95% on six farms; however, between 30% and 
93% reductions were observed on the remaining farms and, in all cases, 
predominantly Cooperia spp., were present in post treatment samples (Eagleson and 
Allerton, 1992).  The survival of C. oncophora in nematode populations that were 
previously not exposed to IVM was also observed in New Zealand, prompting 
speculation that Cooperia spp., may possess mechanisms to better tolerate ML 
compounds than species such as O. ostertagi (Bisset et al., 1990; McKenna, 1995).   
1.2.3.2.2. Efficacy of moxidectin 
Cooperia spp. are also recognised as the dose-limiting species for MOX (Scholl et 
al., 1992), as revealed in studies in which MOX, administered at the recommended 
dose rate, reduced adult male C. oncophora by 94%, in comparison to > 99% 
efficacy achieved against adult O. ostertagi (Ranjan et al., 1992).  Whereas excellent 
efficacy (>99%) against C. oncophora has been reported in some studies (Williams 
et al., 1992), a later report found the percentage reduction in FEC 14 days after 
administration varied between 85 and 94% (Whang et al., 1994).  Moxidectin has 
been shown to have a more persistent effect in the host system than IVM, indicating 
a use in reducing parasite contamination on pasture (Geurden et al., 2004),   It has 
been suggested that the efficacy of MOX depends on the location of the nematode in 
the host and that this anthelmintic is not as effective against small intestinal species 
compared with abomasal species, due to the lower amounts of MOX residues found 
in small intestinal tissues compared to the abomasum (Eysker and Eilers, 1995).  
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1.3 Detection and characterisation of anthelmintic 
resistance 
1.3.1 Anthelmintic resistance  
Anthelmintic resistance can be defined as a heritable reduction in the sensitivity of an 
originally susceptible parasite population to the action of an anthelmintic compound 
(Conder and Campbell, 1995).  With continued reliance on anthelmintics for parasite 
control, the threat of parasites developing resistance increases.  As nematode 
populations are diverse, when individuals able to tolerate a standard drug 
concentration survive and reproduce, resistance alleles become more prevalent 
within the population and resistance to the anthelmintic emerges (Prichard, 1990).   
1.3.2 In vivo methods to detect anthelmintic resistance 
There are currently only two in vivo methods, which have been recommended for the 
detection of anthelmintic resistance in cattle nematodes.  These are the controlled 
efficacy test and the faecal egg count reduction test.  
 
1.3.2.1 Controlled Efficacy Test 
The controlled efficacy test (CET) is described by the World Association for the 
Advancement of Veterinary Parasitology (WAAVP) as the ‘gold standard’ for 
determining the presence of anthelmintic resistance in helminths of a variety of 
animal species (Powers et al., 1982; Coles et al., 1992; Wood et al., 1995).  It is the 
most reliable test of efficacy and can be used for virtually all anthelmintics, 
nematode and host species (Coles et al., 2006).  Experimental animals are either 
naturally infected through grazing pasture, or are experimentally infected with an 
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inoculum of infective larvae which is deemed sufficient to yield a patent infection, 
but not so great as to cause clinical disease (Wood et al., 1995).  In brief, the 
techniques assess the efficacy of a compound to remove nematode infections from 
treated animals compared to untreated infected control animals.  If the objective is to 
examine anthelmintic efficacy based on effects on adult nematodes, animals are 
treated at approximately 28 days following infection (i.e. once infection is deemed to 
be patent by the presence of nematode eggs in the host faeces).  Animals are 
grouped, with one group administered anthelmintic at the recommended dose rate, 
and the remaining group untreated (Powers et al., 1982).  The animals are then 
necropsied seven days later and the surviving adult worms recovered, enumerated 
and compared between the groups.  Originally, the WAAVP considered 
anthelmintics with an efficacy of greater than 90% to be considered “highly 
effective” (Powers et al., 1982); however, with the advent of more efficacious 
products (such as the MLs), this threshold was increased to 98% (Wood et al., 1995).  
Where anthelmintic efficacy is expected to be greater than 99% in a susceptible 
nematode population, anthelmintic resistance is confirmed when less than a mean 
95% reduction in the adult nematode burden is observed in treated animals in 
comparison to burdens enumerated in the control group (Coles et al., 2006).  As this 
test requires the use of experimental animals, time, labour, ethical and cost 
implications need to be considered (Coles et al., 2006).  
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1.3.2.2 Faecal Egg Count Reduction Test 
The faecal egg count reduction test (FECRT) is the most widely used method of 
assessing anthelmintic efficacy as it can be utilised with naturally- or artificially-
infected animals with all classes of anthelmintics (Coles et al, 1992; 2006).  The 
premise is relatively simple, in that faecal samples are taken on the day of 
anthelmintic administration (i.e. Day 0) and WAAVP guidelines recommend that 
faecal samples be taken from animals on the day of treatment (Day 0) and at 10 to 17 
days following anthelmintic administration.  The timing of the second sampling is 
dependent on the class of anthelmintic administered, with recommendations that 
samples be taken 10 days after administration with BZ products and between 14 to 
17 days following ML administration (Coles et al., 1992).  The mean percentage 
reduction in faecal egg count (FEC) is then calculated, together with 95% confidence 
intervals.  Anthelmintic resistance is reported if the percentage reduction in FEC is 
less than 95%, and if the lower 95% confidence interval is less than 90%.  If only one 
if the above statements is true, resistance is suspected, rather than confirmed (Coles, 
et al 1992).  There are issues in following these guidelines for assessment of 
anthelmintic efficacy in cattle in that the guidelines were designed primarily for 
assessing efficacy in small ruminants and there exists a variety of methods for the 
detailing various permutations of the reduction calculation (Presidente, 1985; Dash et 
al., 1988; Coles et al., 1992; Kochapakdee et al., 1995).   
 
Ideally, FECRTs should be conducted in animals excreting a minimum of 150 eggs 
per gram (EPG) in their faeces; however, as cattle generally have lower FECs than 
sheep (Coles, et al 2006), this threshold is not always achievable.  A more recent 
  Chapter 1 
  32 
update of the guidelines (Coles et al, 2006) suggested this problem can be 
circumvented by employing a more sensitive FEC method than that of the standard 
McMaster method, which has a sensitivity of 50 EPG (Gordon and Whitlock, 1939).  
A further complication with treating cattle is the variety of anthelmintic application 
methods available and it has been suggested that when analysing FECRT results, the 
application method be acknowledged in the determination of resistance status, and a 
standardised methodology of testing cattle be established to allow a uniform and 
comparable approach to testing (Sutherland and Leathwick, 2011).  It is also difficult 
to identify surviving eggs to genus and so analysis of L3 following coproculture is 
recommended, thus requiring further time and expense as well as expertise 
identifying the larvae (West et al., 1989).  A further limitation of the FECRT is that 
FECs only provide a measure of adult female nematode fecundity and are unable to 
determine numbers of juvenile nematodes (Wood et al., 1995).  It has been shown 
that FECs do not correlate well with the actual worm burden in calves (Michel, 
1969f; Brunsdon, 1971).  It has been suggested that O. ostertagi FECs are not 
correlated with adult worm number, or the probability of developing disease, but 
instead follow a pattern which depends on the host’s immune status, rather than 
being indicative of total worm burden (Michel, 1969d).  A similar finding was found 
with mixed O. ostertagi and C. oncophora infections, where calves with FECs of up 
to 50 EPG were found to have anywhere between 1,000 and 90,000 adult nematodes 
(Brunsdon, 1971).  For these reasons, the WAAVP guidelines for use in cattle are 
currently undergoing review. 
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1.3.3 In vitro detection of anthelmintic resistance 
As the FECRT and CET have cost and labour implications, in vitro methods of 
detecting and characterising anthelmintic resistance are sought, particularly if they 
are rapid, sensitive, easily interpretable and capable of detecting resistance earlier 
than the in vivo tests (Shoop, 1993).  It has been indicated that the FECRT is only 
effective in identifying resistance once resistance alleles within a population have 
reached a prevalence of 25% (Martin et al., 1989).  The use of in vitro tests to study 
isolates of anthelmintic resistant ovine nematodes are widely documented and utilise 
different life cycle stages (Bartley, 2008); however, some tests are limited to a 
particular developmental stage or anthelmintic compound.  The egg hatch test (EHT) 
is only suitable for screening ovicidal compounds such as BZs and thiabendazole 
(TBZ) is used in the test.  The larval feeding inhibition test (LFIT) (Álvarez-Sánchez 
et al., 2005), assesses the paralysing effects of LEV and MLs on first stage larvae 
pharyngeal musculature  .  The larval development test (Amarante et al., 1984, 
Demeler et al, 2009) and larval motility test (Demeler et al., 2010b) have been used 
to characterise anthelmintic sensitivity in cattle nematode populations; however, 
none of these tests are validated for use with field populations. A test capable of 
discriminating between sensitive and resistant populations of worms, without being 
confounded by different species compositions would be of real benefit to diagnostic 
laboratories in assessing the anthelmintic sensitivity status of field populations. 
1.3.3.1 Egg Hatch Test 
The EHT is a simple bioassay for assessing BZ resistance in sheep nematode 
populations (Hall et al., 1978; Le Jambre et al., 1979; Borgsteede et al., 1992; Von 
Samson-Himmelstjerna et al., 2009).  This test has been assessed to a lesser degree 
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for its utility in assessing anthelmintic sensitivity in cattle nematodes (Demeler et al., 
2010b).  In brief, freshly extracted nematode eggs are incubated in varying 
concentrations of TBZ and deionised water for 48 h.  As TBZ is ovicidal, eggs from 
BZ resistant isolates hatch at higher drug concentrations compared to BZ sensitive 
isolates (Coles and Simpkin, 1977).  The comparison of BZ concentrations that 
prevent 50% of eggs from hatching (ED50 estimate) are then used to compare 
populations.  It has been cited that ED50 estimates of >0.1 g ml
-1
 indicate BZ 
resistance, but this remains to be validated (Coles et al., 1992) (Coles et al., 2006) 
and there are no defined ED50 threshold estimates for use of the test with cattle 
nematodes, particularly in the case of mixed species isolates (Demeler et al., 2012).  
Furthermore, as the test is only suitable for the detection of BZ resistance, its 
usefulness is limited in the UK where ML use is far more common (Barton et al., 
2006).      
 
1.3.3.2 Larval Migration Inhibition Test  
The LMIT, first described in 1979 (Martin and Le Jambre, 1979) is a promising 
candidate for optimisation with mixed species field isolates of cattle nematodes.  It 
works on the basis of exposing L3 to a range of ML concentrations and assessing the 
ability of the larvae to migrate through a mesh of set pore size.  The percentage 
migration is calculated and a dose response curve generated, the results of which are 
extrapolated to give the concentration of ML required to prevent 50% of the larvae 
from migrating (Wagland et al., 1992).  The LMIT has been optimised for mono-
specific isolates of O. ostertagi and C. oncophora.  Optimisation was conducted 
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using IVM susceptible (IVM-S) and IVM resistant (IVM-R) C. oncophora isolates, 
and with BZ susceptible (BZ-S) and resistant (BZ-R) isolates of O. ostertagi as 
assessed by FECR (Demeler et al, 2010a).  As yet, the LMIT has not been optimised 
for use with mixed nematode species isolated; however, it has been found to be 
reproducible across different laboratories when used with single species (Demeler et 
al, 2010b).  
 
1.3.4 Prevalence of anthelmintic resistance  
Anthelmintic resistance in small ruminant nematodes has been well documented 
worldwide, with resistance to BZs, LEV and MLs widespread, and in some places, 
such as the UK, resistance to all three classes in single populations has been 
identified (Bartley et al., 2004; Sargison et al., 2005).  Although not reported to the 
same extent as in sheep and goats, anthelmintic resistance in cattle nematodes has 
been reported, particularly with MLs (Sutherland and Leathwick, 2011).  The first 
case of anthelmintic resistance in cattle nematodes was reported in New Zealand, 
with C. oncophora resistance to oxfendazole (Jackson et al., 1987).  The first case of 
ML resistance was reported in 1995, regarding C. oncophora in New Zealand 
(Vermunt et al., 1995, 1996).  In some cases, in particular, in New Zealand and the 
US, multiple resistance to BZ and ML classes in the same population of Cooperia 
and Ostertagia species have been detected (Waghorn et al, 2008; Gasbarre et al, 
2009a, 2009b).  Researchers in Argentina and Brazil have observed resistance to all 
three anthelmintic classes in Ostertagia, Cooperia, Haemonchus and 
Oesophagostumum populations (Anziani et al., 2004; Soutello et al., 2007).  Within 
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Europe, several studies have documented ML resistance in C. oncophora (Demeler et 
al., 2009; El-Abdellati et al., 2010), with also a report of LEV resistance in O. 
ostertagi in Belgium (Geerts et al., 1987).  
The first case of anthelmintic resistance in UK cattle was reported in 1999, when 
IVM resistance was confirmed in an isolate of C. oncophora (Stafford and Coles, 
1999).  Since then, there have been few observations of treatment failure and 
inefficacy following administration of pour-on MLs; however, no large scale surveys 
have been conducted (Sargison et al, 2009, 2010; Orpin, 2010; Stafford et al, 2010).  
 
1.3.5 The selection of anthelmintic resistant nematodes 
Unless an anthelmintic is 100% effective, with every application that is administered, 
selection for resistant nematodes will occur (Prichard, 1990).  The use of 
anthelmintic products has altered over the past 60 years, in that the majority of 
anthelmintics were once given to treat the clinical symptoms of parasitism, whereas 
practices moved towards prophylactic treatment to prevent clinical disease (Michel, 
1985).  Selection for anthelmintic resistance is an inevitable consequence of 
anthelmintic use, being a heritable trait which obeys the laws of Mendelian genetics 
(Sangster, 1999).  Anthelmintic resistance generally begins with a small number of 
nematodes surviving anthelmintic administration, which reproduce and give rise to 
resistant progeny.  Over time, with repeated treatments with the same chemical the 
number of resistant alleles within the population increases up until the point where 
treatment failure is observed (Prichard et al., 1980).  There are clear indications that 
the development of anthelmintic resistance is associated with the frequency of 
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administration (Armour and Bogan, 1982) and with certain management practices, 
such as under-dosing (Prichard, 1990) or moving cattle to clean grazing (not grazed 
by cattle in the preceding 12 months) immediately after anthelmintic administration, 
a process known as “dose and move” (Michel, 1969b; Eysker et al., 1998).  By 
moving cattle to clean grazing immediately after anthelmintic administration, mostly 
resistant nematodes will contribute to the next generation, instead of being diluted by 
more susceptible worms already (Prichard, 1990).  Currently, parasite management 
strategies employed by UK cattle farmers are unknown, and so changes to control 
practices, for example co-grazing or rotational grazing with sheep, are difficult to 
advise without knowing what is currently happening on farms.  
 
1.3.6 Genetic mechanisms associated with anthelmintic 
resistance 
Benzimidazole resistance in ovine nematodes has been associated with a single 
nucleotide polymorphism (SNP) at position 200 on the β-tubulin isotype-1 gene in C. 
elegans and H. contortus (Kwa et al., 1994). However, this mutation was not 
consistently observed when a BZ-resistant C. oncophora isolate was examined 
(Winterrowd et al., 2003).  A second study also failed to consistently identify a SNP 
at this site (Njue and Prichard, 2004b).  Other studies in ovine and equine nematodes 
have implicated SNPs for BZ resistance at codons 167, 198 and or 200 in the isotype 
1 -tubulin gene (Kwa et al., 1994).   
Whilst LEV is not widely used in cattle, a potential marker has been identified in the 
down regulation of nicotinic acetylcholine receptor gene, unc-63a in two LEV-
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resistant isolates of adult H. contortus (Sarai et al., 2013). However, this was not 
observed in a third resistant isolate, indicating resistance may be multigenic in nature 
(Sarai et al., 2013).   
Potential mechanisms behind ML resistance, in particular IVM resistance, have been 
primarily explored in ovine nematodes.  Since the 1990s, work has been conducted in 
two main areas, focusing on the GluCl channels and ABC transporter P-
glycoproteins (Arena et al., 1992; Cully et al., 1994; Pouliot et al., 1997; Xu et al., 
1998).  Work with anthelmintic resistant cattle nematodes has been focused on GluCl 
genes, in particular on one gene, AVR14 (Njue et al., 2004; Njue and Prichard, 
2004a).  Consistent data regarding specific mutations in different isolates has made 
the discovery of ML associated SNPs a challenge (El-Abdellati et al., 2011). 
Attempts have been made to standardise the nomenclature used to describe GluCl 
channels (Beech et al., 2010), but this does not exist for P-gps, and so variously 
named isoforms are a complicating factor (Kerboeuf et al., 2003).  The number of 
Pgps in parasitic nematodes, included those expressed in non-parasitic stages (such 
as eggs and L3), highlights the complexity in defining resistance markers in PgP 
genes (de Graef et al., 2013b).   
 
1.3.7 Alternative to anthelmintic control of parasites 
At the present time, feasible control alternatives to anthelmintics are not available. 
Work has been conducted on targeted selective treatment (TST) approaches, where 
treatment is based on live weight gain prediction (Greer et al., 2009) and has been 
shown to be successful in reducing anthelmintic use in lambs, without affecting 
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performance (Kenyon et al., 2013). However, a recently published cattle experiment 
utilising this protocol (Höglund et al., 2013), found that whilst anthelmintic use was 
reduced by 92%, performance in calves subjected to TST was not as good as in those 
in which anthelmintics were administered frequently, indicating that further research 
is required.  Other production parameters, such as milk yield and serum pepsinogen 
levels, have been investigated as diagnostic biomarkers for indicating treatment 
requirement for O. ostertagi infection (Charlier et al., 2005a; Charlier et al., 2005b; 
Bennema et al., 2009; Bennema et al., 2010; Charlier et al., 2011).  A disadvantage 
of these tests is that they require individual milk or blood samples to be taken and the 
data generated using these tools cannot be relied upon as a sole measure of 
parasitism (Charlier et al., 2010b).  In addition, there is, as yet, no vaccine available 
against either O. ostertagi or C. oncophora; however work is on-going in both 
parasites (Geldhof et al., 2008; Van Meulder et al., 2013)    
Without a short to medium term sustainable alternative to anthelmintics, there is a 
need to maintain the efficacy of the currently available classes.     
 
1.4 Project aims 
The overall aim is to increase knowledge regarding anthelmintic use and parasite 
management practices and anthelmintic efficacy on UK cattle farms and to evaluate 
the current tools available for detecting anthelmintic sensitivity.  This was achieved 
by the following: 
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 Examining anthelmintic treatment strategies implemented on UK farms 
by questionnaire analysis and identifying risk factors associated with 
anthelmintic resistance as measured by FECRT.   
 Testing efficacy of IVM against nematode populations in FSG calves on 
a cohort of farms using the FECRT, and identifying the nematode genera 
present before and after IVM administration.   
 Confirming the presence of ML resistance in two Cooperia spp. isolates 
obtained in the field trials above and examining the phenotype and 
genotype of parasites within these populations. 
 Optimising an in vitro LMIT for measuring anthelmintic sensitivity in 
field isolates containing more than one nematode species      
By increasing knowledge of the current nematode control practices employed by 
farmers, and their effect on anthelmintic resistance, combined with the improvement 
of detection methods, it was anticipated that this research would influence advice to 
farmers, veterinary surgeons, advisors and the pharmaceutical industry so steps can 
be taken to ensure the longevity of the current anthelmintic products, whilst 
maintaining the health and welfare of cattle. 
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Chapter 2:  Parasite control strategies and 
implementation of “best practice” advice 
regarding helminth control on UK cattle farms   
 
2.1 Introduction 
Anthelmintics are used by farmers worldwide for the preventative control and 
treatment of gastrointestinal helminth infections in grazing cattle; however, there is 
little published information available on management practices or measures used to 
control these pathogens in UK cattle herds (Barton et al., 2006).  As a result, there is 
a lack of knowledge surrounding which anthelmintic classes and application methods 
are most popular and how these products are utilised on farm.  With anthelmintic 
resistance being reported in cattle nematode populations (Sutherland and Leathwick, 
2011), and particularly with the rapid increase in numbers of reports of resistance to 
the macrocyclic lactone (ML) class over the last decade, it is important to know what 
farmers are doing to control nematodes on their farms. It is also essential to 
understand how far their practices adhere to guidelines for limiting the spread of 
anthelmintic resistance (Coles, 1997). This is particularly pertinent in the cattle 
sector as no new classes of anthelmintics appear likely to be licensed for use in cattle 
in the short to medium term (Epe and Kaminsky, 2013).  In light of increasing 
reports of anthelmintic resistance in cattle, an industry-driven initiative has lead to 
the publication of best practice guidelines, the Control of Parasites Sustainably 
manual (COWS, EBLEX, 2010), with a view to reducing the risk of anthelmintic 
resistance developing.   
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2.1.1 Publication of “Best Practice” Guidelines 
 
2.1.1.1The COWS manual 
The COWS manual is a 56-page publication, intended as a reference document for 
those responsible for prescribing and distributing anthelmintics, such as veterinary 
surgeons, pharmacists and suitably qualified persons (SQPs), as well as farmers and 
animal producers.  The manual provides an overview of the life cycles and diseases 
associated with common helminths infecting cattle; the diseases that infection with 
parasites can cause; the anthelmintics licensed for use in cattle; an overview of 
anthelmintic resistance in nematodes; laboratory diagnostic techniques (such as 
faecal egg counts; FEC) and a series of eight guidelines designed to preserve the 
efficacy and utility of anthelmintics in cattle.  The guidelines are comparable to those 
set down in the Sustainable Control of Parasites in Sheep (SCOPS) guidelines 
launched in 2003 (Taylor, 2012). A summary of the COWS guidelines is shown in 
Table 1, adapted from the manual (EBLEX, 2010). 
Table 1: Summary of COWS guidelines for sustainable use of anthelmintics on cattle farms 
(adapted from EBLEX, 2010) 
1. Work out a control strategy with veterinary surgeon or advisor 
On-going consultations between farmers, veterinary surgeons and farm and animal 
health advisors to develop a feasible parasite control strategy on-farm, as a 
culmination of parasitological knowledge and practical understanding of a particular 
farm (for example, presence of handling facilities and manpower).  Must be kept up-
to-date based on results from faecal egg count reduction tests (FECRT) conducted on 
farm.   
2. Use effective quarantine strategies 
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All new stock brought onto farm should be treated with an anthelmintic, ideally with 
an oral drench formulation of a benzimidazole (BZ; Class I) or an injectable or pour-
on application of levamisole (LEV; Class II).  Ideally, both products sequentially, but 
not simultaneously (NB: no time period between administrations is specified).  After 
anthelmintic administration, cattle should be held off pasture for 24-48 hours until 
nematode eggs have been passed out in faeces and then turned out onto “dirty” 
pasture contaminated with eggs and larvae deemed to be representative of the farm 
population.  Efficacy of the quarantine treatment should be tested via FEC two weeks 
post-treatment and if the FEC are in excess of zero eggs per gram (EPG), the animals 
should be re-treated and retested.   
3. Test anthelmintic efficacy on farm 
The use of faecal egg FECRT or ‘Wormer Tests’ (where FECs are only taken after 
treatment) to determine anthelmintic sensitivity, is encouraged.   
4. Administer anthelmintics effectively 
Cattle should be dosed at the volume recommended for heaviest in group, based on 
the weight of two or three of the heaviest animals or to split the group into two 
subgroups and determine weight of heaviest in group.  If the anthelmintic is for 
quarantine purposes, the full dose rate should be given.  Dosing equipment (such as 
drench guns, syringes and pour-on applicators) needs to be checked “regularly” via 
the dispensing of two or more doses into a measuring device prior to treatment, using 
the anthelmintic product.   
5. Use anthelmintics only when necessary 
The treatment of adult cows is deemed not usually necessary due to development of 
immunity. Treatment of calves at turn-out should not be necessary as calves should 
be worm-free, however if pasture contamination is deemed to be high, the use of  BZ 
bolus or a persistent ML (Class III) to prevent disease and further pasture 
contamination is recommended.  Calves should be put onto uncontaminated or low 
risk pasture at the start of the season, so no need to treat at this time.  If pasture is 
medium or high risk, they should be treated or moved onto silage aftermath after 
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July.  Alternatively, treat at 3, 8 and 13 weeks with ivermectin or 0 and 8 weeks with 
doramectin or use ruminal boli.  FEC are recommended for optimisation of 
anthelmintic treatment.   
6. Select appropriate anthelmintic for the task 
Farmers are encouraged to use narrow spectrum anthelmintics where possible, stating 
LEV may be equally as effective as “a more broader spectrum” ML (sic).  
Inadvertent use of combinations should be avoided and a flukicide used alone if fluke 
is the target species.  The use of a larval culture with FEC is also encouraged, along 
with rotation of anthelmintics where appropriate (without jeopardising quarantine 
treatments).  The use of products with a persistent action is also encouraged. 
7. Adopt strategies to preserve susceptible worms on farm 
Cattle should not be treated and moved to new pasture: i.e. “dose and move”.  
However it is noted that delaying the move may be difficult to do on a practical level.  
It is also noted that there is a lack of evidence on use of targeted selective treatments 
(TSTs) based on whole herd FEC monitoring. 
8. Reduce dependence on anthelmintics 
The use of grazing management is recommended, by grazing calves on pasture to 
allow sufficient exposure in order for immunity to develop, but not so much as to 
cause disease.   
 
2.1.1.2 Moredun Foundation ACME message 
In addition to the COWS manual, there are other advice resources available, such as 
the Moredun Foundation guidelines (www.moredun.ac.uk).  The message in this 
resource is more succinct than the COWS guidelines, but the focus on the 
responsible use of anthelmintics remains the same.  These guidelines (ACME; named 
as such after the initials of the guidelines below) were first released for use by sheep 
and goat farmers; however, the four areas are also applicable to cattle helminth 
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management and are as follows, with the corresponding COWS guideline number 
added in brackets: 
• Adopt a quarantine strategy (Guideline 2) 
• Check efficacy of treatments (Guideline 3) 
• Monitor herds to determine when to treat (Guidelines 5 and 8) 
• Ensure best practice is followed (Guidelines 4 to 7) 
 
2.1.1.3 Previously conducted questionnaire studies regarding 
anthelmintic usage 
The areas of best practice, as highlighted in the COWS and ACME guidelines, have 
been used for many years in parasitological studies, primarily conducted in sheep 
(Taylor, 2012).  Questionnaire studies directed at farmers have predominately 
presented descriptive results, in terms of quoted percentages regarding farmers’ 
general beliefs of their current (and potential future) parasite management systems 
(Coles, 1997; Sargison and Scott, 2003; Bartley, 2008).  More recent studies in 
sheep, two from Australia (Suter et al., 2004; Sweeny et al., 2012) and one from 
Great Britain and Ireland (Morgan et al., 2012), detail more advanced analysis of 
parasite control measures at farm level by incorporation of logistic regression 
analysis to identify risk factors associated with suspected anthelmintic resistant 
nematodes on farm and to compare observed signs of disease, and treatment of, liver 
fluke and lungworm.  Suter et al, (2004) generated risk factors for IVM resistance, 
based on a combination of questionnaire analysis and FECRT data from 120 farms.  
The results revealed that farmers who applied anthelmintics over the winter months 
and who had owned farms for longest were more likely to have anthelmintic resistant 
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nematodes present on farm.  Sweeny et al, (2012) focused primarily on the causes of 
diarrhoea in meat lambs, combined with a geographical and climatic model.  In the 
third study, Morgan et al, (2012), measured the uptake of SCOPS guidelines in on-
farm practices in the sheep sector, and found that farmers with less awareness of the 
SCOPS guidelines were more likely to have poor anthelmintic efficacy compared to 
those that were aware of SCOPS .   
Work conducted in this area with regard to cattle helminth control has been more 
limited, with only one survey published in the UK in the last 20 years (Barton et al., 
2006).  A survey conducted in England and Wales by Michel et al (1981), covered 
the relative “costs” of applying anthelmintics sold in 1978 and farmers decisions 
behind treatment of cattle, but did not investigate parasite prevalence and was 
conducted prior to the launch of ML anthelmintics.  This research concluded that 
timing of anthelmintic treatments was not always optimal (for example, when pasture 
contamination was low) and adult cattle were treated when this may not have been 
necessary, due to the development of immunity to infection developing over the 
previous grazing seasons (Michel et al., 1981).  A second study, published by 
Gettinby et al., (1987), focused on the practices of sheep and cattle farmers registered 
with a veterinary practice.  Sixty-eight questionnaires from cattle farmers were 
received, with 15 ‘cattle-relevant’ questions predominantly exploring usage of 
anthelmintic class and grazing strategies involving co-grazing with sheep.  Farmers 
were found to treat beef calves on average 1.5 times per annum, with dairy calves 
treated twice per year on average.  Anthelmintic treatments were applied on 84 and 
86% of beef and dairy farms respectively, with 84% of dairy farms administering an 
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anthelmintic treatment to calves at autumn housing (Gettinby et al., 1987).  A further 
descriptive study (Barton et al., 2006), explored the use of anthelmintic classes and 
application methods on 72 beef farms in South West England.  The results revealed 
75% of treated first season grazing (FSG) calves with ML product, with ML use 
rising to 82% with adult cattle.  Topical pour-on applications were used by 58% of 
respondents and 88% of farmers indicating they treated cattle at housing time 
(Barton et al., 2006).  In 2010 a large scale survey of dairy farms in five north-
western European countries (including the UK) was conducted, where bulk milk tank 
Ostertagia ostertagi enzyme-linked immunosorbent assay (ELISA) optical density 
ratios were compared to parasite control practices, such as anthelmintic use and 
associated management practices such as herd stocking density was predominately 
descriptive (Bennema et al., 2010).  Higher optical density ratios (ODRs) were 
positively correlated to turn-out earlier in the grazing season and housing later in the 
grazing seasons and climatic conditions were thought to play a role in differences 
observed between countries.  Further work conducted in Europe has focused on the 
use of serum pepsinogen levels and grazing management with anthelmintic 
treatments. A study in the Netherlands found that on 30% of farms, dairy cattle were 
given preventative anthelmintic treatments, in addition to grazing on aftermath 
grazing, which is unlikely to provide a substantial parasite challenge, and so 
anthelmintic treatment may be unnecessary (Borgsteede et al., 1998).  Another study 
in Sweden utilised serum pepsinogen levels to ascertain the subclinical levels of O. 
ostertagi infection in 1% of farms, and FEC levels were below 500 EPG in 97% of 
cattle tested, to which the authors associated with good pasture management and 
supplementary feeding (Hoglund et al., 2001).   
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More detailed research has been conducted in dairy cattle in Costa Rica (Jiménez et 
al., 2010) and Brazil (Charles and Furlong, 1996).  The Brazilian study focused on 
levels of milk production and farmers decisions regarding anthelmintic 
administration on a relatively descriptive level, such as 63% of the 89 respondents 
estimating animal weight to ascertain anthelmintic dosage rates.  As with the Michel 
et al 1981 study, anthelmintic applications were applied indiscriminately across age 
categories of cattle, resulting in an increase in costs of worm control (Charles and 
Furlong, 1996).  The Costa Rican study focused on parasite prevalence and climatic 
factors and included logistic regression analysis for determining risk factors for 
anthelmintic programs, based on the results of 73 farms (Jiménez et al., 2010).  A 
major finding from this study is that although the majority of farmers (90%) claimed 
to administer anthelmintics at the recommended dose rate, none weighed the animals 
prior to treatment.   
 
2.1.2 Aims of Chapter 
The aim here was to explore anthelmintic usage on cattle farms and which parasite 
control practices, if any, are implemented in line with advice proposed by initiatives 
such as COWS and ACME.  Data provided by the questionnaire included 
information on geographical location, farming protocols, enterprise type and parasite 
management practices which could be examined in light of the farms resistance 
status.  Logistic regression analysis were performed to investigate the association 
between current best practice guidelines on farming practices and to investigate 
potential risk factors for anthelmintic resistance on some of these farms.   
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2.2. Materials and Methods  
2.2.1 Questionnaire design and distribution  
A questionnaire was devised, based on previously distributed questionnaires for 
Moredun Foundation sheep farmers by Dr David Bartley.  Prior to dissemination, the 
questionnaire was reviewed by Dr Johannes Charlier (Ghent University, Belgium) 
and his comments incorporated.  The questionnaire was piloted on a group of seven 
farmers and stockmen, with no changes made after piloting.  The finalised 
questionnaire comprised 44 close-ended questions (Appendix 1) and was designed to 
cover areas of farm demographics (such as herd size and farm acreage); herd 
management (for example, time spent grazing and purchase of stock); anthelmintic 
use (for example, number of anthelmintic treatments per year and dosing regimen); 
awareness of parasites on farm (including liver fluke and ectoparasites) and sources 
of advice sought on parasite and nematode control programs.  The questionnaire was 
distributed by post to the 840 Scottish-based members of the Moredun Foundation 
(http://www.moredun.org/charitable-work/the-moredun-foundation) in July 2010.  
To increase return rates, the questionnaire was redistributed to the same members the 
following year (July 2011).  Three hundred questionnaires were also distributed to 
members of the Scottish Beef Cattle Association in November/ December 2010.  An 
information sheet was included in all mailings that listed background information on 
anthelmintic classes, product brand names and active ingredient in each product and 
a final flyer was included to offer farmers the opportunity to take part in an IVM 
faecal egg count reduction test (FECRT).  
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2.2.2 Data entry and manipulation 
Questionnaire responses were entered into an Excel spreadsheet; one row used per 
questionnaire, one column per question.  A final column was used to include any 
additional information provided by farmers.  As some questions produced answers 
which were under-represented compared to other answers, it was clear that certain 
questions could be simplified.  Each column was subsequently simplified to provide 
as many binary variables as possible.  For example, the question “Do you monitor 
faecal egg counts?” had three possible responses: “No”, “Yes, occasionally” and 
“Yes, routinely”, and was subsequently expanded to form three columns “FEC No” 
“FEC Occasionally” and “FEC routinely” with Yes/No responses as per Table 2.  
This was performed for each question, resulting in a data file spanning 300 columns.   
Table 2: Example of data simplification: the second column represents the respondent’s selected 
answer with columns three to five displaying the expanded, simplified data. ‘NA’ indicates an 
answer was not provided by the respondent 
Farm ID Monitor FEC? FEC ‘No’ FEC ‘Occasionally’ FEC ‘Routinely’ 
001 Occasionally No Yes No 
002 No Yes No No 
003 Routinely No No Yes 
004 NA NA NA NA 
 
Following data entry, any missing values were classified as NA (not answered).  The 
data was converted to a comma-separated variable (.csv) file and imported into 
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RStudio (R version 2.13.1; R studio version 0.97.551) for statistical analysis.  
Analysis was performed in R Studio using packages ‘epicalc’ (version 2.15.1.0; 
Virasakdi, 2012) for deriving odds ratios and ‘ggplot2’ (version 0.9.3.1; Wickham, 
2013) for drawing graphs.  
2.2.3 Statistical analysis 
2.2.3.1 Selection of variables for analysis 
Analysis was directed towards exploring the principles laid down in the COWS 
guidelines and ACME message.  As the principle and intent behind both guidelines is 
similar, the analysis was designed to encompass five main areas of interest.  These 
are displayed in Table 3 and this combination of COWS and ACME messages shall 
subsequently be referred to as ‘Areas of Best Practice Advice’ (ABPA).  In order to 
address each ABPA and the associated questions for investigation, the questions 
comprising the questionnaire were allocated to as many ABPA as deemed relevant.  
For example, questions regarding how FECRTs were performed were allocated to 
‘checking anthelmintic efficacy’ and ‘ensuring best practice is followed’.  For all 
ABPA, questions relating to general farm demographics were included, such as farm 
type and herd size.   
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Table 3: Areas for statistical analysis: areas of best practice advice (ABPA) displayed on the left 
column, with associated areas investigated in the right column 
Areas of ABPA for analysis Associated areas of investigation 
Adoption of quarantine practices Are anthelmintics applied for quarantine treatments? 
Which classes of anthelmintic are used for quarantine? 
Do farmers isolate new stock post-quarantine treatment? 
For how long do farmers isolate new stock? 
Check anthelmintic efficacy Do farmers conduct faecal egg count reduction tests? 
Do farmers feel their anthelmintics are becoming less 
effective compared to efficacy in previous years? 
Monitoring herds to decide 
treatments 
Do farmers conduct faecal egg counts? 
Ensuring best practice is 
followed 
Do farmers weigh animals prior to treatment? 
Do farmers treat their animals on an individual basis 
(‘selectively’) or treat as a whole herd or age group? 
Do farmers calibrate anthelmintic dosing equipment? 
Sources of advice sought on 
parasite control 
Where do farmers seek advice about parasite control and 
anthelmintic use? 
Which advice sources do they rank as most important?   
 
2.2.3.2 Univariable analysis 
Two statistical approaches were used to analyse the data.  For the first approach, 
odds ratios (OR) were generated using univariable logistic regression analysis, 
referred to subsequently as ‘univariable’ analysis.  Odds ratios provide an estimate of 
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the increase (or decrease) in likelihood of an outcome associated with the exposure 
of a named variable than would be otherwise expected due to chance. Dependent 
variables were chosen based on their best fit to the ABPA as described in Section 
2.2.3.1.  
In this analysis, OR were considered significant if the P Wald value (Wald, 1943) 
was equal to, or less than, 0.05, with 95% confidence intervals (95% CI) outside of 
0.95 – 1.04 (i.e. not spanning a value of 1).  An OR of 1, or with 95% CI with values 
between 0.95 – 1.04, was considered to be indicative of a lack of relationship 
occurring between the variables selected.  An OR greater than one, with lower 95% 
CI greater than 1.04, meant the occurrence of a particular variable increased the 
likelihood of an outcome occurring by the factor described by the OR.  For example, 
an OR of 12, would indicate the odds of selected outcome occurring are twelve times 
greater to occur in response to a named variable than would otherwise be expected 
due to chance.  ORs are determined per defined unit, so where numerical categories 
were involved (for example, number of hectares farmed or number of calves), the OR 
reflects the likelihood of an outcome occurring for the addition of a single cow or 
hectare.  To address this issue, analysis was conducted using both raw and rounded 
data values, to ensure the analysis reflected practically relevant figures.  Numbers of 
lambs and ewes farmed (if applicable) were rounded to the nearest 100 animals; 
pasture size was rounded to the nearest 50 hectares; all cattle groups (adults, stirks 
and calves) were rounded to the nearest 10 animals, as were the number of rams kept.  
The length of time that the farm had been owned for was rounded to the nearest 10 
years and the percentage of pasture kept as permanent grazing was rounded to the 
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nearest 10%. Colinearity of variables was considered for each univariable model, by 
checking all model terms by eye to ensure they were not included – for example, use 
of LEV anthelmintics and oral forumlations (LEV is only available as an oral 
anthelmintic). 
2.2.3.3 Multivariable univariable analysis 
The second approach was to conduct a multivariable univariable logistic regression 
analysis (Hosmer and Lemeshow, 2000), subsequently referred to here as 
‘multivariable’ analysis.  All output from the univariable analysis with a P value of 
less than, or equal to, 0.25 was collated and sorted by outcome to be explored.  A 
maximal model was formed to include all explanatory variables, and terms were 
dropped sequentially by largest P (Wald) value until significance was achieved for 
all remaining variables (P < 0.05). For example, for outcome “CheckGun”, relating 
to whether farmers checked an oral dosing gun prior to use, variables in the 
univariable analysis such as “BeefAdult” (number of adult beef cattle on farm), 
“PourOn” (if farmer used pour-ons) and “Bolus” (if farmer used bolus) all had a P 
value of 0.25 or lower. The maximal model was as shown: CheckGun ~ 
BeefAdult+PourOn+Bolus and the model run. The term with the highest P (Wald) 
value (“Bolus”) was dropped from the next model run, e.g. CheckGun ~ 
BeefAdult+PourOn, until all the remaining variables were significant.    
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2.3. Results  
2.3.1 General description of questionnaire data  
The response rate was 4.2%, based on the return of 84 questionnaires from 1,980 
distributed.  Questionnaires were received from 84 respondents, of which 89% (75 
farmers) farmed beef cattle, either as a sole enterprise (74%; 62 farmers) or in 
addition to dairy cattle (15%; 13 farmers).  Nine farms (11%) had dairy cattle only.  
A total of 69% (58 farms) of all respondents also farmed sheep, with the distribution 
of sheep farmers displayed in Figure 4.  Postcodes provided by respondents were 
entered into publically available, open-source map generation software 
(www.batchgeo.com) to create the map shown in the left hand pane of Figure 5.  The 
map in the right hand pane of Figure 5 displays the numbers of cattle listed in 
Scotland in the 2011 Agricultural Census (data obtained through DigiMap EDINA 
software; http://edina.ac.uk/agcensus/).   
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Figure 3: Histogram displaying the distribution of respondents who farm sheep in addition to 
cattle, across farm types 
 
 
Figure 4: The left-hand pane displays location map of questionnaire respondents, one 
respondent per individual marker.  Right-hand pane displays a map of cattle density, based on 
total numbers of cattle in Scotland as collated by Agcensus 2011 (Digimap EDINA).   
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Respondents were predominately located in the central and Southern regions of 
Scotland, depicting the distribution shown by the cattle density census data (Figure 
2.2).  Data relating to farm demographics is displayed in Table 4: on average, 52% of 
pasture owned or rented by the respondents was reported as kept as permanent 
pasture (i.e. only used for grazing purposes).  In general, more adult dairy cattle are 
kept per farm, compared to adult beef cattle (mean of 151 adult dairy cattle compared 
to mean of 94 adult beef cattle per farm) however numbers of younger beef cattle (< 
24 months; stirks and calves) were higher in the beef than in the dairy sector, with 
means per farm of 85 and 81 compared to 64 and 56 for stirks and calves, 
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Table 4: Farm demographic data, based on replies from the 84 respondents where applicable. 
For each variable, the mean, median, standard deviation (S.D.) and range are displayed, 
rounded to the nearest integer. 
Variable Responses 




Time land owned or rented 
(years) 
77 48 45 34 4-200 
Size of Land owned or rented 
(Hectares) 
82 338 123 915 5-8000 
Percentage of land held as 
permanent pasture 
76 52 50 39 0-100 
Beef – adult cattle (> 24 
months) 
70 94 70 120 0-776 
Beef – stirks (12 – 24 months) 70 85 45 190 0-1500 
Beef – calves (< 12 months) 70 81 62 94 0-532 
Dairy – adult cattle (> 24 
months) 
22 151 132 74 52-360 
Dairy – stirks (12 – 24 months) 22 64 58 35 0-150 
Dairy – calves (< 12 months) 22 56 50 30 0-130 
Sheep - ewes (if farmed)  58 386 140 594 0-3512 
Sheep - lambs (if farmed) 58  487 155 751 0-4000 
Sheep - rams (if farmed) 58 12 4 20 0-90 
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Calving occurred year round, but most frequently in March (54 respondents; 66%), 
April (66; 80%) and May (58; 71%).  Similarly, April and May were the months 
most frequently selected for turnout to grazing, with 78% of animals turned out over 
these months, across all age groups.  Ten respondents (12%) grazed their cattle all 
year round.  Of the remaining farmers, October and November were the most popular 
months for housing with 62% of adult cattle, 78% of stirks and 74% of calves 
brought into housing during these months.  Sixty-nine percent of respondents co-
grazed cattle with sheep (n=55), with the remainder grazing cattle separately (n=25).  
Sixty-seven respondents (91%) grazed adult cattle for 24 hours per day.  Two 
farmers with beef and dairy cattle grazed adult cattle for 10 or fewer hours per day, 
and one farmer grazed for 20 hours per day.  Three dairy farmers grazed adult cattle 
for between 12 and 20 hours per day.  All stirks and calves were grazed for 24 hours.  
The majority of adult cattle were grazed at stocking densities of less than three cows 
per hectare (n=44, 71%), with 35% (n=25) grazed at stocking densities of between 
three and five cows per hectare.  Only two respondents grazed adult cattle at a 
density of greater than five cows per hectare.  A similar pattern was seen with the 
stocking density of stirks: 47 respondents (70%) grazed less than five stirks per 
hectare, 19 grazed between five and ten stirks per hectare (28%) and one respondent 
grazed greater than ten stirks per hectare.      
From the analysis (Table 5), farmers who stated that they did not change their 
grazing pasture over the course of a grazing season (i.e. animals kept on the same 
pasture from turn-out to housing) were significantly more likely to anthelmintic treat 
cows and heifers at turn-out (ORs >9.7, 95% CI 1.1-87, P<0.044) and more likely to 
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farm dairy cattle (OR 3.4, 95% CI 1.2-10, P=0.026).  Farmers who stated that they 
changed their grazing to different pasture during the course of a grazing season were 
more likely to take advice from magazines (OR 3.5, 95% CI 1.2-10.2, P=0.021) and 
were less likely to treat heifers at turn-out (OR 0.2, 95%CI 0.1-0.7, P=0.015).  Beef 
cattle farmers were more likely to graze cattle of different age categories together 
(for example, cows and calves), compared with those who farmed dairy cattle (OR 
25.3, 95%CI 4.3-150.5, P<0.001) and were also significantly more likely to seek 
advice on parasite control from meetings (OR 6.11, 95%CI 1.2-30.1, P=0.026).  
Seventy-eight farmers stated they treated their cattle with anthelmintics (96% of 
respondents), with eight farms also using grazing management, and two farms 
relying solely on the use of grazing management for parasite control, one of which 
was declared to be organic.  On farms where anthelmintics were administered, beef 
cattle were treated on average 1.8 times per year (SD 0.9, range 0-4) and dairy cattle 
treated on average twice per year (SD 0.9, range 1-4).  Sixty percent of respondents 
(44 famers) had used ML anthelmintics solely in the previous year, with a further 15 
(20%) stating that they had administered ML and BZ class anthelmintics.  Eleven 
farmers (15%) stated that they administered BZ anthelmintics solely and three (4%) 
stated that they had used levamisole alone.   
As shown in Table 5, farmers who administered BZ were significantly more likely to 
use a bolus application, compared to other methods of application (OR: 3.3, 95% CI 
1.2-9.1, P=0.023) and farmers using ML anthelmintics were less likely to take advice 
from other farmers on parasite control and were also significantly less likely to use 
oral drenches (ORs 0.2, 95%CIs 0.06-0.08, P ≤ 0.022).  
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Table 5: Significant outputs from univariable analysis that related to anthelmintic use and grazing management out with areas of best practice advice 





response OR (95% CI) P-value 
N (%) N 




Advice from farmers 76 12 15.8 64 0.2  (0.06-0.8) 0.022 
Use of oral drenches 73 13 17.8 60 0.2 (0.06-0.7) 0.013 
Changed grazing Never 
Cows treated at turn-out 54 6 53.7 25 9.7 (1.1-87.0) 0.043 
Heifers treated at turn-out 63 17 27.0 46 8.5 (2.4-30.1) <0.001 
Farms dairy cattle 80 15 18.8 65 3.4 (1.2-10.0) 0.026 
Advice from magazines 73 17 23.3 56 0.26 (0.1-0.7) 0.008 




Advice from magazines 75 22 29.3 53 3.5 (1.2-10.2) 0.021 
Heifers treated at turn-out 63 4 6.35 59 0.2 (0.1-0.7) 0.015 
Different age groups 
grazed together 
 
Farms beef cattle 74 59 79.7 15 25.3 (4.3-150) <0.001 
Advice from  meetings 70 30 42.9 40 6.11 (1.2-30.1) 0.026 
More than half of grazing 
pasture mowed per season 
72 9 12.5 63 0.21 (0.1-0.8) 0.019 
Cows treated at calving 52 4 7.7 48 0.07 (0.01-0.5) 0.005 
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2.3.2 Analysis of responses with respect to best practice 
guidelines 
Statistically significant results from all analyses are presented in the following 
sections, under the corresponding ABPA.  
2.3.2.1 Adoption of quarantine practices 
Forty-five percent of respondents did not administer a quarantine anthelmintic 
treatment to animals brought onto farm (33 farms).  On the 42 farms for which it was 
stated that a quarantine anthelmintic treatment was administered, 32 administered a 
ML class anthelmintic (76%), eight a BZ class anthelmintic (19%) and two 
administered ML and BZ class anthelmintics (5%).  Thirty-three respondents (39%) 
employed a post-quarantine isolation period, averaging 27 days (range 7-60).  In the 
univariable analysis, farmers were significantly more likely to administer an 
anthelmintic as a quarantine treatment if new stock were bought at auction (OR 3.7, 
CI 1.3-10.9, P = 0.018); however, the use of an isolation period of any length was 
significantly less likely to occur on farms with dairy cattle (OR 0.2, CI 0.1-0.7, P = 
0.013, Table 6).  In the multivariable analysis, farmers who sought advice on 
anthelmintic use from pharmaceutical representatives were also significantly more 
likely to administer an anthelmintic treatment at quarantine (OR 4.1, CI 1.3-13.1, P = 
0.017) and isolation after the quarantine treatment was less likely to occur on farms 
where advice was sought from other farmers (OR 0.25, CI 0.08-0.8, P = 0.021).  
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OR (95% CI) P-value 
 N (%) N 
Quarantine Treatment   New stock bought auction 73 18 24.7 55 3.7 (1.3-10.9) 0.018 
Isolation Post-Quarantine   Farms dairy cattle 74 4 5.4 70 0.2 (0.06-0.7) 0.013 
 
 









OR (95% CI) P-value 
 N (%) N 
Conduction of faecal egg 
counts (FEC) 
No  Farms dairy cattle 79 18 22.8 61 7.1 (1.5-33.4) 0.013 
Occasionally  Farms dairy cattle 79 2 2.5 77 0.2 (0.04-0.7) 0.043 
Regularly  Uses anthelmintics 77 2 2.6 75 0.06 (0.01-0.9) 0.042 
  Chapter 2 
  64 
2.3.2.2 Check efficacy  
Only one farmer stated that he had previously conducted a FECRT on farm.  When 
asked how effective farmers perceived their anthelmintics to be in comparison to 
previous years, 88% (68 respondents) stated efficacy to be unaltered and 9% (7 
respondents) believed efficacy was greater.  Only two farmers stated that their 
anthelmintics were less effective compared to their effect in previous years.  No 
significant correlations were observed in either the univariable or multivariable 
analyses.  Only one farmer stated they had a ‘serious’ problem with ‘worms’ on 
farm, but believed efficacy of anthelmintics used on farm to be more efficacious than 
in previous years.  Of the other respondents, 40% (n=33) stated they did not have any 
problems with worms, 30% and 23% stated they had ‘minor’ or ‘moderate’ 
problems, respectively (n=24, 19 respectively), and five farmers (6%) stated that they 
were unsure as to the extent of worm problems on their farm.  
 
2.3.2.3 Monitor herds to decide treatment 
Fifty-one respondents (66%) did not monitor FECs at all, with 23 (30%) stating that 
they undertook FEC analysis on an “occasional” basis.  In the univariable analysis 
(Table 7), dairy cattle farmers were significantly less likely to monitor FECs 
“occasionally” (OR 0.2, CI 0.04-0.09, P = 0.043) and were significantly more likely 
not to perform any FECs at all (OR 7.1, CI 1.5-33.4, P = 0.013).  Farmers who said 
they “routinely” monitored FECs were significantly less likely to use anthelmintics 
(OR 0.06, CI 0-0.9, P = 0.042); however, this was only three respondents.  No 
additional outcomes were found to be significantly associated in the multivariable 
analysis.   
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2.3.3.1 Ensure best practice advice is followed  
2.3.3.1.1 Effective anthelmintic administration  
Farmers were asked how they determined the volume of anthelmintic to administer. 
Thirty-seven (46%) said that they estimated weights of the animals, with 22 (27%) 
stating that they administered the dose based on the heaviest animal, 12 (15%) 
administered on the dose according to weight of individuals and 10 (12%) calculated 
the dose according to the average weight of the group.  In the univariable analysis 
(Table 8), where farmers stated that they based treatment dose on the weight of the 
heaviest animal, this was significantly more likely if the farmer also grazed sheep 
(OR 6.2, CI 1.3-29.0, P =0.021).  There was also a significant association between  
the administration of treatment doses on average weight and the statement that the 
farmer sought advice on worming practices from their veterinary surgeon (OR 0.13, 
CI 0.02-0.7, P = 0.02).  
Where farmers stated that they used oral drench equipment, the accuracy of the dose 
gun was significantly less likely to be checked prior to use if the famer stated that 
he/she estimated the treatment volume to give each animal (OR 0.19, CI 0.04-0.8, P 
= 0.02).  There was also a significant association between the statement that the dose 
gun was less likely to be checked and where farmers said that they never changed the 
class of anthelmintic used (OR 0.17, CI 0.04-0.8, P =0.02) or never changed grazing 
pastures (OR 0.06, CI 0.01-0.6, P = 0.013).  In the multivariable analysis, where 
farmers stated that they checked the dosage gun there was a significant association 
with a statement that they considered their farm to have had problems with liver 
fluke (OR 7.11, 95% CI 1.02-50, P = 0.047).  
  Chapter 2 
  66 









OR (95% CI) P-value 
 N (%) N 
Establishment of 
treatment volume 
Average weight of herd  Advice from vets 74 6 8.1 68 0.1 (0.02-0.7) 0.02 
Establishment of 
treatment volume 
Heaviest animal weight  
Farms sheep in addition to 
cattle 








74 3 4.1 71 0.2 (0.1-0.8) 0.023 
Anthelmintic changed Annually  
Uses an oral drench 
application 
75 7 9.3 68 4.9 (1.4-17.8) 0.016 
Dosage Gun checked 









41 7 17.1 34 0.2 (0.04-0.8) 0.022 
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2.3.3.1.2 Strategic or selective use of anthelmintics  
Farmers were asked if they treated the three categories, calves, stirks or cows, on a 
selective basis (for example, on an individual basis according to need) as opposed to 
treating the group as a whole in a non-targeted program.  Univariable analysis (Table 
9), revealed that farmers with dairy cattle were significantly less likely to treat adult 
cows or calves as whole groups (OR 0.28, CI 0.1-0.8, P = 0.018; OR 0.28, CI 0.1-
0.8, P = 0.038, respectively).  Farmers who said that they treated all stirks or all 
calves at the same time on farm were significantly more likely to use pour-on 
applications (ORs >5.8, CI 1.9-98.7, P < 0.025).  The multivariable analysis showed 
that, in addition to the results found to be significant in the univariable analysis, 
farmers were also significantly more likely to treat all stirks at once if they also 
farmed sheep (OR  7.2, 95% CI 1.5-33.8, P = 0.013).  Stirk stocking density was 
found to be associated with the treatment of calves identified by respondents as 
belonging to a “set worming program” (i.e. a whole group, non-targeted treatment).  
If the stirk stocking density was less than 5 stirks per hectare, calves were 
significantly less likely to be treated as a whole group (OR 0.2, CI 0.1-0.8, P = 
0.014).  However, if stirk stocking density was between 5 and 10 stirks per hectare, 
calves were significantly more likely to be treated as a whole group (OR 3.5, CI 1.1-
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response OR (95% CI) 
P-
value 
 N (%) N 
Non-selective Treatment Adults  Farms dairy cattle 77 7 9.1 70 0.3 (0.1-0.8) 0.018 
Non-selective Treatment Calves 
 Advice from vets 76 59 77.6 17 7.9 (1.5-40.6) 0.014 
 Pour-on application 77 59 76.6 18 5.9 (1.3-27.5) 0.024 
 Also farms sheep  78 48 61.5 30 4.0 (1.2-13.3) 0.024 
 Farms dairy cattle 78 14 18.0 64 0.28 (0.1-0.8) 0.038 
Non-selective Treatment Stirks 




 Advice from meetings 75 23 30.7 52 0.3 (0.09-0.9) 0.04 
Anthelmintic treatment of calves Set programs 
 
Stirk stocking (5-10 per 
hectare) 
60 10 16.7 50 3.5 (1.1-11.2) 0.033 
 
Stirk stocking (<5 per 
hectare) 
60 10 16.7 50 0.2 (0.1-0.8) 0.014 
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Anthelmintic treatment of calves At turn-out  Advice from  meetings 71 5 7.0 66 0.2 (0.1-0.6) 0.006 
Anthelmintic treatment of calves At weaning  Advice from  magazines 71 5 7.0 66 0.2 (0.1-0.7) 0.009 
Anthelmintic treatment of cows At calving 
 Farms dairy cattle 56 5 8.9 51 8.3 (1.7-42.1) 0.01 
 Farms beef cattle 56 5 8.9 51 0.1 (0.02-0.7) 0.02 
 
Stirk stocking (<5 per 
hectare) 
48 2 4.2 46 0.1 (0.02-0.7) 0.017 
 
Adult stocking (<3 per 
hectare) 
50 1 2.0 49 0.1 (0.01-0.6) 0.016 
Anthelmintic treatment of heifers 
At signs of 
disease 
 Pour-on application 63 3 4.8 60 0.1 (0.01-0.9) 0.036 
Anthelmintic treatment of heifers At turn-out 
 Bolus 63 13 20.6 50 6.0 (1.9-18.8) 0.002 
 Advice from magazines 61 10 16.4 51 0.3 (0.1-0.9) 0.036 
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2.3.3.1.3 Preservation of anthelmintic susceptible helminths  
Farmers who stated that they treated animals before moving them onto different 
pasture (“dose and move”) were significantly more likely not to give any 
supplementary feeding such as silage (OR 5, CI 1.2-20.3, P=0.024, Table 10).  
Farmers were significantly more likely to graze mixed-age groups of cattle if they 
farmed beef cattle (OR 25.29, CI 4.3-150.2, P<0.001) and if they used farmers 
meetings as a source of advice for parasite control (OR 6.1, CI 1.2-30.1, P=0.026).  
Only three respondents (3.6%) did not use anthelmintics on their farm, all of whom 
farmed beef cattle with one classed as organic.  The remaining two were not organic, 
but the farmers stated they used grazing management in place of anthelmintic 
treatments for parasite control.  On farms where anthelmintics were not used, the 
mean herd sizes were 92, 67 and 77 for adult cattle, stirks and calves respectively.  
These figures correlate well with the mean herd sizes reported by all respondents for 
beef cattle (as displayed Table 4) with mean herd sizes of 94, 85 and 81 for adult 
cattle, stirks and calves respectively.  A further six farmers stated that they used 
grazing management in addition to anthelmintics for helminth control.  
2.3.4 Sources of advice on helminth control practices 
From the responses, veterinary surgeons were cited as the most selected source of 
advice for anthelmintic use and helminth  control (71 respondents, 89%), followed 
by magazine articles  (48; 60%), pharmaceutical company representatives (42; 53%), 
farmers’ meetings (36; 45%),  advertisements (30; 38%), other farmers (23; 29%) 
and sources other than those mentioned above (10; 13%).  When asked to rank the 
most important sources of advice, veterinary surgeons were selected by 48 of the 
respondents (76%).  Farmers who stated that they sought advice from magazines (i.e. 
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farming press and related publications ) were significantly more likely to state that 
they had problems with mites and lice (OR 4.2, 95% CI 1.4-12.1, P = 0.008) and 
were also more likely to farm sheep as well as cattle (OR 2.9, CI 1.1-7.9, P = 0.037).  
As seen in Table 11, farmers who ranked ‘meetings’ as their most important source 
of information regarding control practices were significantly more likely to be unsure 
if worms were considered a problem on their farm (OR 38, CI 2.6-548, P = 0.037).  
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OR (95% CI) P-value 
 N (%) N 
Dose and move   No supplementary feeding 76 9 11.8 67 5 (1.2-20.3) 0.024 
 
 









OR (95% CI) P-value 
 N (%) N 
Advice Source Magazines  
Problems with mites and 
lice 
77 24 31.2 53 4.2 (1.4-12.1) 0.008 
Advice Source Magazines  
Farms sheep in addition to 
cattle 
78 38 48.7 40 2.91 (1.1-7.9) 0.037 
Advice Source Meetings  Farms dairy cattle 78 4 5.1 74 0.18 (0.1-0.6) 0.006 
Advice from source 
ranked most important 
Meetings  Unsure of worm problem 63 2 3.2 61 
38 (2.7-546.7) 0.007 
 




The main objective here was to gain information about current helminth control 
practices on cattle farms and to compare how the cited practices align with those 
written in the publically available best practice guidelines.  The results indicated that 
farmers are not always following the best practice advice and the barriers to this must 
be ascertained.  The response rate here was low.  This has been reported to be 
common in studies such as this  (Coles, 1997).  However, in other studies, notably in 
Belgium, response rates of 61% and greater than 90% have been recorded (Charlier 
et al., 2010; Claerebout et al., 2000).  One issue with obtaining such a low response 
rate, is the increased potential for bias, for example, there is no way to determine if 
these respondents were particularly interested or well-informed in regard to the 
subject prior to the survey.  As a result, the practices of these respondents may not be 
indicative of the general population of cattle farmers in the UK.  A personal 
interview approach has been used in surveys conducted with sheep farmers in 
Northern Ireland (McMahon et al., 2012) in an attempt to increase response rates.  
Given that the actual number of interviews conducted was only 81, the benefit of this 
approach may be limited.  Other studies have targeted farmers via telephone 
questionnaires (Morgan et al., 2012) and via veterinary practices (having been 
identified as being more likely to respond) (Stafford and Coles, 1999); however, both 
approaches introduce their own bias. For example, in a study conducted on farms 
served by a veterinary practice (Sargison et al, 2003), farmers were surveyed before a 
meeting held by the practice and participants were noted to be, on the whole, owners 
of large well-established farms with high levels of veterinary care  and higher than 
average output compared with other sheep farms.  Bias may occur when recording 
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responses from these as farmers who attend meetings may be the most interested in 
keeping up-to-date, so may be better informed than the population as a whole.  
Alternatively, farmers may also be more likely to take part if they suspect they may 
have a problem and so bias may be implicated in that instance (Thrusfield, 2007).  
Even when farmers have previously expressed a willingness to participate in 
questionnaire studies, return rates can still be lower than expected (Stafford and 
Coles, 1999), for example, a return rate of 80% was observed with the study by 
Barton et al., 2006, despite previous assertions that farmers were willing to 
participate (Barton et al., 2006).  Other, more qualitative methods may also be 
employed to gain insight into the practices and opinions of farmers, such as the use 
of focus groups or a more conversational interview approach, where the questions are 
open-ended, leading to a discussion between the interviewer and the interviewee (C. 
Jack, Moredun, Personal communication).   
The issue of low response rates may also be, in part, due to the current perceptions of 
the importance of anthelmintic resistance in the cattle sector.  Due to the relatively 
few cases of anthelmintic resistance reported in cattle nematodes in the UK (Stafford 
and Coles, 1999; Sargison et al., 2009; Sargison et al., 2010; McArthur et al., 2011; 
Bartley et al., 2012), it could be conjectured that farmers may not be as aware of this 
issue as sheep farmers.  The findings here revealed that 70% of respondents believed 
they had no problems or minor problems with parasitic nematodes on their farm.  If 
more cattle farmers recognised the potential threat of anthelmintic resistance and its 
effects on parasite control, then the response rate may have been higher.  Oppenheim 
(1992) has suggested a number of ways of increasing questionnaire response rates, 
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including sending reminder notices and the importance of an introductory letter to 
highlight reasons for the survey.  Both of these approaches were tried here, and the 
questionnaire designed to be as easy to complete as possible (through the use of 
close-ended questions), but the response rate remained low.  The same author 
(Oppenheim, 1992) also suggested incentives to increase response rates, and in the 
instance of this study, farmers were offered the opportunity to conduct a FECRT 
inclusive of all required materials (including anthelmintic).  Similarly, a previous 
study surveying the nematode control practices of UK sheep farmers (Coles, 1997) 
used a prize draw with the chance to win one of five £25 vouchers to encourage 
participation and had a return rate of 22.8% (684 questionnaires).  Although the 
questionnaire here was kept as short as possible to aid comprehension and 
willingness to participate, it may have been informative to include a question 
pertaining to clinical signs of parasite infection (such as poor weight gain or 
diarrhoea).  In a survey of sheep famers in Australia, a photographic display of  the 
“dag” reference chart for breech soiling (scored from 1 “no evidence of soiling” to 5 
“heavy soiling”) has been used in an attempt to assess this (Sweeny et al., 2012); 
however it may require a caveat as other infections can cause diarrhoea, and that 
diarrhoea may not necessarily occur during parasite infection.  Due to the low 
response rate here, care must be taken in extrapolation of the results, as they do not 
represent an expansive survey, but the information garnered does add to the 
information previously published in smaller surveys (Barton et al., 2006).  In 
addition, the location of the farms from where the data was collated follow areas of 
high cattle density, so even with small survey size, respondent location appears to be 
representative of the cattle density in Scotland.   
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Due to the lack of published data regarding cattle anthelmintic treatments and 
management regimes, it is difficult to make comparisons to other studies.  In terms of 
general practices such as turn-out and housing, these reflect similar findings 
previously published in Northern Europe.  In the UK, calves , particularly beef calves 
were turned out in April or May with their dams, grazed all summer and housed in 
October or November in preparation for winter (Michel et al., 1981; Gettinby et al., 
1987).   In Belgian studies,  (Charlier et al., 2005a; Bennema et al., 2010; Charlier et 
al., 2010a), which focused on the dairy sector  generally, cattle are turned out in 
spring and housed in late autumn or winter and grazed extensively, with the majority 
grazed for 24 hours a day during the summer season.  With regards to levels of 
treatment and classes of anthelmintics applied, similar findings (averaging one to two 
treatments per year, predominantly with ML products) were found by Barton et al 
(2006), where 75% of respondents administered some form of ML anthelmintic to 
beef calves, increasing to 82% for adult cattle.  In contrast to the current survey, only 
29% of respondents received parasite control advice from their veterinary surgeons.  
An earlier study (Gettinby et al., 1987) found that although farmers that employed 
grazing management practices were more likely to treat more frequently, 
anthelmintic treatment of calves was at similar levels to those reported here (average 
1.5 and 2 times per year, beef and dairy, respectively).  
It is clear from the results that there is confusion regarding appropriate quarantine 
anthelmintic treatments for cattle.  The fact that farmers who bought new stock at 
auction were found to be significantly more likely to administer a quarantine 
anthelmintic is indicative of an awareness of biosecurity; however, it is less 
  Chapter 2 
77 
 
encouraging when the selected anthelmintic is examined.  The current best practice 
advice is to give a BZ treatment, or a LEV treatment or both treatments sequentially 
(EBLEX, 2010).  This is because anthelmintic resistance in cattle nematodes has 
only been reported in MLs to date.  The suggested use of a BZ administration in 
addition to LEV is that LEV is not effective against inhibited Ostertagia spp. 
(Grimshaw et al., 1996).  The results here showed that only 40 respondents gave any 
anthelmintic at quarantine and of those that did, only six administered a BZ class 
anthelmintic and none administered LEV.  Two farmers administered a BZ class 
treatment as well as a ML treatment, but it is unknown how close together 
administrations were given.  This confusion is not limited to the cattle sector, as the 
study by Morgan et al (2012) revealed that 86% of sheep farmer respondents 
believed they were administering the correct quarantine anthelmintics to new stock, 
whereas only 3% were administering LEV and MOX (the best practice advice for 
sheep at the time, SCOPS 3
rd
 edition;(Abbott et al., 2009)).  Sargison and Scott 
(2003) also found differences in quarantine procedures compared to best practice 
advice, as 17% of respondents from their survey administered IVM or doramectin 
(other ML class anthelmintics) and not MOX and LEV.  The average length of 
isolation periods 27 days compared to the 24-48 hours stipulated under best practice 
advice (EBLEX, 2010).  This may be attributed to farmers isolating for other 
diseases, such as Bovine Viral Diarrhoea virus infection, acknowledged to be a 
concern when purchasing new cattle (Brennan and Christley, 2012).  If farmers are 
already employing a lengthy quarantine period, this may be the ideal opportunity to 
promote use of an effective anthelmintic quarantine treatment, potentially combined 
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with a FECRT to examine efficacy of treatment, as part of a cohesive herd health 
approach.   
Clear trends have been shown from the survey results, particularly with the 
differences between beef and dairy farmers in relation to best practice advice.  This 
could be attributed to the fact that there is a positive, albeit not statistically 
significant, association between beef cattle farmers and farmers that also raise sheep 
in addition to cattle.  This might have an indirect influence on treatment of cattle 
parasites, as the SCOPS guidelines have been published since 2003, and so the 
message of sustainable use of anthelmintics has been promoted in the sheep sector 
for much longer than in the cattle sector, particularly as anthelmintic resistance in 
UK was not published until 1999 (Stafford and Coles, 1999).   
Monitoring FECs was found to be significantly less likely to occur on farms with 
dairy cattle.  This finding is in agreement with a study conducted in Costa Rica, 
where no FEC were conducted prior to treatment and decisions were based on 
subjective appearance of clinical signs (including “sad animals” or diarrhoea) or 
change of season (such as from low to high rainfall period) (Jiménez et al., 2010).  
Only one farmer had previously conducted a faecal egg count reduction test, and 
provided additional information revealing that it was conducted using LEV and 
provided 100% efficacy.  From the rest of his questionnaire completed, it was 
apparent that this farmer was only using ML products on farm, so the results of the 
LEV FECRT may be limited in their application at the present time.  This result is 
not unique to the cattle sector, as it has been previously asserted that few sheep 
farmers currently assess anthelmintic efficacy in their flocks, and are subsequently 
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unaware of the potential extent or the true resistance status of their farm (Morgan et 
al., 2012).  This may be linked to farmers’ belief that their anthelmintics are still as 
effective compared to previous years, with only two believing they were less 
effective.  However, it has also been proposed that farmers may hold unrealistic 
expectations as to anthelmintic effectiveness, particularly if they are being used to 
improve the condition of animals who may have underlying or unknown ailments 
(Riffkin et al., 1984).  
The use of targeted anthelmintic treatments in cattle has been proposed since the 
1980’s when a survey by Michel et al, (1981) used the number of anthelmintics sold 
in 1978 to produce an analysis of administrations to different cattle age groups and 
equated that only 20% of this cost was spent on “potentially useful” treatments.  It 
was stated that the remaining 80% spent on anthelmintics that year was used in 
treatments of “doubtful or marginal” value, or “outright wasted” (Michel et al., 
1981).   The use of FEC to ascertain levels of pasture contamination and so 
determine potential benefits of deciding when best to administer anthelmintic 
treatment should be continued to be disseminated to farmers.  This view is shared by 
researchers in The Netherlands who predominantly investigated the use of 
anthelmintic treatments in the control of lungworm infection in calves.  Through the 
use of ‘inappropriate’ treatments, such as the use of a non-persistent anthelmintic at 
turn-out, and the use of persistent anthelmintics during winter housing, it was 
postulated that farmers may be in danger of ‘overprotecting’ their herds and better 
decision making processes were required (Borgsteede et al., 1998).   Overprotection 
was considered to be present when an anthelmintic treatment program was still 
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providing protection against re-infection when the grazing season ended and 
subsequently followed by an anthelmintic treatment at housing (Borgsteede et al., 
1998).  Use of anthelmintic treatments in this way provides strong selection for 
anthelmintic resistance.  The degree of selection pressure is dependent upon the 
intensity of selection pressure through the frequency of treatments, the dose rate 
applied, the proportion of larvae left untreated and the contribution of larvae which 
have survived anthelmintic treatment, either through resistance or surviving a sub-
optimal application (Prichard et al., 1980).   
Here, farmers who stated that they treat their animals to the average weight of the 
herd were found to be significantly less likely to seek advice on worming from their 
veterinary surgeons.  A study in Costa Rican dairy cattle showed that although 89.8% 
of the farmers surveyed stated they administered anthelmintics at the recommended 
dose rate, none of the farmers weighed animals prior to treatment (Jiménez et al., 
2010). Barton et al (2006) reported cattle were weighed on only 36% of the farms 
surveyed in their study, whereas here, 42% of respondents administered doses to 
either individual or heaviest weights in their herds.  It has previously been asserted 
that the determination of accurate dose rates by weighing animals, or using weigh 
tapes to estimate weight, is of utmost importance for anthelmintic efficacy (Cabaret 
and Berrag, 2004). The finding that farmers who treated to the heaviest weight in the 
herd were significantly more likely to farm sheep is encouraging, as it is a 
recommendation in the SCOPS guidelines and demonstrates an important flow of 
information from the sheep to cattle sector.  Whereas dosing a group of animals to 
the heaviest weight may be considered wasteful, as some animals will receive a 
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larger volume of anthelmintic than is strictly required, the alternative of potentially 
underdosing animals by basing treatment volumes on estimated body weight 
provides stronger selection for anthelmintic resistance (Smith et al., 1999).  
Farmers who stated that they did not treat calves on a selective basis were 
significantly more likely to seek worm control advice from their veterinary surgeons.  
This may be a factor of farmers wishing to maintain, or increase, productivity with 
the belief that the absence of parasites will increase growth rates and result in higher 
levels of productivity (Michel, 1985).  Those farmers who sought veterinary advice 
were significantly more likely to use a pour-on product, which may be due to the 
convenience of this application method (Bogan and Armour, 1987). The use of a 
whole group, non-targeted treatment program to treat stirks kept at medium stocking 
density (5-10 per hectare) could also be indicative of convenience to the farmer.  As 
with ‘overprotection’, the reduction of the population of untreated larvae (“in 
refugia”) will increase the selection pressure on pasture, as there will be fewer 
untreated larvae developing on pasture to dilute larvae surviving anthelmintic 
treatment (Van Wyk, 2001).   
A difference was observed between dairy and beef cattle farmers with regards to 
anthelmintic treatment at calving with dairy cattle significantly more likely to be 
treated then  and is probably due to the perception that  anthelmintic treatment at 
calving increasing milk yields (Bisset et al., 1987). Previous studies found no effect 
on milk yield with the application of BZ or LEV products at calving time (Michel et 
al., 1982); however, a review of studies conducted during dry season or mid-
lactation, showed varying levels of increased milk production in various countries 
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(Gross et al., 1999).  As adult cattle are known to have low FEC and are likely to 
have developed a substantial degree of immunity following the previous grazing 
seasons, anthelmintic treatment for parasitic disease is not always necessary (Michel, 
1985).   In addition, refugia  on pasture from not treating older calves and adult cattle 
has been considered an important reason why anthelmintic  resistance is not more 
widely found in cattle (Coles, 2002).  However, with the development of 
eprinomectin (ML), milk yields were found to be significantly increased following 
administration (Reist et al., 2011). Eprinomectin was developed as the first ML 
product with a zero milk withdrawal period, and as such, could be used in lactating 
dairy cattle (Shoop et al., 1996a; Shoop et al., 1996b) and has also been shown to be 
associated with increased weight gain in treated cattle (Kunkle et al., 2013).  
Consequently, the desire for increased productivity in the short term should not be 
considered greater than the longer term sustainability of the cattle management 
system (Michel, 1985; Morgan et al., 2012).  
Forty-three percent of farmers (n=33) said they administered anthelmintics to cattle 
and moved them; however it is not known whether this was to new pasture or due to 
animals being housed.  This finding was also highlighted by Barton et al (2006) who 
reported 42% of their respondents also adopted a ‘dose and move’ strategy.  Dose 
and move’ is a strategy first advocated in  1912 (Thelier, as cited in (Van Wyk, 
2001)), the general premise being worms could be eradicated if animals were treated 
and then moved to pasture that had not been grazed for a year.  In this system, any 
larvae which had previously hatched on this pasture would be unlikely to have 
survived over the winter period, resulting in a clean pasture for cattle to graze on.  
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Having been administered with an anthelmintic prior to moving, susceptible 
nematodes would be removed and the animals would carry a low risk of infection 
onto these clean pastures (Van Wyk, 2001).  This practice has been implicated as a 
risk factor for anthelmintic resistance because any nematodes surviving anthelmintic 
treatment will be at  a greater prevalence on these previously clean pastures, allowing 
populations of resistance genes to proliferate at a greater rate than if they were 
diluted by susceptible populations (Prichard et al., 1980) but this is clearly still being 
conducted despite best practice advice to the contrary.  
In addition to direct parasite control as a result of anthelmintic application, the 
importance of grazing management should be considered.  Only six farmers stated 
that they used grazing management in addition to anthelmintics for helminth control.  
Previous publications have highlighted the clear need to integrate parasite control 
with grazing management (Sangster, 1999), with Barger (1999) proclaiming grazing 
management to be one of the most crucial aspects of parasite control. Whilst there is 
a need to prevent parasitic disease, grazing management should also allow for low 
levels of parasitic infection, in order for immunity to develop in the calves, in 
addition to providing refugia to slow the selection of anthelmintic resistance (Barger, 
1999).  To generate a greater awareness of the influence grazing management can 
exert in a helminth control program, there is a need for greater weight to be given in 
publications such as SCOPS and COWS and more research on epidemiology of 
cattle parasites under current farming strategies, given that most epidemiological 
studies were conducted prior to the release of ML anthelmintics, for example 
(Armour et al., 1969b; Michel, 1969a).  It has been proposed that the primary 
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responsibility for preserving efficacy of anthelmintics lies with the individual farmer 
and they should seek advice on use from veterinary surgeons (Coles, 1997). The 
results here would indicate that whilst a variety of information sources are sought, 
when asked to rank the most important sources, veterinary surgeons were the most 
frequent choice.  As such, there is a clear role for veterinary surgeons in promoting 
the sustainable use of anthelmintics; a role which is currently not being fulfilled.  
This is evident from the findings in this survey, in particular, the lack of effective 
quarantine practices, the heavy reliance on ML anthelmintics, the lack of 
anthelmintic class rotation, the treatment of adult cattle and the lack of FEC 
monitoring to determine treatment requirements.  This finding concurs with Morgan 
et al., (2012), who stated that veterinary surgeons need to be more proactive in 
providing decision support.  The subject of making anthelmintics available only 
through veterinary surgeons in the UK is currently being discussed (Veterinary 
Record, p 145, 9 February 2013), with a view to removing the prescribing rights of 
Suitably Qualified Persons (SQPs) to maintain anthelmintic efficacy.  The use of 
SQPs as an advice source was omitted from this survey; however, in hindsight and in 
view of recent developments, it would be of use to know how farmers viewed the 
role of SQPs.  In Europe, several countries, such as Denmark and Switzerland, have 
adopted the prescription only by veterinarians approach, however there is evidence 
that it has not stopped the development of resistance in these countries and the 
restriction of product prescription may lead to importation from other countries or a 
“grey market” of distribution from other sources, such as Internet retailers (Nielsen et 
al., 2006).  
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In studies conducted in New Zealand, (Kettle et al., 1981; Kettle et al., 1982)  
sources of advice on parasite control were grouped as being either of ‘commercial’ or 
‘non-commercial’ origin. Advice from veterinary surgeons and pharmaceutical 
representatives were considered amongst the ‘commercial’ sector, whereas advice 
from other farmers and the respondents own experience was classed as ‘non-
commercial’.  Articles in magazines were considered to be 50% of each class.  If the 
same approach is taken with this study, the advice sources selected here, would 
currently be predominantly skewed towards ‘commercial’ aspects, however if re-
categorisation were to occur, the roles of veterinary surgeons may change, and the 
influence of pharmaceutical representatives may alter.  
Further work would be required to ascertain the provenance of meetings being 
provided for farmers (for example, are they led by veterinary practices or by 
pharmaceutical industry) as this may affect the bias of advice presented.  It is clear 
that although farmers may consult a variety of information sources, ultimately they 
make their own decisions.  Decisions made with regards to management practices 
have been described as a compromise between activities they must do to ensure farm 
survival, those that they would like to do and those that are not achieved (Magne et 
al., 2012).  Farmers willing to undertake preventative measures to control parasite 
populations have also had their success attributed to this forward thinking approach 
(Cabaret, 2003), and in beef producers, animal health has been ranked highly as an 
essential factor in ensuring farm survival (Magne et al., 2012).  In addition, it has 
been reported that farmers trust scientific reports regarding animal disease, as 
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reported in farming press, but are not always seen as relevant or providing practical 
advice (Garforth et al., 2013).   
Work by Salmona (1994, as cited by (Cabaret et al., 2009)) described decisions in 
agriculture being based on three types of knowledge: algorithmic (learnt through 
reading or teaching, for example, at college); memetic (learnt through demonstration, 
for example, from veterinary surgeons, advisors or other farmers) and phoric (what is 
felt by the individual, learnt through past experiences). It has been hypothesised that 
the difference in weight of these three areas will differ considerably between 
veterinary surgeons and farmers, and needs to be considered when disseminating 
advice (Saddiqi et al., 2012).  From the results shown in this study, it is clear that the 
effect of meetings is an influence on farmer behaviour with respect to worm control, 
particularly on beef farms.  On a more applied level, Morgan et al (2012) highlight 
the difficulties faced when proposing changes to parasite control programs; as 
maximal and sustainable use of anthelmintics are mutually exclusive targets.  As a 
result, long term cost-benefit analysis of changing anthelmintic usage may be 
influential.  An updated version of the study conducted by Michel (1981) to highlight 
the potential for farmers to maximise their investment in nematode control, by 
targeting treatments at the most pertinent times of the year, together with analysis on 
potential productivity losses attributed to the use of ineffective anthelmintics (once 
resistance has developed) may act as an incentive to commercial farmers, as well as 
promoting the sustainable use of anthelmintics and the importance of checking 
efficacy. 
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An area where this may be more likely to change than most may be in the organic 
cattle sector.  Work by Cabaret (Cabaret, 2003) suggests organic cattle farmers may 
be more open to alternative preventative measures due to greater motivation to adopt 
new practices due to inability to use conventional anthelmintics.  Greater 
dissemination of advice was also shown to be an influential factor in Brazil, where 
the study conducted in 1996 showed that although 95% of respondents were planning 
to continue with their current control program, nearly all (97%) said they would be 
willing to alter plans to try new measures of parasite control if they were made aware 
of them (Charles and Furlong, 1996). This was given further credence by findings of 
a study (Garforth et al., 2013) where  farmer attitudes to implementing biosecurity 
measures were surveyed  and found farmers willing to be convinced about measures 
they do not use (such as isolating new stock) but needed further supporting evidence 
from a source seen as credible, such as a trusted veterinary surgeon, and an 
assessment of relevance as perceived by the individual farmer.  
The results here have shown that best practice advice does not appear to be followed 
universally by Scottish cattle farmers and that beef and dairy farmers implement 
different approaches to helminth control..  While farmer decisions are clearly 
determined by a number of factors, the role of veterinary surgeons and SQPs needs to 
be addressed in order for changes to be made.  There is a need for further 
understanding of the dynamics behind farmer and veterinary interactions so that a 
cohesive strategy can be defined to benefit the farmer, in terms of maximum benefit 
from anthelmintic treatments applied to their cattle, whilst maintaining efficacy of 
anthelmintics used.  
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Chapter 3: The use of faecal egg count 
reduction tests to assess ivermectin sensitivity 
in UK cattle nematodes * 
 
*A proportion of the results from this Chapter have been published in a peer-
reviewed journal article, see Appendix 2.  
3.1 Introduction 
The extent of anthelmintic resistant nematodes in ruminant and equid populations 
globally requires the standardisation of robust tests to correctly identify resistance to 
assist farmers and veterinary surgeons in the selection of suitable anthelmintics 
classes for treatment and control (Kaplan, 2004).  Anthelmintic resistance (AR) has 
previously been described as being a heritable reduction in the relative sensitivity of 
a nematode population to the action of an anthelmintic (Conder and Campbell, 
1995).  The faecal egg count reduction test (FECRT) is one of two in vivo tests that 
can be used for the detection of AR in parasitic nematodes and is generally 
considered to be a relatively straightforward and effective test for the assessment of 
drug efficacy (Coles et al., 1992). In the FECRT, infected animals are treated at the 
appropriate dose rate with an anthelmintic and faecal egg count (FEC) analysis is 
conducted using faecal samples taken on the day of treatment and 14 - 17 days after 
treatment (Coles et al., 1992).  The FECRT is suitable for assessing efficacy of all 
classes of anthelmintic and in many species of grazing animals (Coles et al., 1992). It 
also holds an advantage over controlled efficacy tests, in that it does not require 
necropsy of treated animals to determine the effect of treatment on nematode burden 
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(Wood et al., 1995).  However, a disadvantage of the FECRT is that FEC values are 
only representative of a patent infection (Michel, 1968).  There is also some debate 
as to whether FECs provide an accurate representation of adult worm burden.  A 
positive correlation between FEC and adult worm burden in cattle has been reported 
(Bryan and Kerr, 1989); however other studies in cattle have reported a lack of 
correlation (Michel, 1969e; Brunsdon, 1971; Smeal et al., 1977).  FEC values do not 
provide a quantitative measure of the numbers of developing or inhibited larvae in 
the abomasal or small intestinal mucosa (Michel, 1963) such that a high FEC is not 
necessarily indicative of high worm burden and vice versa (Michel, 1969f).  
Consequently, a FECRT can only estimate anthelmintic efficacy as it relates to egg 
output of mature female nematodes (Presidente, 1985), which can be indicative of 
levels of pasture contamination (Kloosterman, 1971). However, in lieu of any other 
non-invasive detection methods, FECs remain the easiest and cheapest technology 
for diagnostic purposes (Vercruysse and Claerebout, 2001).   
The World Association for the Advancement of Veterinary Parasitology (WAAVP) 
has developed a series of guidelines for a standardised FECRT (Coles et al., 1992; 
Wood et al., 1995; Coles et al., 2006); however, these guidelines are designed 
primarily for use in sheep and goats, with optimised tests for AR detection in cattle 
nematodes currently unavailable (Sutherland and Leathwick, 2011).  Within the 
published guidelines, there are many points that are the subject of debate (van Wyk 
and Groeneveld, 1997) and it is recognised that there needs to be a degree of 
flexibility when testing anthelmintic products in different host species (Wood et al., 
1995).  Discussions surround issues such as the number of animals to be tested, the 
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use of control groups and the use of composite, or pooled, faecal samples (Coles et 
al., 1992; Ward et al., 1997; Presland et al., 2005; Coles et al., 2006; McKenna, 
2007).  Amongst the most debated, however, is the determination of which FEC 
method is most suitable for a particular host species and the associated downstream 
statistical analysis of the data from which sensitivity is inferred (Presidente, 1985; 
Dash et al., 1988; Presland et al., 2005; Torgerson et al., 2005; Rinaldi et al., 2011; 
Dobson et al., 2012; Levecke et al., 2012; Torgerson et al., 2012).   
From the questionnaire data presented in Chapter 2, it would appear that many 
farmers on UK beef farms administer anthelmintics to cattle on average twice a year, 
usually to coincide with turn-out in spring and housing in late autumn and winter.  It 
was noted that farmers prefer to use macrocyclic lactone (ML) anthelmintics, 
particularly pour-on applications.  This can be attributed to a combination of the 
greater efficacy of ML anthelmintics (González Canga et al., 2009) and the 
convenience of  topical applications (Brooker and Goose, 1975).  These findings 
concur with those of a previous small questionnaire study conducted in the south-
west of England (Barton et al., 2006); however, the effectiveness of the anthelmintics 
used on these farms was unknown.  Information regarding the prevalence of different 
nematode species on UK cattle farms is largely based on studies conducted prior to 
the widespread use of broad-spectrum anthelmintics and studies relating to this fall 
into two major categories.  First, those that investigated the epidemiology of parasitic 
nematodes, predominantly published before 1980, and which focused on 
standardisation of helminthological nomenclature (Oldham, 1938) and confirmation 
of species not previously identified in the UK (Baylis, 1938; Morgan and Soulsby, 
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1956).  Studies of nematode species present on pasture and the pathogenicity of these 
species in cattle were often published in the form of clinical case reports (Michel, 
1963, 1969a, f), abattoir studies (Bairden and Armour, 1981) and examination of 
pasture contamination (Bairden et al., 1985).   
IVM resistance in cattle nematodes in the UK was first reported in Cooperia spp. 
(Coles et al., 1998; Stafford and Coles, 1999) in a study where dairy calves on a farm 
in Somerset were reported to be in poor condition and subsequently treated with an 
injectable IVM product.  On two successive occasions, faeces were found to be 
positive for nematode eggs seven days after treatment, with a mean FECR of 65% 
recorded.  Following necropsy of two of the calves, worm burdens predominantly 
comprised Cooperia spp. (88%) and Nematodirus helvetianus (12%).  Cooperia spp. 
larvae were also cultured from faeces obtained from calves on the farm and were 
used to infect eight, helminth-naïve calves under controlled experimental conditions 
and an efficacy test was performed (Stafford and Coles, 1999).  Four calves were 
treated with injectable IVM at the recommended dose rate of 0.2 µg kg
-1
 body 
weight.  Calves were necropsied seven days after treatment and only a 16% reduction 
in Cooperia spp. worm burdens was observed compared to untreated control calves.  
As a result, the first report of IVM (and hence ML) resistance in Cooperia spp. in the 
UK was confirmed.  A second report followed, in which FECs were reported to have 
increased when FEC analysis was performed 21 days after administration of 
injectable IVM (Coles et al., 2001).  A mean FEC of 155 eggs per gram (EPG)  of 
faeces was reported and Cooperia spp. were present in larval cultures derived from 
faeces from the treated calves (Coles et al., 2001).  Following this, reports of ML 
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inefficacy have been predominantly restricted to small clinical studies, where 
anthelmintic failure was suspected (Coles et al., 2001; Sargison et al., 2009; Sargison 
et al., 2010).  In 2009, there was a report of a lack of efficacy after administration of 
DOR pour-on product to cattle on two farms (Sargison et al., 2009).  On both farms, 
Highland calves were observed to be passing loose faeces following DOR pour-on 
treatment.  Subsequent administration of an injectable formulation of DOR was 
100% efficacious in reducing trichostrongyle FECs on both farms and the previous 
presumed reduced efficacy attributed to the method of application (Sargison et al., 
2009).  A report followed in 2010 where a DOR pour-on application was observed to 
fail in preventing nematode infection of first season grazing (FSG) calves grazed for 
five weeks prior to housing (Sargison et al., 2010).  The calves were reported to be in 
poor condition, FECs increased whilst housed and larval cultures indicated the 
presence of Cooperia spp.  In another study (Coles et al., 2008), faecal samples were 
analysed from 16 farms on the day of anthelmintic administration, and again, 14 days 
later.   Here, a sensitive FEC method (FLOTAC; (Cringoli, 2006)) was employed 
following treatment and FECR values after pour-on IVM administration ranged from 
0 to 99% (10 farms: 0, 0, 37, 40, 73, 38, 89, 91, 92 and 99% efficacy); 43 to 100% 
after injectable IVM administration (two farms: 43 and 100% efficacy) and 91 to 
98% after pour-on MOX administration  (three farms: 91, 97 and 98% efficacy).  
However, as this study was conducted using different FEC methodologies, 
comparisons of FEC before and after anthelmintic administration may not be 
statistically valid.  Together, these studies would appear to suggest the presence of 
anthelmintic-resistant Cooperia species in the UK. 
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It is clear that there is relatively little recent information regarding the efficacy of 
ML anthelmintics in the UK cattle population.  The aim of this chapter is, first, to 
examine the sensitivity of IVM in nematode populations in FSG calves on a cohort 
of 20 UK farms and the changes in nematode species prevalence as a result of 
anthelmintic administration.  The second aim is to examine the impact of FEC 
methodology on the outcome of the efficacy testing.  Parameters examined include a 
comparison of two FEC methodologies of varying sensitivity (1 EPG versus 50 
EPG), comparison of utilising arithmetic or geometric means, and a comparison of 
different analytical methods used to calculate efficacy values.  By examining the 
impact of these parameters on the outcome of FECR testing, the objective is to 
develop a robust method for investigating nematode anthelmintic sensitivity in vivo 
in cattle.   
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3.2 Materials and methods 
3.2.1 Participating farms and sample collection 
Farmers wishing to participate in the IVM FECRT were identified following the 
questionnaire mailing to Moredun Foundation members, as described in Chapter 2 
(Section 2.2.1).  All interested parties were issued with an information sheet, 
describing the FECRT procedure in detail.  Farmers were then contacted via 
telephone or email to discuss the sample collection procedure.  At this time, farmers 
were asked to provide details of the next time they would expect to administer 
anthelmintics to their first season grazing (FSG) calves and if they had access to a 
weigh crate and animal handling facilities.  Approximately two weeks prior to the 
anticipated anthelmintic administration date, a sampling kit was posted to farmers.   
Items within the kit included:  
 injectable IVM (Ivomec Super®, 1% (w/v) IVM, 10% (w/v) clorsulon, Merial 
Animal Health, 0.2 µg kg
-1
 body weight; BW),  
 ‘Ziploc’ polythene sample bags (300 mm x 200 mm; Gripwell)  
 disposable syringes and sterile needles (17 ½” gauge) (Dunlops Veterinary 
Supplies);  
 cattle weigh tape (Coburn Company, Inc) if required.   
 mailing packaging with Freepost labels 
 letter reiterating IVM administration and sample collection protocol.  
Participants were asked to randomly identify 10 to 15 FSG calves that had been 
grazing on pasture for more than six weeks prior to the anticipated anthelmintic 
administration date.  On day of treatment (Day 0), they were asked to collect a “fresh 
as possible” sample from each calf and place the sample in a Ziploc bag, labelled 
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with the animal number.  Then, they were asked to administer the IVM 
subcutaneously at the manufacturer’s recommended dose rate of 0.2 μg IVM kg
-1
 
BW.  As much air as possible was to be excluded from the sample bags, before being 
sealed and posted to Moredun Research Institute in the supplied packaging.  As far as 
possible, samples were processed on day of arrival, with all faecal samples processed 
within 48 h of arrival.   
3.2.2 Parasitological techniques 
3.2.2.1 Faecal egg count method  
For all samples obtained from all farms, FEC analysis was conducted in duplicate 
using the following centrifugal flotation method adapted from Jackson (1974).  
Faecal samples were thoroughly mixed and 10 g subsample removed into a plastic 
bag.  To this, 100 ml tap water were added and the contents fully homogenised.  A 
10 ml aliquot was removed and passed over a 1 mm sieve into a 250 ml beaker and 
washed through with 5 ml tap water.  The remaining 90 ml suspension was mixed 
again and the process repeated for a second 10 ml aliquot.  The beaker contents were 
poured into 15 ml polyallomer tubes (Beckman Coulter) and centrifuged for 2 min at 
203 x g.  The supernatant was removed using a vacuum line, the tubes refilled with 
saturated sodium chloride solution (NaCl, specific gravity 1.2) and gently inverted 
several times to resuspend the faecal pellet.  The tubes were centrifuged for a second 
time for 2 min at 203 x g.  Artery forceps were then used to clamp the tubes 
approximately 0.5 cm below the meniscus of the supernatant and this portion of the 
supernatant (containing the nematode eggs) was poured into a 2.5 ml 
spectrophotometer cuvette (Fisher Scientific).  Additional NaCl solution was added 
to rinse the upper portion of the tube and added to the cuvette.  A lid was placed on 
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the cuvette and the latter then placed on a stereomicroscope stage. To aid 
enumeration of eggs, a Miller Square graticule was used (Graticules Ltd, UK).  If the 
number of eggs present were at low density (for example, less than 50 eggs per gram 
(EPG)), all of the eggs in the cuvette were counted.  Under these circumstances, one 
egg counted is equivalent to one EPG faeces.  If the eggs were deemed to be of 
moderate density (for example, between 50 and 100 EPG), then the eggs were 
counted by making two traverses of the cuvette, counting the eggs which appeared in 
the larger square in the graticule, as demonstrated in Figure 6(A).  After two 
traverses, the number of eggs counted were added together and multiplied by three to 
give the equivalent EPG.  Similarly, when the number of eggs appeared to be in 
excess of 100 EPG, two traverses were made, counting the eggs which appeared in 
the smaller of the graticule squares, demonstrated in Figure 6(B).  As this is 
equivalent to counting one ninth of the cuvette, the number of eggs counted were 
added together and multiplied by nine to give the EPG.  As two cuvettes were 
counted for each sample, both EPG were recorded and an arithmetic mean was taken 
of the two counts.  All enumeration was conducted at x40 magnification. 
 
 
Figure 5: Use of Miller square graticule when counting nematode eggs using the adapted FEC 
method (Jackson, 1974).  The cuvette in the left hand pane (A) demonstrates two traverses with 
the large square.  All eggs that fall within this square are recorded over two traverses, are added 
together and multiplied by three to give the number of eggs per gram.  The cuvette in the right 
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pane demonstrates the protocol when counting at higher egg density with the smaller square; 
the number of eggs counted being multiplied by nine following two traverses. (Image 
reproduced with permission by Dr David Bartley, Moredun Research Institute 
 
3.2.2.2 McMaster faecal egg count method 
To allow results from this study to be directly comparable to those from other 
FECRT studies, faecal samples from 16 farms (005 – 024) were also subjected to 
McMaster FEC analysis.  The protocol followed was adapted from that of Gordon 
and Whitlock (1939).  For each calf, a 3 g subsample was removed from the 
homogenised faecal sample and placed into a plastic bag.  To this, 42 ml saturated 
NaCl solution (specific gravity 1.2) were added, the suspension thoroughly mixed 
and poured over a 1 mm aperture sieve into a 250 ml plastic beaker.  The suspension 
was mixed and a 3 ml Pasteur pipette (Sterilin) used to withdraw 1.5 ml faecal 
solution.  This was used to rapidly fill two chambers of a McMaster counting slide 
(Chalex Corporation, UK).  The remaining solution was mixed again before a further 
1.5 ml aliquot removed and used to fill two chambers of a second McMaster 
counting slide.  The slides were enumerated under x 40 magnification, and the 
number of eggs observed under each counting grid was noted.  For each slide, the 
number of eggs observed under the two counting grids were added together and 
multiplied by 50 to give the number of EPG of faeces (Gordon and Whitlock, 1939).  
The two EPG values were averaged to produce a mean McMaster EPG.  
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3.2.2.3 Dictyocaulus viviparus enumeration using the Baermann 
method 
To ascertain the presence of Dictyocaulus viviparus larvae, an existing protocol was 
adapted (M.A.F.F., 1986).  A modified Baermann apparatus was constructed using a 
small catheter tap connected to the tip of a 50 ml syringe.  The syringe was held 
upright in a stand, with the tap closed and pointing down.  The plunger was removed 
and the barrel filled with tap water.  For each animal, 10 g faeces were removed from 
the homogenised sample, and enclosed in two layers of muslin, secured with a 
wooden cocktail stick.  This was placed into the syringe barrel, with tap water added 
as necessary to ensure the faeces were fully submerged, and incubated overnight at 
20°C.  The next day, the tap was opened and the D. viviparus larvae collected into a 
50 ml Falcon tube (Sterilin).  The Falcon tubes were then centrifuged at 203 x g for 2 
min, the supernatant removed to leave a volume of approximately 2 ml.  This was 
transferred to a Petri dish and examined under x 40 magnification.   
 
3.2.2.4 Fasciola hepatica egg sedimentation method 
For the examination of faecal samples for the presence of Fasciola hepatica eggs, the 
following protocol was used (McCaughy and Hatch, 1964).  For each homogenised 
sample, 3 g of faeces were removed into a plastic bag, to which 42 ml tap water were 
added and thoroughly mixed to an even suspension.  The faecal suspension was 
poured over a 150 µm aperture sieve (Fisher Scientific) into a 250 ml inverted 
conical measuring cylinder (McKay and Lynn Ltd).  A further 125 ml tap water was 
added to the sieve to wash into the cylinder.  The cylinder was left to stand at a 45 
degree angle for 3 min at 20 °C, to allow the eggs to sediment.  After this time, the 
  Chapter 3 
99 
supernatant was removed via vacuum line, the sediment stained with one drop of 
methylene blue (2% w/v, Sigma Aldrich) and transferred to a Petri dish (Sterilin).  
The Petri dish contents were examined on a dissecting microscope at x 40 
magnification.  For each animal, the number of F. hepatica eggs counted was divided 
by three to give the number of F. hepatica EPG of faeces.     
 
 
3.2.2.5 Fluorescent peanut agglutinin (PNA) lectin staining method 
A fluorescent peanut agglutinin lectin staining method was used to determine the 
presence of Haemonchus spp. eggs in submitted samples.  Faecal suspensions 
remaining from the nematode CF FEC method (approximately 80 ml per animal) 
were pooled from all animals on one farm and washed over a series of sieves, 
decreasing in pore diameter (1 mm, 500 µm, 212 µm, 125 µm and 38 µm; Fisher 
Scientific).  Collected eggs were retained on the 38 µm sieve, poured into 
polyallomer tubes and centrifuged for 2 min at 203 x g.  The supernatant was 
removed, tubes refilled with saturated NaCl solution and centrifuged for a further 2 
min at 203 x g.  The tubes were clamped with artery forceps and the recovered eggs 
washed over a clean 38 µm sieve.  The eggs were rinsed with tap water to remove 
residual salt and transferred to a clean centrifuge tube.  Five aliquots of 10 µl 
nematode egg suspension were counted under x 100 magnification and the 
concentration of eggs adjusted to one egg per ml.  The ‘clean’ nematode egg solution 
was then used in an adapted lectin staining method (Palmer and McCombe, 1996).  A 
working solution of PNA was made by adding 10 µl PNA stock solution  (PNA 5 mg 




; 10 mM HEPES, 0.15 M sodium chloride, 0.08% sodium azide, 0.1 mM 
calcium; Vector Laboratories) to 990 µl PBS (phosphate buffered saline) and 
vortexed briefly.  To 900 µl egg suspension (approximately 900 eggs), 100 µl 
working solution PNA were added (final concentration 0.5 µg ml
-1
 PNA) and 
incubated for 1 h at 20 °C in darkened Eppendorfs (Axygen).  A separate 
monospecific suspension of Haemonchus contortus eggs (kindly provided by Mrs 
Alison Morrison, Moredun Research Institute) were incubated to provide a positive 
control.  After 1 h, eggs were transferred to a glass slide for counting and examined 
under x 100 magnification using an inverted fluorescence stereomicroscope fitted 
with a UV blue range filter (495 nm).  
 
3.2.2.6 Culture of faeces and larval extraction for species differentiation 
With the exception of Farm 001, equal quantities of faeces from all animals (Farms 
002 – 024) were pooled for culture to provide third stage larvae (L3) for 
morphological identification.  Due to the small sample sizes submitted, all excess 
faeces from animals from Farm 001 were pooled and cultured.  The faeces were 
mixed with equal volumes of vermiculite, formed into balls approximately 5 cm in 
diameter, placed into plastic trays, covered with perforated polythene bags to allow 
air circulation and incubated at 22 °C for 14 - 17 days.  This was conducted for 
samples obtained on both Day 0 and Day 14 following IVM treatment.  A 
coproculture was not conducted on Day 14 samples from Farm 002, due to zero FEC, 
as in keeping with previously published research (Waghorn et al., 2006; Demeler et 
al., 2009; El-Abdellati et al., 2010a), however for all other farms, both sets of 
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samples were cultured, regardless of FEC.  This was conducted to investigate if 
samples with a zero FEC would yield any larvae once cultured.  If larvae were found, 
this would indicate the FEC result was not truly zero, with the potential for 
trichostrongyle eggs to have survived IVM administration.  After incubation, trays 
were flooded with tepid tap water and incubated for 4 h at 22 °C.  The supernatant 
was then poured over a 1 mm sieve into a 10 l bucket and the faeces discarded.  The 
supernatant was incubated overnight at room temperature, the volume reduced to less 
than 1 l and transferred to a plastic jug.  Next, L3 were collected by a modification of 
the Baermann technique (Baermann, 1917).  A Baermann device was constructed by 
securing two sheets of Whatman© filter (GE Healthcare Companies) paper between 
two plastic collars.  The paper was moistened with tap water and the contents of the 
jug slowly poured through the device.  A 400 ml glass jar was filled with tepid water 
and the device placed into the neck of the jar, and left overnight at room temperature.  
The next day, the Baermann device was removed and the volume reduced via a 
vacuum line to give approximately 20 ml larval culture.  The larval suspension was 
transferred to vented culture flasks (Corning) and the L3 identified to genus level 
using morphological keys (M.A.F.F., 1986) and with reference to previously 
published  studies (Hansen and Shivnani, 1956).  For each sample, 100 randomly 
selected L3 were examined at x 100 magnification.  
 
3.2.3 Statistical analysis  
Data was recorded and arithmetic and geometric calculations performed in Microsoft 
Excel 2007.  Larval genus results were subjected to a test of equal proportions, to 
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ensure that the proportions of larvae surviving passage were similar to those 
originally found on farm  (“prop.test”; (Newcombe, 1998)),  and together with the 
parametric bootstrapping analyses, conducted in R statistical environment (version 
3.0.1), using R Studio (version 0.97.551).  Graphs were drawn using Minitab 15 
(Minitab Inc, 2006) and Microsoft Excel 2007 and with the use of ‘ggplot2’ package 
in R (Team, 2013).    
3.2.3.1 Arithmetic and geometric mean calculations 
The current WAAVP method for calculating FECR value (Coles et al., 1992) does 
not account for multiple counts made from one faecal sample.  Here, FECs were 
conducted in duplicate for each sample, resulting in the generation of two EPG 
values per animal.  To examine this effect on FECR calculation, the data was initially 
analysed in two ways.  First, as every animal had two EPG counts, each EPG value 
generated was treated as a separate count; for example, samples from 10 animals 
resulted in a total of 20 EPG values.  Using this method, all data collected went 
forward to the FECR calculation, referred to as “raw”.  For the second method, an 
arithmetic mean of the two EPG values was made, and this combined value went 
forward to the overall FECR calculation, referred to as a “combined” value.  Unless 
explicitly stated, the “combined” mean was used to generate arithmetic and 
geometric means in the remainder of the statistical analyses.  Overall, arithmetic 
means were calculated from datasets from each farm by adding the FEC values 
together and dividing by the number of samples present.  Geometric means were also 
calculated using the GEOMEAN function in Microsoft Excel, which calculated the 
anti-log of log-transformed counts (Dash et al., 1988).  In order to calculate 
geometric means, a nominal value of one was added to each EPG prior to analysis, 
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and subsequently removed following analysis, as accepted practice (Fulford, 1994). 
There is no universal standard for the value that is required to be added prior to 
analysis (Fulford, 1994).  The addition of a nominal value serves to address any zero 
EPG values in the dataset and is subsequently removed following analysis, to avoid 
influencing the final FECR result.  In addition, for the McMaster method-generated 
data, a value of 25 was added to each EPG value (half the minimum detection level 
of a McMaster count), as suggested by Dash (1988).  The formula used was as 
follows: 
Geometric Mean = ((X1)(X2)(X3)........(Xn))
1/n 
 Where ‘n’ is the number of calves tested and ‘X’ is the “raw” or “combined” FEC 
for a particular sample.  
In order to examine the degree of aggregation (i.e. clumping) of FEC prior to 
anthelmintic administration, k values were generated, by examining the estimated 
variance to mean ratio of the samples.  Here, k values equal to one indicate the 
variance is equal to mean, indicating a Poisson (random) distribution (Shaw and 
Dobson, 1995).  Values of less than 1 indicate a highly aggregated data set.  The 




 – (v/n)/ v – m  
Where ‘m’ is mean FEC, ‘v’ equals the variance between the FECs of selected 
samples and ‘n’ is the number of animals tested.  
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3.2.3.2 Standard faecal egg count reduction calculation 
Following data processing, FECR was calculated using the following formula 
(Kochapakdee et al., 1995):  
R = 100 x ([T1 – T2]/T1) 
where ‘R’ is the FECR value, ‘T1’ is the mean FEC on day of treatment, and ‘T2’ is 
mean post-treatment FEC.  This calculation is similar to that published in the 
WAAVP guidelines (Coles et al., 1992) but does not include FECs derived from 
untreated control groups. The 95% confidence intervals were calculated as described 
by (Anderson et al., 1991) and (Coles et al., 1992). Any negative values (observed, 
for example, if FEC values increased following treatment) were corrected to zero 
(McKenna, 1990) and all values rounded to the nearest integer.  This process was 
used for FECs generated by centrifugal flotation and McMaster methods and for data 
generated by calculating the geometric and arithmetic means of the FECs.  This 
calculation, when used with the “combined” FEC data, was used as the reference 
calculation to compare all other methods of analysis, marked as [WAAVP].  
 
3.2.3.3 Parametric bootstrapping  
A comma separated values (.csv) file was generated from the FECRT dataset 
comprising four columns, namely Farm ID, the arithmetic mean Day 0 and Day 14 
EPG values for each farm and the number of animals sampled from each farm.  This 
file was imported into Rstudio and an empty four-dimensional array constructed. For 
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all 20 farms. there were 20 rows (to contain the Day 14 FEC values for each farm), 
20 columns (to contain the maximum number of Day 0 FEC values, as the maximum 
number of calves sampled was 20), and a dimension to fit 10, 000 bootstrapping 
iterations.  Next, values from the Poisson distribution (Hunter and Quenouille, 1952) 
were randomly generated from Day 0 values, 10,000 times for each farm, with 
sampling length limited to the number of individual samples from a particular farm.  
The Poisson distribution was chosen because although FEC within a group of cattle 
are thought to be negative binomial distribution, FEC within a sample were found to 
fit Poisson distribution.  Next, 10, 000 bootsrapping iterations were run for each of 
the Day 0 values. Then,, a FECR calculation (as described in Section 3.2.3.2; 
(Kochapakdee et al., 1995) was performed using the bootstrapped Day 14 values by 
Day 0 values (10, 000 calculations performed in total, for each farm) to get a 
percentage efficacy value and this was added to the array.  The fourth dimension of 
the array was flattened to allow graphs to be drawn, and mean, median and 95% 
confidence interval values were generated for each farm and exported as a .csv file.  
This was conducted for both centrifugal flotation and McMaster derived data sets.     
3.2.3.4 Determination of ivermectin resistance 
For all methods of analysis, IVM resistance was indicted where the mean FECR was 
less than 95%, with a lower 95% confidence interval of less than 90% (Coles et al., 
1992).  If only one of these two criteria was met, then IVM resistance was suspected.  
Hereafter, farms indicated as “R” met both criteria for IVM resistance, farms marked 
as “S” met neither criteria (i.e. IVM sensitivity indicated) and farms marked as “S?” 
showed a FECR value of 95% or greater, but had a lower 95% confidence interval of 
less than 90%.    
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3.2.4. Analysis of risk factors for IVM resistant nematodes  
All farms conducting the FECRT had completed the questionnaire described in 
Chapter 2.  In order to elucidate potential differences in parasite control and 
management strategies between farms considered to have IVM resistant or sensitive 
nematodes, univariable logistic regression analysis was conducted.  Analysis was 
conducted as described in Chapter 2, Section 2.2.  Briefly, a column (“IVM 
resistant”) was added to the existing csv. file and the resistance status of each farm 
added.  The FECR classification result used for this purpose was that of the AM 
analysis conducted with the CF methodology.  The outcome “IVM resistant” was 
then tested against all areas of best practice advice parameters described in the 
COWS (Control of Worms Sustainably) manual (EBLEX, 2010).  




3.3.1 General descriptive results  
Participating farms were located across the UK, with five farms located in England 
and 15 farms in Scotland.  Postal codes provided by respondents were entered into 
publically available, open-source map generation software (www.batchgeo.com) to 
create the map shown in Figure 7. 
 
Figure 6: Map of participating farms, generated from farm postal codes 
FECRTs were undertaken in the autumn and winter periods of 2010 (Farms 001 – 
004), 2011 (Farms 005 – 019) and 2012 (Farms 020 – 024).  In total, 20 farms 
completed a FECRT, with Farm 004 supplying samples from two cohorts of FSG 
calves: 004a were calves grazed with their dams since birth, with calves from 004b 
grazed on different pastures and turned onto pasture one month later.  All calves 
tested had been born in the spring of that year and had grazed over the preceding 
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summer months.  One farmer (Farm 009) chose to use pour-on IVM (Ivomec 
Classic® Pour-On, 0.5% (w/v) IVM, Merial Animal Health, 0.5 mg/kg BW) on all 
animals in the test group and at Farm 015, pour-on IVM (Ivomec Classic® Pour-On, 
0.5% (w/v) IVM, Merial Animal Health, 500 µg/kg BW) was administered to 7 
animals and injectable IVM (Ivomec Super®, 1% (w/v) IVM, 10% (w/v) clorsulon, 
Merial Animal Health, 0.2 µg IVM kg
-1
 BW) to a further seven animals.  For farms 
001, 008, 010, 015, 020 and 021, the farmers were issued with a weight tape to 
estimate the weight of the calves, and on the remaining farms, calves were weighed 
on weigh crates.  Information regarding weight data (obtained using crate scales) and 
volume of anthelmintic administered to each calf was volunteered from farmers on 
Farms 002, 004 and 015.  A further five farmers volunteered electronic identification 
tag output from weight scales. 
 
3.3.2 Basic parasitological analysis on samples derived from 
all test farms 
All faecal samples (n = 260) predominantly contained trichostrongyle eggs.  The 
presence of Moniezia benedeni eggs were recorded in nine calves in low numbers.  
As neither the CF nor the McMaster FEC methods are thoroughly validated as a 
quantitative detection method for Moniezia spp., detailed results are not presented 
here.  The distribution of trichostrongyle egg counts obtained using the CF method 
are shown in Figure 8 for all pre-treatment samples (n = 260).  The majority of FEC 
values (i.e. 90%) were below 150 EPG, with only 26 animals having FECs in excess 
of 150 EPG.  No trichostrongyle eggs were detected in faecal samples obtained from 
16 calves and in samples from 61 animals, fewer than 10 EPG were enumerated.  























Figure 7: Distribution of trichostrongyle FEC from all calves (n = 260) prior to IVM 
administration.  Data was generated using CF methodology and is presented as “combined” 
mean FEC for each sample tested. 
When FECs were split by year of submission (2010, 2011 or 2012), similar 
distributions were observed (Figure 9).  The mean FEC levels per year were not 
found to be significantly different between years (p>0.05, (Kruskal and Wallis, 
1952). 
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Figure 8: Distribution of trichostrongyle FEC prior to IVM administration by year.  Number of 
samples submitted per year is indicated by n. Data was generated using CF methodology and is 
presented as “combined” mean FEC for each sample tested. 
The k value generated for all 260 samples submitted on day of anthelmintic 
administration was 0.69, indicating that the FEC dataset was highly aggregated.  
When analysed for each year, k values of 0.91, 0.65 and 0.67 were generated for 
years 2010, 2011 and 2012, respectively.  The higher k value generated from the 
2010 dataset is due to the fewer zero FEC results compared to the two following 
years.   
D. viviparus larvae were not observed in any samples obtained on Day 0 (n = 260), 
and so the analysis was not conducted on samples obtained after IVM treatment.  
Similarly, PNA lectin stains were negative for all samples (n = 21), indicating that 
Haemonchus spp. eggs were not observed in these samples.  Low numbers of F. 
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hepatica eggs were observed in three samples prior to treatment, from Farms 006, 
010 and 019, with a maximum of 3 EPG observed in one sample from Farm 019.  No 
F. hepatica eggs were observed in samples obtained after anthelmintic treatment (n= 
260).     
All submitted samples were analysed for trichostrongyle eggs using the CF FEC method 
(Section 3.2.2.1).  The majority of FECs analysed on Day 0 were below 100 EPG, with the 
mean FEC across all samples 54 EPG (± 4 standard error of mean; SEM).  At farm level, 
mean FEC ranged from 3 EPG (Farm 008) to 145 EPG (Farm 013).  The FEC values 
differed among farms and, as suggested by the level of aggregation indicated above, samples 

































Figure 9: Trichostrongyle FEC values per gram of faeces taken on day of treatment with IVM, 
for each farm tested.  The grey markers indicate FEC of each individual and the blue triangles 
indicate the mean EPG for each farm.  All samples were analysed in duplicate using the CF 
FEC method.  
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The FEC data derived from samples submitted 14 days after IVM treatment are 
displayed in Figure 11.  Zero eggs were detected in all samples from Farms 002, 006, 
008, 010 and 021 and the mean FEC across all post-treatment samples was 12 EPG 
(± 2 SEM).  At farm level, the highest mean FEC was observed with samples from 
Farm 013, with a mean FEC of 71 EPG (± 24 SEM).  As with the Day 0 samples, 
FEC values varied between farms and between individuals at farm level.  Sixteen 
farms had at least one zero FEC following IVM treatment.  The largest range in FEC 
on a single farm was observed in samples from Farm 023, where FECs ranged from 
2 to 248 EPG.  With respect to Farm 015, there was no significant difference 
observed in FECs at Day 14 after treatment between samples submitted from the 
seven calves that were treated with pour-on IVM compared to the seven animals that 
had been administered with injectable IVM.    
































Figure 10: Trichostrongyle FEC values per gram of faeces taken 14 days following IVM 
administration, for each farm tested.  The grey markers indicate FEC of an individual animal 
and the blue triangles indicate the mean EPG for each farm as measured by the CF method.  All 
samples were analysed in duplicate.   
 
3.3.3. Assessment of efficacy of IVM 
Arithmetic mean reductions in FEC were calculated using the formula described in 
Section 3.2.3.2 and the results displayed in Figure 12.  Based on criteria published by 
WAAVP (Coles et al., 1992), where a declaration of ML resistance is dependent 
upon a mean FECR of less than 95% and a lower 95% CI of less than 90%, thirteen 
of the twenty populations tested showed indications of IVM resistance.  
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Figure 11: FECRT values per farm.  The blue bars represent the mean percentage reduction in 
FEC for each farm 14 days after IVM treatment.  Error bars represent the 95% confidence 
intervals.  The red dashed line indicates the FECR threshold for resistance as determined by 
WAAVP (Coles et al., 1992).  
 
3.3.4 Identification of third-stage larvae before and after IVM 
treatment 
Culture of pooled faecal samples was undertaken to allow identification of 
trichostrongyle L3 to genus level to monitor any change in percentage genus 
composition following IVM administration (MAFF 1986).  One hundred L3 were 
identified from all Day 0 samples (n= 21), despite low FEC levels in some samples.  
Nineteen Day 0 cultures contained a combination of Ostertagia spp. and Cooperia 
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spp. L3 (Table 12).  One culture (Farm 008) was comprised entirely of Cooperia spp. 
L3, and cultures from three farms (Farms 006, 010 and 013) contained 
Trichostrongylus spp. L3.  Following IVM administration, there were changes in the 
proportions of trichostrongyle L3.  Cooperia spp. dominated these cultures (range: 96 
- 100%) and lower proportions of Ostertagia spp. L3 (range: 1 – 4%) were present.  
No Trichostrongylus spp. were found to be present following IVM administration.  
Cultures were also conducted on samples from farms where no eggs were observed 
following IVM treatment (Farms 006, 008, 010 and 021) and these failed to yield any 
L3.  From all other farms, a minimum of 100 L3 were selected from each pooled 
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Table 12 : Percentage genus composition of trichostrongyle L3 following faecal culture on 
samples obtained on the day of treatment (Day 0) and 14 days after IVM administration.  
Identification was performed using morphological keys (Hansen and Shivnani, 1956; M.A.F.F., 
1986) on 100 randomly selected L3 from all samples from each farm.  No Trichostrongylus spp. 
were observed at Day 14.  SNA = samples not analysed.  Samples from Farm 002 following IVM 
administration were not cultured due to zero FEC, however in order to investigate potential for 
eggs to be present in ‘negative’ samples, cultures were conducted for all other farms, regardless 















001 15 85 0 4 96 
002 22 78 0 SNA SNA 
003 16 84 0 0 100 
004a 38 62 0 0 100 
004b 29 71 0 0 100 
005 19 81 0 0 100 
006 33 63 4 0 0 
007 15 85 0 3 97 
008 0 100 0 0 0 
009 30 70 0 0 100 
010 44 3 53 0 0 
011 20 80 0 3 97 
012 28 72 0 1 99 
013 11 81 8 0 100 
015 4 96 0 0 100 
017 26 74 0 2 98 
019 5 95 0 2 98 
020 14 86 0 0 100 
021 10 90 0 0 0 
023 17 83 0 0 100 
024 8 92 0 0 100 
 
Results from the proportion test analysis revealed a statistically significant change in 
Ostertagia spp. in cultures from all farms following IVM administration (P < 0.05), 
with the exception of Farm 019.  There was a statistically significant change in 
Cooperia spp. prevalence in cultures on all farms following IVM administration, 
with the exception of Farms 010, 015 and 019 (P > 0.05).   
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Figure 12: Percentage genus composition of trichostrongyle L3 following faecal culture on 
samples obtained on day of IVM administration (Day 0).  Identification was performed using 
morphological keys (Hansen and Shivnani, 1956; M.A.F.F., 1986) on 100 randomly selected L3 
from all samples from each farm. Blue, red and green bars indicate the presence of Ostertagia 
spp., Cooperia spp., and Trichostrongylus spp., respectively.  
 




Figure 13: Percentage genus composition of trichostrongyle L3 following faecal culture on 
samples 14 days following IVM administration.  Identification was performed using 
morphological keys (Hansen and Shivnani, 1956; M.A.F.F., 1986) on 100 randomly selected L3 
from all samples from each farm. Blue and red bars indicate the presence of Ostertagia spp. and 
Cooperia spp., respectively.  The absence of bars for Farms 006, 008, 010 and 021 indicate that 
no L3 were obtained following IVM administration. Culture of samples following IVM 
administration from Farm 002 was not performed.  
 
3.3.5 The impact of using different methodologies in 
analysing FEC and FECRT data 
3.3.5.1 The influence of using ‘raw’ or ‘combined’ FEC data on FECR 
calculation  
All faecal samples were analysed in duplicate for FEC, resulting in the production of 
two FEC results for each sample.  WAAVP guidelines (Coles et al., 1992) do not 
currently account for having more than one count per sample and, as such, there may 
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be variation in the way data is analysed between studies.  To examine this, arithmetic 
means (AM) of percentage reduction in FEC for each farm were calculated using 
both “raw” data (i.e. using both FEC results from each sample) and “combined” data 
(i.e. an arithmetic mean produced from combining the results of each individual 
sample).  The results from this analysis are presented in Table 13.  For samples from 
every farm, the classifications are the same for both “raw” and “combined” data.  
Production of a “combined” mean results in larger 95% CI compared to the use of 
“raw” data; however these smaller CI are a consequence of treating each FEC value 
as a separate animal, and as such, artificially inflates the dataset.  In order to control 
this inflation, the “combined” FEC data was used for subsequent comparisons with 
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Table 13: Table of mean percentage efficacy values generated using “raw” or “combined” FEC 
data to generate the arithmetic mean (AM) for each treatment population.  The 95% confidence 
intervals are displayed in brackets.  Green boxes indicate ‘IVM sensitive’ populations; orange 
boxes indicate ‘IVM resistant’ populations. 
  AM (“combined”) 
(95% CI) [WAAVP] 
AM (“raw”) 
(95% CI) Farm ID N 
001 6 72 (15 – 91) 72 (40 – 87) 
002 10 100  100  
003 16 84 (72 – 90) 84 (77 – 89) 
004a 10 87 (69 – 95) 87 (77 – 93) 
004b 10 65 (0 – 91) 65 (12 – 87) 
005 15 78 (53 – 90) 78 (63 – 87) 
006 14 100  100  
007 12 74 (0 – 93) 76 (33 – 92) 
008 10 100  100  
009 15 98 (95 – 99) 98 (96 – 99) 
010 15 100  100  
011 15 66 (45 – 79) 66 (52 – 76) 
012 15 88 (74 – 95) 89 (78 – 94) 
013 12 51 (0 – 77) 51 (17 – 72) 
015 14 67 (0 – 92) 67 (12 – 88) 
017 13 97 (93 – 99) 97 (95 – 99) 
019 6 67 (0 – 91) 67 (17 – 87) 
020 20 97 (92 – 99) 98 (95 – 99) 
021 11 100  100  
023 12 0 (0 – 63) 0 (0 – 49) 
024 9 86 (73 – 92) 86 (78 – 91) 
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3.3.5.2 The influence of generating geometric versus arithmetic means 
of FEC data to calculate efficacy  
The use of arithmetic means has been considered to over-estimate the prevalence of 
anthelmintic resistance (Dash et al., 1988) and that for calculation of FECR values, 
the generation of a geometric mean (GM) is more appropriate.  This is because the 
GM is based on the median FECR value which takes into account the variation 
between animals and reduces the effect of a few extremely high FEC values 
(Presidente, 1985; Dash et al., 1988; Vercruysse et al., 2001).  The geometric mean 
also addresses the range of values within a sampling frame, and allows equal weight 
to be given to samples from a small range (i.e. 1 – 50) and those from a larger range 
(i.e. 1 – 500).  The data is transformed to resemble a normal distribution, which is 
not always successful and can often increase error rates in subsequent analyses 
(Torgerson et al., 2005). However, the GM provides an estimate of the FEC of the 
“average” calf within a sample group, and as such, can be useful.  An arithmetic 
mean is easier to calculate mathematically and is more often used so is more 
commonly the comparator across studies (Dash et al., 1988).  Moreover, the 
arithmetic mean is not biased by the transformations applied to the GM (Fulford, 
1994) and so is likely a better representative of egg output and predictions of future 
larval infections (Dash et al., 1988).  In view of these opposing opinions, a 
comparison was conducted to compare FECR values generated by calculating 
geometric versus arithmetic means of the FEC data.  The results from the geometric 
mean analysis are compared with the arithmetic mean analysis in Table 14.  Efficacy 
values generated using AM indicated that 14 of the tested populations were IVM 
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‘resistant’; whilst the values generated using GM indicated that one of these 
populations (Farm 020) was IVM ‘sensitive’.  GM analysis of samples from Farm 
017 indicated IVM resistant nematodes were suspected, indicated by the lower 95% 
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Table 14: Table of FECR values generated using arithmetic (AM) and geometric means (GM), 
with 95% confidence intervals displayed in brackets.  ‘N’ represents the number of samples 
submitted for each population.  Green, orange and blue boxes indicate IVM sensitive, resistant 
and suspected resistant populations, respectively.   
  AM  
(95% CI) 
[WAAVP] 
GM FECR  
(95% CI)  Farm ID N 
001 6 72 (15 – 91) 63 (0 – 90) 
002 10 100  100  
003 16 84 (72 – 90) 81 (69 – 89) 
004a 10 87 (69 – 95) 81 (52 – 93) 
004b 10 65 (0 – 91) 49 (0 – 86) 
005 15 78 (53 – 90) 71 (36 – 87) 
006 14 100  100  
007 12 74 (0 – 93) 52 (0 – 92) 
008 10 100  100  
009 15 98 (95 – 99) 97 (95 – 98) 
010 15 100  100  
011 15 66 (45 – 79) 56 (23 – 75) 
012 15 88 (74 – 95) 77 (12 – 94) 
013 12 51 (0 – 77) 42 (0 – 74) 
015 14 67 (0 – 92) 57 (0 – 89) 
017 13 97 (93 – 99) 95 (84 – 99) 
019 6 67 (0 – 91) 52 (0 – 89) 
020 20 97 (92 – 99) 86 (0 – 100) 
021 11 100  100  
023 12 0 (0 – 63) 0 (0 – 54) 
024 9 86 (73 – 92) 79 (56 – 90) 
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3.3.5.3  The influence of parametric bootstrapping analysis on FECR 
calculation 
The use of arithmetic and geometric means for generating FECR values has been 
said to fail to account for the distribution of nematode eggs within well-mixed faecal 
samples (Torgerson et al., 2012).  If a sample is correctly mixed prior to FEC 
analysis, the nematode eggs are assumed to follow a Poisson distribution (Torgerson 
et al., 2012), as previously indicated in the enumeration of yeast cells in a 
haemocytometer (Student, 1907).  It is known that variability within faecal samples 
will often result in different EPG values being generated when duplicate counts from 
a single sample are analysed (Vidyashankar et al., 2007), particularly when a 
relatively insensitive FEC method is used. To address this variability, it has been 
suggested that bootstrapping the data by repeated re-sampling from a Poisson 
distribution (for example, 10,000 times) will decrease diagnostic error rate and 
provide a more appropriate measure of variance between samples (Torgerson et al., 
2012).  Therefore, the FEC data generated from all farms before and after treatment 
with IVM, using the mean FEC value for each animal, was subjected to parametric 
bootstrapping (Torgerson et al., 2012) to produce an efficacy value.  The parametric 
bootstrapping results are displayed in Table 15 and Figure 15.  The arithmetic mean 
WAAVP calculated-FECR values and bootstrapping results correlate well, with 
classifications for all farms matching.  Graphical representation of the bootstrapping 
analysis is shown in Figure 15.  The greater the spread of the data, as indicated by the 
pale blue bars, the more variable the FECR values were.  With Farm 020, the FECR 
values were closer together in comparison to other farms, indicating that the 
  Chapter 3 
125 
frequency of FECR values are similar and in the region of 95% efficacy.  Arithmetic 
mean (represented by the blue line) is the most frequently occurring FECR value, as 
calculated by Coles et al., (1992).  As this value occurs in the middle of the pale blue 
bars (generated by parametric bootstrapping analysis), this serves as confirmation 
that the AM analysis (in combination with CF FEC method) provides an appropriate 
representation of the data set.  Bootstrap confidence intervals were not available 
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Table 15: Parametric bootstrapping results compared to AM FECRT values.  ‘N’ represents the 
number of samples submitted from each farm.  Green and orange boxes indicate IVM sensitive 
and resistant populations, respectively. 





001 6 72 (15 – 91) 72 (50 – 84) 
002 10 100  100  
003 16 84 (72 – 90) 83 (56 – 95) 
004a 10 87 (69 – 95) 87 (75 – 94) 
004b 10 65 (0 – 91) 65 (8 – 88) 
005 15 78 (53 – 90) 77 (43 – 93) 
006 14 100  100  
007 12 74 (0 – 93) 75 (0 – 100) 
008 10 100  100  
009 15 98 (95 – 99) 97 (93 – 100)  
010 15 100  100  
011 15 66 (45 – 79) 66 (45 – 78) 
012 15 88 (74 – 95) 86 (72 – 97) 
013 12 51 (0 – 77) 51 (30 – 64) 
015 14 67 (0 – 92) 67 (27 – 85) 
017 13 97 (93 – 99) 97 (91 – 100) 
019 6 67 (0 – 91) 67 (38 – 82) 
020 20 97 (92 – 99) 97 (88 – 100) 
021 11 100  100  
023 12 0 (0 – 63) 0 (0 – 32) 
024 9 86 (73 – 92) 85 (75 – 91) 




Figure 14: Graphical representation of the parametric bootstrapping analysis of IVM FECR utilising the centrifugal flotation FEC dataset for each farm.  Dark 
blue bars represent the mean FECR as calculated by the standard WAAVP method, with the light blue bars representing the spread of FECR values after 10,000 
resamplings.  The purple and green lines indicate the 95 and 99% confidence intervals, with the purple boxes indicating where efficacy was less than 0%, (i.e. FEC 
increased following IVM administration).   
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3.3.5.4 Summary of FECRT classifications based on enumerating 
trichostrongyle nematode eggs using the CF method 
A summary of the IVM sensitivity classifications produced by each type of FECR analysis is 
shown in Table 16.  Incongruity between methods was observed for data derived from Farm 
020, where a call for IVM resistance was made using the geometric mean methodology and 
IVM sensitivity with WAAVP arithmetic mean and parametric bootstrapping analyses.  Data 
derived from samples from Farm 017 resulted in a classification of suspected IVM resistance 
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Table 16: Summary table of the IVM sensitivity classifications generated using different types of analysis: 
WAAVP arithmetic means (AM), geometric means (GM) and parametric bootstrapping.  The number in 
the square brackets indicates the value added to each FEC prior to GM analysis 
Farm ID N AM  
FECR  
[WAAVP] 




001 6 R R R 
002 10 S S S 
003 16 R R R 
004a 10 R R R 
004b 10 R R R 
005 15 R R R 
006 14 S S S 
007 12 R R R 
008 10 S S S 
009 15 S S S 
010 15 S S S 
011 15 R R R 
012 15 R R R 
013 12 R R R 
015 14 R R R 
017 13 S S? S 
019 6 R R R 
020 20 S R S 
021 11 S S S 
023 12 R R R 
024 9 R R R 
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3.3.6 Impact of FECRT analysis with McMaster FEC method  
It has been recommended that for the examination of cattle FEC samples, a sensitive method 
is employed (Coles et al., 2006).  Whilst the CF method employed in the previous section is 
sensitive up to 1 EPG, the McMaster technique (Gordon and Whitlock, 1939) is the current 
“gold standard” and is used widely in practice and so facilitates direct comparison between 
published studies (Sutherland and Leathwick, 2011).  As the CF FEC technique produced 
similar results in the comparison of statistical analyses, it was decided to investigate the 
effect of the less sensitive McMaster technique on FECRT analysis, as FECR precision is 
known to decrease with a less sensitive FEC method (Levecke et al., 2011).  To this effect, 
FECRT samples from Farms 005 to 024 were also analysed in duplicate using the McMaster 
technique sensitive to 50 EPG (Gordon and Whitlock, 1939).  
From Figure 16 it can be seen that the FEC taken on day of treatment were low, with an 
average FEC of 65 EPG (± 6 SEM).  At a farm level, mean FEC ranged from 6 EPG (Farm 
007) to 195 EPG (Farm 024).  As seen with the CF method, FEC were seen to differ between 
farms and with samples from the same farm, for example, FEC values for Farm 011 range 
from 0 to 550 EPG. 


































Figure 15: Trichostrongyle FEC values per gram of faeces taken on day of treatment with IVM, for each 
farm tested.  The grey markers indicate FEC of each individual and the blue triangles indicate the mean 
EPG for each farm. All samples were analysed in duplicate using the McMaster FEC method 
Results from samples submitted 14 days after IVM treatment are displayed in Figure 17.  
Zero eggs were observed in samples from Farms 005, 006, 007, 008, 010 and 021, with the 
mean FEC of 15 EPG (± 3 SEM) across all post-treatment samples.  At farm level, the 
highest mean FEC was observed with samples from Farm 013 with a mean of 75 EPG (± 23 
SEM).  The largest range between post-treatment FEC was seen with Farm 023, with FEC 
ranging from zero to 275 EPG.  


































Figure 16: Trichostrongyle FEC values per gram of faeces taken 14 days following treatment with IVM, 
for each farm tested.  The grey markers indicate FEC of each individual and the blue triangles indicate 
the mean EPG for each farm. All samples were analysed in duplicate using the McMaster FEC method 
 
The arithmetic mean reduction in FEC was calculated using the formula described in Section 
3.2.3.2 and the results displayed in Figure 18.  Based on the WAAVP criteria described 
previously, data from eight farms indicated the presence of IVM resistant nematodes.  Data 
from six farms indicated IVM-sensitivity; i.e. FECR values in excess of 95% and lower 95% 
CI in excess of 90%.  The results from the remaining two farms indicated that IVM-resistance 
was suspected, as FECR values were 97% and 95%, but with lower 95% CI of 76% and 75%, 
on Farms 012 and 017, respectively.    
 




Figure 17: IVM FECRT results as assessed using the McMaster method (Gordon and Whitlock, 1939).  
Each bar represents percentage reduction in FEC per farm, 14 days after IVM treatment.  Error bars 
represent the 95% confidence intervals.  The red dashed line indicates the threshold for resistance as 
determined by WAAVP (Coles et al., 1992). 
 
 
3.3.6.1 The influence of using ‘raw’ or ‘combined’ FEC data on FECR 
calculation using McMaster FEC method  
As described in Section 3.4.1, there are no published guidelines on the use of duplicate FECs 
from a sample and so the effect of using “raw” or “combined” data was examined and the 
results are presented in Table 17.  The data indicated that seven farms showed signs that the 
nematodes were  IVM-sensitive, four in agreement with the CF FEC method analysis (Table 
13; Farms 006, 008, 010, 021).  Data from farms 012 and 017 indicated a “suspected 
resistant” population, with FECR values of 97% and 95%, respectively, but with lower CI of 
below 90%.  With the CF methodology, Farm 012 was classified as being an IVM resistant 
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nematode population in all analyses, whereas for Farm 017, resistance was suspected with 
GM analysis and the population considered sensitive with the AM and bootstrap analysis.  
Table 17: Table of FECR data derived using the McMaster FEC method, based on using “raw” or 
“combined” data to generate arithmetic means (AM). 95% confidence intervals are displayed in brackets.  
Green boxes indicate “IVM sensitive” populations, orange boxes indicate “IVM resistant” populations 
and blue boxes indicate “suspected IVM resistance” populations.   




(95% CI) Farm ID N 
005 15 100  100  
006 14 100  100  
007 12 100  100  
008 10 100  100  
009 15 90 (76 – 96) 90 (75 – 96) 
010 15 100  100  
011 15 69 (13 – 89) 69 (34 – 85) 
012 15 97 (76 – 100) 97 (76 – 100) 
013 12 58 (11 – 80) 58 (24 – 76) 
015 14 11 (0 – 65) 11 (0 – 59) 
017 13 95 (74 – 99) 95 (75 – 99) 
019 6 67 (0 – 97) 67 (0 – 97) 
020 20 83 (36 – 95) 83 (41 – 95) 
021 11 100  100  
023 12 3 (0 – 69) 3 (0 – 59) 
024 9 89 (72 – 95) 89 (76 – 95) 
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To ensure comparable results with the CF FEC method, it was decided to use the “combined” 
FEC data for the comparisons with geometric means and parametric bootstrapping analysis.  
 
3.3.6.2 The influence of generating geometric versus arithmetic means of 
McMaster FEC data to calculate efficacy  
The results from the GM analysis are presented in Table 18 and are predominantly in 
agreement, with the dataset which used AM in the analysis.  Two exceptions were observed: 
one with Farm 012, where the addition of 1 prior to GM analysis produces an IVM-resistant 
result.  In contrast, a ‘suspected resistance’ result was generated with AM analysis and GM 
when 25 was added prior to analysis.  The second exception was observed with Farm 017, 
where the GM analyses indicate IVM resistance, whereas the AM analysis suggests 
‘suspected resistance’.  Overall, the McMaster GM (with the addition of 25) appears to 
compare more favourably to the results generated with the McMaster AM data, than the 
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Table 18: Table of FECR values obtained using McMaster method to generate arithmetic (AM) and 
geometric means (GM), with 95% confidence intervals displayed in brackets. ‘N’ represents the number 
of samples submitted from each farm. Green boxes indicate IVM sensitive farms, orange boxes indicate 
IVM resistant farms and blue boxes indicate suspected IVM resistant farms 
  AM FECR 
(95% CI) 
[WAAVP] 
GM  FECR  
(95% CI)  
[+1] 
GM FECR  
(95% CI)  
[+25] 
Farm ID N 
005 15 100  100  100  
006 14 100  100  100 
007 12 100  100  100  
008 10 100  100  100  
009 15 90 (76 – 96) 88 (73 – 95) 92 (73 – 98) 
010 15 100  100  100  
011 15 69 (13 – 89) 0 (0 – 96) 55 (0 – 93) 
012 15 97 (76 – 100) 92 (43 – 99) 97 (42 – 100) 
013 12 58 (11 – 80) 47 (0 – 76) 69 (10 – 89) 
015 14 11 (0 – 65) 0 (0 – 52) 26 (0 – 82) 
017 13 95 (74 – 99) 72 (0 – 100) 93 (20 – 99) 
019 6 67 (0 – 97) 0 (0 – 100) 65 (0 – 99) 
020 20 83 (36 – 95) 0 (0 – 100) 75 (0 – 98) 
021 11 100  100  100  
023 12 3 (0 – 69) 0 (0 – 81) 14 (0 – 89) 
024 9 89 (72 – 95) 86 (65 – 94) 90 (67 – 97) 
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3.3.6.3 The effect of parametric bootstrapping on FECR calculation with 
McMaster method  
As explained in Section 3.4.3, there is a need to account for the FEC variability seen within 
samples and so the McMaster FEC data were treated in the same way, with FEC values 
resampled 10,000 times from a Poisson distribution (Torgerson et al., 2012) .  The FECRT 
values are presented in Table 19 and in Figure 19.  The McMaster data presented here shows 
greater variability in FECR frequencies compared to the CF results, made apparent by the 
wider spread of the data in Figure 19 compared to that in Figure 15.  From Table 19, the 
classifications using the AM method and bootstrapping, are the same for 14 of the 16 farms 
tested.  The exceptions are seen with Farms 012 and 017.  With Farm 012, where the FECR 
values are the same (97%) but a lower 95% CI of 76% gives a call for suspected IVM 
resistance with the AM, whereas the bootstrapping method generates a call for sensitivity 
based on a lower 95% CI of 91%.  With Farm 017, the AM method produces a call for 
suspected IVM sensitivity, due to a FECR of 95% and lower 95% CI of 74%, however this 
changes to IVM resistant when bootstrap analysis is conducted, producing a FECR of 94% 
and a lower 95% CI of 88%.  Bootstrap confidence intervals were not available when there 
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Table 19: Parametric bootstrapping results for McMaster method, compared to FECR values generated 
with AM. ‘N’ represents the number of samples submitted from each farm.  Green boxes indicate IVM 
sensitive farms, orange boxes indicate IVM resistant farms and blue boxes indicate suspected IVM 
resistant farms 





005 15 100  100  
006 14 100  100  
007 12 100 100  
008 10 100  100  
009 15 90 (76 – 96) 90 (84 – 95) 
010 15 100  100  
011 15 69 (13 – 89) 69 (54 – 81) 
012 15 97 (76 – 100) 97 (91 – 100) 
013 12 58 (11 – 80) 58 (45 – 68) 
015 14 11 (0 – 65) 12 (0 – 47) 
017 13 95 (74 – 99) 94 (88 – 99) 
019 6 67 (0 – 97) 68 (33 – 89) 
020 20 83 (36 – 95) 82 (65 – 94) 
021 11 100  100  
023 12 3 (0 – 69) 3 (0 – 33) 
024 9 89 (72 – 95) 88 (83 – 93) 
 




Figure 18: Graphical representation of the parametric bootstrapping using McMaster data for each farm tested. Dark blue bars represent the mean FECR as 
calculated by the standard WAAVP AM method, with the light blue bars representing the spread of FECR values after 10,000 resamplings.  The purple and green 
lines indicate the 95 and 99% confidence intervals purple boxes indicating where efficacy was less than 0%, (i.e. FEC increased following IVM administration).   
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3.3.6.4 Summary of FECRT classifications based on enumerating 
trichostrongyle nematode eggs using the McMaster method  
A summary of the classifications produced for each FECR analysis, for the McMaster FEC 
data is shown in Table 20.  Disagreements in classification are seen with Farms 012 and 017.  
Both GM methods are in agreement, but with Farm 012, the AM method indicates suspected 
IVM resistance, and bootstrapping indicated IVM sensitivity.  With Farm 017, both GM 
methods call IVM resistance, but this is only suspected IVM resistance with AM and 
bootstrapping.  Overall, as seen with the CF analysis above, AM analysis with the McMaster 
FEC method appears to be as robust as the more mathematically involved processes of the 
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Table 20: Summary table of the IVM resistance classifications generated using different analysis 
methodologies: arithmetic means (AM), geometric means (GM) and parametric bootstrapping.  The 
numbers in the square brackets indicate the value added to each FEC prior to GM analysis 
Farm ID N AM  
FECR 
[WAAVP] 
GM FECR   
[+1] 




005 15 S S S S 
006 14 S S S S 
007 12 S S S S 
008 10 S S S S 
009 15 R R R R 
010 15 S S S S 
011 15 R R R R 
012 15 S? R R S 
013 12 R R R R 
015 14 R R R R 
017 13 S? R R S? 
019 6 R R R R 
020 20 R R R R 
021 11 S S S S 
023 12 R R R R 
024 9 R R R R 
 
From the samples where the McMaster and CF techniques were both conducted, five 
classifications  from a total of 16 did not agree in all analyses, namely  Farms 005, 007, 009, 
012, 017 and 020.  With Farms 005 and 007, both were classified as resistant with the CF 
method and as sensitive with the McMaster analyses, whereas the inverse was found with 
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Farm 009. With the remaining farms, differences in classification were not restricted to FEC 
method, but differed dependent on the use of GM analysis.        
3.3.7. Comparison of CF and McMaster percentage efficacies 
 
 
Figure 19: Comparison of percentage efficacies for farms where FEC were conducted using both CF and 
McMaster methodologies. Data labels indicate farm name. 
Figure 19 illustrates a graphical comparison between percentage efficacies calculated for the 
farms where both FEC methodologies were employed. 
  
3.3.8. Analysis of risk factors for IVM resistance 
From the univariable odds ratio (OR) analysis, there were two areas where a statistically 
significant difference was found.  First, on farms where IVM resistant nematodes were 
present, farmers were significantly less likely to seek advice on parasite control from either 
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other farmers or pharmaceutical representatives (ORs < 0.07, 95% confidence intervals (CI) 
0.01 – 0.8).  Second, on farms where IVM resistance was present, farmers were significantly 
more likely to isolate newly acquired cattle following quarantine (OR 18, 95% CI: 1.3 – 255).  
Fewer stock were farmed where IVM resistance was identified (mean of 52 animals per age 
group) compared to farms with IVM sensitive populations (67 animals per age group), but 
adult cattle were managed at slightly higher stocking densities (3 – 5 per hectare) on four 
farms.  The number of anthelmintic treatments administered each year was also similar; with 
an average of 1.6 treatments administered on farms where IVM resistant nematodes were 
identified compared to an average of 1.9 treatments administered per year on farms where 
IVM sensitive nematodes were identified.  ML treatments were used by all farmers and 
administered as a pour-on application.  None of the farmers in either group believed their 
anthelmintic efficacy was lower compared to previous years.  One area where the groups (i.e. 
farms where IVM resistant vs. IVM sensitive nematodes were identified) differed in 
management was in the treatment of adult cows.  On five of the farms where IVM-resistant 
nematodes were detected, the farmers treated adult cattle at housing, compared to the group 
in which where IVM-sensitive nematodes were detected where only one farmer treated cows 
at this time.  In addition, on six of the 13 farms where IVM resistance was detected, the 
farmers treated all of their adult cows.  This is in contrast to treating them on a selective 
basis, which was conducted on one of the farms where IVM sensitive nematodes were 
identified.  Treatment practices for younger cattle (stirks and calves) were similar in both 
groups, with all animals receiving anthelmintic treatments on average twice a year. 
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3.4 Discussion  
As a result of the increase in the number of reports of AR in cattle nematodes 
worldwide, there is a need for robust tests to improve detection of resistance and 
allow comparisons to be conducted between studies (Sutherland and Leathwick, 
2011).  Here, IVM efficacy was assessed on 21 sets of faecal samples from 260 FSG 
calves on 20 farms, with IVM resistant Cooperia spp. identified on 13 farms.  FEC 
recorded prior to IVM treatment were relatively low, with 90% of samples below 
150 EPG, with a mean of 54 EPG across all 260 calves tested.  Highly aggregated k 
values (i.e. k < 1) in the FEC generated from these samples indicate that the 
distribution of nematode eggs in these cattle fits well with the negative binomial 
distribution, which has been previously shown to be an appropriate distribution for 
macroparasites (Shaw and Dobson, 1995) and widely believed to be representative of 
all gastrointestinal nematode infections (Shaw et al., 1998; Morrill and Forbes, 
2012).  These FEC results correlate well with FEC levels observed previously in 
naturally infected FSG calves at this time of year, albeit calculated using differing 
FEC methodologies (Cornwall et al., 1971; Lyons et al., 1995; Ellis et al., 2011).   
In the UK, FEC research has predominately focussed on experimental infections for 
anthelmintic registration purposes; however work recently conducted on an organic 
cattle farm in Scotland found low FEC (<50 EPG) in FSG calves throughout the 
winter housing period (Ellis et al., 2011).  An earlier study also identified that, 
between farms, mean FEC can differ, and the time at which FEC peak in the season 
can differ, dependent on pasture management and climatic factors (Cornwall et al., 
1971).  This has also been observed in other temperate regions, such as parts of the 
USA (Lyons et al., 1995) and mainland Europe (Kerboeuf et al., 1996; Poot et al., 
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1997; Jäger et al., 2005; El-Abdellati et al., 2010a).  Other studies also reported low 
FEC in FSG calves, with mean FEC of 50 EPG to 100 EPG reported in France 
(Kerboeuf et al., 1996); the Netherlands (Poot et al., 1997) and Germany (Jäger et al., 
2005). Little information was reported regarding the FEC method employed in these 
studies; however, a study conducted across Belgium and Germany reported a mean 
FEC of 90 EPG when a McMaster FEC method sensitive to 50 EPG was used (El-
Abdellati et al., 2010a).  The similarity of FEC distribution across the three years of 
sampling (2010 – 2012) here matches a previously published observation (Gasbarre 
et al., 1996), where the largest source of variation in FEC was found between 
samples from calves on the same farm.  The relatively low FEC values observed here 
may also be attributed to the time of year when sampling was conducted, as FECs 
have previously been shown to be lowest at housing in the UK (Michel et al., 1970a; 
Bairden et al., 1985).   
The current FECRT study was designed to follow the farmers’ routine treatment 
regimes as far as possible (Chapter 2), which included treatment of FSG calves at 
housing after grazing over the summer months with their dams.  A benefit of 
conducting the FECRT sampling at housing is that for collection of samples 
following treatment, calves do not have to be gathered in from grazing thus reducing 
time and labour costs and increasing the willingness of participants to comply with 
sampling schedules.  Consequently, the results provide valuable data regarding FEC 
levels when this anthelmintic treatment is normally administered.  It is important to 
note that FECs are not particularly informative of total nematode infection levels, 
especially as both Ostertagia spp. and Cooperia spp. larvae are known to inhibit in 
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the gastrointestinal tract during winter months (Armour et al., 1969a; Michel et al., 
1970a).  The re-emergence of inhibited Ostertagia spp. larvae in spring, can lead to 
Type II ostertagiosis, which can prove fatal (Martin et al., 1957; Armour, 1970; 
Armour and Duncan, 1987) and this is one of the main reasons that a treatment at 
housing with an appropriate anthelmintic is recommended, i.e. to eliminate these 
larvae.  MLs are currently the only anthelmintic class licensed in UK cattle with 
claims of high efficacy against inhibited O. ostertagi larvae (NOAH, 2014).  
Efficacies against inhibited O. ostertagi stages have been reported to be in excess of 
99% when compared to untreated control animals (Egerton et al., 1981; Yazwinski et 
al., 1981; Benz et al., 1983; Alva-Valdes et al., 1984).  In contrast, there have been 
conflicting reports as to the effectiveness of BZ anthelmintics, particularly 
fenbendazole (FBZ), against these inhibited stages (Anderson and Lord, 1979).  
Some studies have published efficacies in excess of 97% (Duncan et al., 1976; 
Lancaster and Hong, 1977; Duncan et al., 1978); however, others demonstrated 
efficacies in the region of only 20% (Lancaster and Hong, 1977) or no significant 
difference in inhibited larval burdens when treated animals were compared to 
untreated infected control animals (Elliott, 1977).   
Based on an arithmetic mean FECR calculation as recommended by the WAAVP 
(Coles et al., 1992), with the CF FEC technique, 13 farms tested here showed 
indications of IVM resistance, based on a FECR of less than 95% and a lower 95% 
CI of less than 90%.  Despite little published information regarding FECRT analyses 
in UK cattle, this finding is not wholly unexpected, given previous reports of IVM 
resistance from Coles and Stafford (1999), Coles et al., (2001) and reports of ML 
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inefficacy in calves from Sargison et al., (2009, 2010).  The current study is the 
largest conducted in the UK to date.  Within northern Europe, FECRT reporting is 
limited to two main studies (Demeler et al., 2009; El-Abdellati et al., 2010a).  In the 
first, results similar to those reported here were found in samples collected from 
farms in Belgium (n = 8), Germany (n = 9) and Sweden (n = 5), before and after 
parenteral administration of IVM (Demeler et al., 2009).  Samples from three farms 
were taken 14 days following treatment, with the remainder sampled seven days 
following treatment.  All animals were then sampled again 21 days after treatment.  
Analysis at Day 7 or 14 revealed six farms with nematode FECR of less than 95%, 
increasing to 16 farms at 21 days following treatment (Demeler et al., 2009).  
Collection of samples seven days following IVM administration is not advised for 
FECRT analysis, as egg suppression in female nematodes following ML treatment 
has been reported (Presidente, 1985; McKellar et al., 1988; Coles et al., 2006).  It is 
currently recommended to sample cattle 14 – 17 days after ML anthelmintic 
administration, to avoid false results (Coles et al., 2006).  After 14 days, the egg 
suppressive effect on adult nematodes is thought to be minimal (Leathwick and 
Miller, 2013).  In the previous EU study (Demeler et al., 2009), faecal cultures taken 
before and after IVM administration showed the presence of Ostertagia and 
Cooperia spp. larvae prior to treatment, with Cooperia spp. predominating following 
treatment in samples analysed at Day 7 and Day 21 after treatment.  These were 
reported as presence/absence for each species as opposed to the relative proportions 
of species identified.  As IVM is not licensed for high efficacy against immature 
larval stages of Cooperia spp. (NOAH, 2014), eggs present in samples collected 21 
days after treatment may be the result of these stages reaching patency, rather than 
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resumption of egg laying from surviving adult nematodes (Wood et al., 1995).  In a 
subsequent study conducted in Belgium, a FECR of less than 95% was identified 
after ML administration on 33 of 84 farms studied (El-Abdellati et al., 2010a).  
Faecal cultures conducted using samples from 20 of the farms with positive FEC 
results following treatment revealed that, again, Cooperia spp. larvae dominated the 
cultures, although the presence of other species (including Ostertagia spp.) were 
noted (0.5 – 2.5%; (El-Abdellati et al., 2010a).  
For subsequent control programs to be optimised, differences in parasite 
management practices between farms where IVM resistance has been detected and 
those where IVM was deemed efficacious, need to be considered.  From the 
univariable OR analysis here, on farms where IVM resistance was present, farmers 
were significantly more likely to isolate newly acquired cattle following quarantine.  
This was an unexpected finding, as it would be thought that farmers who operated an 
effective quarantine procedure would be less likely to have selected for drug resistant 
parasites.  However, when the class of anthelmintic used for quarantine purposes was 
examined, an ML anthelmintic was preferred (see Chapter 2, Section 2.3.2.1); 
indicating appropriate quarantine procedures were not being followed.  Fewer stock 
were farmed on farms where IVM resistance was identified, but adult cattle were 
kept at slightly higher stocking densities on four of the farms where IVM resistance 
was detected.  The number of anthelmintic treatments administered each year was 
similar between farms where IVM resistance was detected and those where it was 
not.  None of the farmers in either group believed anthelmintic efficacy to be reduced 
compared to previous years.  One area where the groups differed in management was 
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in the treatment of adult cows.  On farms where IVM sensitive nematodes were 
identified, adult cattle were administered with anthelmintics less frequently or on a 
more selective basis. These results indicate that selection pressure for anthelmintic 
resistance may be being applied through the treatment of adult cattle.  Although adult 
cows are considered to carry low nematode burdens due to immunity, worms can be 
present, and due to the greater faecal volume produced, this can potentially amount 
to substantial contamination over the course of a grazing season (Borgsteede, 1978).  
In studies on anthelmintic resistance in sheep, the practice of not administering 
anthelmintics to adult ewes whilst they are grazing with lambs has been reported to 
provide refugia for some parasitic nematode species such as Cooperia spp., but not 
for others such as Nematodirus spp. (Leathwick et al., 2008).   
The presence of predominantly Cooperia spp. in faecal samples following IVM 
administration is a finding not unique to this study (Coles et al., 1998; Coles et al., 
2001).  Cooperia spp. have previously been identified to be one of the dose-limiting 
species for IVM, requiring higher levels of anthelmintic to achieve efficacy 
compared to other nematode species (Egerton et al., 1981; Eagleson and Allerton, 
1992)  (Sutherland and Leathwick, 2011).  Cooperia spp. have been reported to be 
more fecund than Ostertagia spp., and hence responsible for a high proportion of 
eggs counted in FEC analysis (Kloosterman, 1971).  However, they are considered to 
be less pathogenic than Ostertagia spp. and so risk being considered less important 
(Sutherland and Leathwick, 2011).  As a result, it has been suggested that parasite 
control practices should focus on the control of O. ostertagi  (Malczewski et al., 
1996).   Nonetheless, reports have been published regarding weight loss and 
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diarrhoea in  experimental monospecific infections with Cooperia spp. (Coop et al., 
1979; Sutherland and Leathwick, 2011). Softening of faeces during infection has 
been reported (Borgsteede and Hendriks, 1979; Coop et al., 1979; Armour et al., 
1987) and statistically significant differences in live weight gain were identified 
between calves infected with 200,000 C. oncophora L3 and calves infected with 
20,000 L3 (Borgsteede and Hendriks, 1979)  In one study, a mean weight gain 
difference of 16 kg was observed between Cooperia infected calves and infected 
animals treated effectively with an anthelmintic after 10 weeks (Armour et al., 1987).  
Furthermore calves infected with IVM resistant isolates have been reported to show 
diarrhoea and remain in poor condition compared to calves infected with an IVM 
sensitive isolate (Coles et al., 2001; Sargison et al., 2010).  Diarrhoea, rough hair 
coat and unthriftiness have also been reported in calves infected with 10,000 larvae 
from an IVM resistant C. oncophora isolate; symptoms which were not observed 
with calves infected with an identical number of larvae from an IVM sensitive C. 
oncophora isolate (Njue and Prichard, 2004c) .  
In regions where more, or larger, studies have been performed (for example, New 
Zealand), detection of ML resistant Cooperia spp. has often preceded the observation 
of AR in other nematode species and multi-class resistance (Sutherland and 
Leathwick, 2011).  Sampling of a larger cohort may have revealed ML resistance in 
O. ostertagi in the current study.  It should also be considered that the FECRT is only 
really able to define resistance in adult nematodes, and so the possibility of 
developing resistance, for example in the increased survival of inhibited O.ostertagi 
larvae in the abomasal mucosa after treatment would go undetected  (Eysker and 
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Ploeger, 2000; Vercruysse and Claerebout, 2001).  With this in mind, the presence of 
ML resistant O. ostertagi isolates in UK cattle cannot be discounted.    
The FECRT is not a perfect test; any guidelines set in place for detection of AR 
require a degree of flexibility (Coles et al., 1992; van Wyk and Groeneveld, 1997).  
The WAAVP guidelines recommend a minimum of 10 animals per treatment group, 
and each animal should have a nematode FEC in excess of 100 EPG (Coles et al 
2006).  This figure is based on McMaster FEC methodology, usually only sensitive 
to 50 EPG (Gordon and Whitlock, 1939).  The guidelines also stipulate that animals 
should not have been treated with anthelmintic in the preceding 8 to 12 weeks and 
that an untreated cohort of animals is sampled concurrently, to monitor any ‘natural’ 
change in FEC output not associated with treatment.  The use of oral anthelmintics is 
encouraged, and resistance determined based on a calculation of FECR using the AM 
where a reduction of less than 95% is indicative of resistance, when combined with a 
lower 95% confidence interval of less than 90% (Coles et al., 1992).  Several of these 
requirements are not particularly appropriate for use with cattle.  First, the FEC at the 
time of treatment may be low as identified here; however, a sensitive FEC method 
can be employed (Jackson, 1974) to overcome the statistical limitations of defining 
resistance based on low initial FECs.  The impact of using a sensitive FEC method 
here was the ability to detect FEC down to 1 EPG, and this led to less variability 
between classifications derived from the subsequent data analysis.  Second, the 
recommendation of using oral anthelmintics is not feasible in UK cattle, as ML 
compounds are now only available as pour-on or injectable formulations (NOAH, 
2013, VMD database).  The use of an untreated control group could also prove 
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contentious, with all the participating farmers in this survey intending to treat all of 
their calves at housing.  In this study, a number of measures were put in place to 
facilitate completion of the FECRT as far as possible in accordance with the 
WAAVP guidelines.  Equipment for administering anthelmintic treatment and weigh 
tapes were provided to ensure all animals were given a dose appropriate for 
individual weight.  Sampling was always conducted on the day of treatment and 14 
days following treatment.  As recommended (Coles et al., 1992) , faecal cultures 
were used to provide larvae that were analysed to identify any change in nematode 
genus/ species proportions following treatment.   
As there is no standardised method for the FECRT in cattle, comparisons between 
studies are difficult (Sutherland and Leathwick, 2011).  Whilst the McMaster FEC 
method has been found to be highly repeatable, with little confounding effect on 
variance within faecal samples (Denwood et al., 2012), it has been identified that 
there is a significant increase in the precision of a FECR result when a more sensitive 
FEC method is used (Levecke et al., 2011).   Previously published work  has shown 
that use of a FEC technique sensitive to 1 EPG is significantly more precise in the 
attribution of FECR classification (P <0.0001) than a FEC technique sensitive to 50 
EPG, and this has been attributed to the greater multiplication effect of the McMaster 
technique (Levecke et al., 2011). Due to the low FEC levels at treatment observed 
here, it is logical that a technique with a higher degree of sensitivity be employed for 
the FECRT.  Here, greater numbers of zero FECs were observed with McMaster 
methodology; specifically 35% of the day of IVM administration FECs compared to 
only 3% detected as 0 FEC using the CF method.  Variations in bovine FECs have 
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been largely associated to be a result of variation between individual animals 
sampled, rather than the variation within the faecal sample (Gasbarre et al., 1996); 
however, decreases in the variability of bovine and ovine FECs have been observed 
in the use of repeated counts (Gasbarre et al., 1996; Morgan et al., 2005).  When a 
zinc sulphate centrifugal flotation FEC (sensitivity < 10 EPG) was used, sample 
variance was reduced by 20% when duplicate FEC were made instead of one count 
(Gasbarre et al., 1996).  This was reduced further (by a total of 30%) by undertaking 
five repeat FECs per sample, but the additional time and effort involved in 
conducting analysis past two counts was deemed not to be worthwhile  (Gasbarre et 
al., 1996).  Similarly, for McMaster FEC methods, there was a substantial decrease 
in the predicted improvement of FEC accuracy when more than two slides (i.e. four 
chambers) were counted (Morgan et al., 2005).  Consequently, the decision to use 
duplicate FEC for both CF and McMaster methods in this study is justified.   
The geometric mean is considered by some to be the most appropriate analysis for 
skewed data (such as helminth egg distributions) as it accounts for the variation 
within a selection of faecal samples.  In doing so, GM analysis provides a mean FEC 
value for a sampled cohort which is not influenced by outlying data points, such as 
FECs with zero values, and is close to the median value, which indicates a data point 
in the middle of the data set (Smothers et al., 1999).  To achieve this, all data must be 
transformed to fit a log-normal population distribution, achieved by taking the 
logarithm of each FEC value (Smothers et al 1999).  The subsequent GM value is 
then used for making a statistical inference on anthelmintic efficacy and can allow 
comparison between populations, with the caveat that identical transformations are 
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made (Presidente, 1985; Smothers et al., 1999; Vercruysse et al., 2001). The GM is 
influenced less by a small percentage of high values (Fulford, 1994), as present in 
this dataset.  In contrast, the AM is thought to be more suitable for determining levels 
of nematode egg output from animals on an individual basis.  This is because AM 
values are directly representative of the total egg output of the group (Dash et al., 
1988), as they are not biased by transformations required for generating GM 
(Fulford, 1994).  The AM is also simpler to calculate and is considered a more 
conservative estimate of parasitic isolate sensitivity to anthelmintics (Dash et al., 
1988). As a result of the transformation processes, GM values are lower than AM 
values (Smothers et al., 1999).  On a practical level, this means that when used with 
FECRT data, GM means may generate a lower FECRT value, and by labelling a 
population as resistant when it may not be when the FECRT is calculated by another 
method, resistance levels in nematode populations may be overestimated.  
Additionally, if GM FEC values are used to determine when to give an anthelmintic 
treatment, the low mean values generated may lead to animals not receiving a 
treatment when one is anticipated based on that individual’s FEC (McKenna and 
Simpson, 1987).  Based on the CF results presented here, 18 of the 21 FECRT results 
concurred regarding IVM sensitivity classification across all types of analyses.  With 
the McMaster data, 14 of the 16 sets of FECR results agreed, indicating generally a 
good agreement between the AM and GM analyses.  This is comparable to data 
analysed by Dash et al (1988), where the results from only three FECRTs from a 
total of 22 did not concur in sensitivity classification when GM+1 FECRs were 
compared to  AM and GM+20 FECR results.  Overall, from this study, FECR 
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analysis based on the calculation of the AM appears to be as robust as the more 
mathematically involved processes of the GM, regardless of FEC methodology.  
Two main sources of error when counting particles in a liquid (such as nematode 
eggs in solution) have been identified (Student, 1907).  First, the aliquot taken may 
not be representative of the bulk of the liquid and the distribution of cells over the 
area that is examined is never uniform, leading to an error of random sampling 
(Student, 1907; Torgerson et al., 2012). It is has also been proposed that  there is no 
effect of ‘interference’ between particles, so there is as much chance as of a particle 
falling in on an area which already has several particles as on one altogether 
unoccupied (Student, 1907). The aim of the parametric bootstrapping analysis is to 
encompass such sampling errors in the FECR calculation (Torgerson et al., 2012).  
The benefit of bootstrapping FECR data in this way is that the sampling distribution 
is not mathematically generated but is determined from the original FECRT data set 
(Cabaret and Berrag, 2004).  From the data analysed here, for the CF method, with 
AM versus bootstrapping analysis, the sensitivity status concurred for all farms but 
differed on two occasions when the GM based method was compared to 
bootstrapping analysis.  This would indicate that the AM analysis as conducted here 
is comparable to the parametric bootstrapping method.      
Presently, anthelmintic resistance in UK cattle nematodes is restricted to Cooperia 
spp. surviving ML treatments (Coles et al., 1998; Sargison et al., 2010; McArthur et 
al., 2011) and, as yet, resistance in other nematode species or resistance to multiple 
anthelmintic classes has not been identified.  However, suspected IVM-resistant 
Ostertagi spp., were identified on three farms in Germany and Sweden following 
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IVM administration (Demeler et al., 2009), with the caveat that further investigation 
is required to confirm these findings.  Isolates resistant to more than one class of 
anthelmintic have  yet to be reported in Europe, but have been reported elsewhere 
(Sutherland and Leathwick, 2011).  Most notably, in New Zealand, researchers found 
a predominance of IVM-resistant Cooperia spp., with resistance suspected on 56 of 
61 beef cattle farms participating in a FECRT (Waghorn et al., 2006) and identified 
IVM-resistant Ostertagia spp. on four farms and IVM-resistant Trichstrongylus spp. 
on one farm.  Overall, resistance to all three classes was identified on four farms, 
however the species involved on these farms was not reported  (Waghorn et al., 
2006).  It was suggested that farmers use LEV in order to control Cooperia spp., as it 
was the most prevalent genus surviving treatment, but little has been published 
regarding future control strategies for these drug resistant populations (Waghorn et 
al., 2006).  Further testing on the farms studied here with BZ and LEV products 
would now be recommended.   
As there are currently no new anthelmintic classes available for cattle, further work 
is required regarding the role of grazing management in the preservation of the 
efficacy of the three available classes.  With concerns raised about efficacy of pour-
on preparations (Eagleson and Allerton, 1992), and the prospect of side-resistance 
developing against other members of an anthelmintic class (Prichard et al., 1980), it 
is of clinical and epidemiological relevance to know if AR to one anthelmintic 
product, such as IVM injection tested here, is also observed when using other MLs 
(such as MOX) and if the results generated after subcutaneous administration differ 
from those achieved using other application methods.  Further evaluation, for 
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example in the form of a controlled efficacy test, can be used to confirm resistance 
suspected in the field.  The exploration of potential mechanisms behind resistance, 
with the view to developing better diagnostic technique may help improve the 
sensitivity of existing techniques.  To that effect, two of the isolates generated here 
were selected for further investigation in a controlled efficacy test and molecular 
characterisation experiments, reported in Chapters 4 and 5.  
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Chapter 4: Use of a controlled efficacy test to 
confirm macrocyclic lactone resistance in two 
field isolates of Cooperia oncophora*  
 
*A proportion of the results from this Chapter have been published in a peer-
reviewed journal article, see Appendix 3.  
4.1 Introduction 
The controlled efficacy test (CET) is the current gold standard test for the detection 
of anthelmintic resistance (Coles et al., 2006).  First described in 1941, it requires the 
necropsy of animals at a set time after anthelmintic administration, having previously 
been experimentally, or naturally, infected with nematode larvae (Moskey and 
Harwood, 1941).  The reduction in adult worm burdens of treated animals is 
compared to those of untreated control animals, and so can be used to determine the 
efficacy of compounds and also the presence of anthelmintic resistance in nematode 
populations where inefficacy is suspected (Prichard et al., 1980).  The CET is 
considered the definitive and unequivocal test for identifying and confirming 
anthelmintic resistance (Johansen, 1989) as efficacy can be established against all 
developmental stages of a wide range of species in a large number of hosts (Wood et 
al., 1995).  This is an advantage over the faecal egg count reduction test (FECRT), 
which can only provide a measure of anthelmintic efficacy against a patent adult 
female nematode infection, with measurement of the reduction in FEC following 
administration (Presidente, 1985).  Furthermore, following the CET, adult nematodes 
can be identified to species level by morphological identification, rather than 
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generally to genus level as can be achieved when conducting larval differentiation 
following the FECRT (Prichard et al., 1980).   
As reported in Chapter 3, the FECRT can be constrained by relatively low FECs at 
the time of anthelmintic administration and conducting a FECRT often requires the 
compliance of farmers to undertake accurate drug administration and faecal 
sampling, issues that are enhanced by a lack of a standardised protocol for the 
FECRT in cattle (Sutherland and Leathwick, 2011).  Guidelines that outline the 
procedure of a CET have been published by the World Association for Veterinary 
Parasitology (WAAVP) (Powers et al., 1982; Wood et al., 1995).  The original 
WAAVP guidelines were published to provide a framework for researchers to use 
when evaluating the efficacy of new anthelmintic products, to ensure meaningful 
data was captured and so time, labour and experimental animals could be used 
efficiently (Powers et al., 1982).  The most recent guidelines describing the CET 
were published in 1995 (Wood et al. 1995) to address advances made since the 
original guidelines were published in 1982.  One such advance was the development 
of anthelmintics with an efficacy of greater than 98%, such as compounds in the 
macrocyclic lactone (ML) class.  Based on efficacies of earlier classes of 
anthelmintics, developed in the 1960s and 1970s, the previous guidelines had 
indicated an efficacy of greater than 90% be classed as “very good” (Wood et al., 
1995).  The use of a standardised protocol enables derived data to be compared 
between studies; in particular, data can be compared to CETs that were conducted 
during the development and registration of an anthelmintic to ascertain efficacy at 
known dose rates against a known infection of various nematode species (Johansen, 
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1989) in different regions of the world.  The current guidelines recommend that 
animals selected for use in a CET are of as similar age and breed as possible, and 
kept under controlled conditions, such as identical diet and housing, to minimise 
differences associated to external influences between treatment groups (Powers et al., 
1982).  Each animal is infected with a predetermined number of larvae (within 
ranges determined adequate to generate a patent infection, but not so high as to cause 
clinical disease), and is randomly allocated to a treatment group on the basis of 
factors as weight, age and FEC (Wood et al., 1995).  Anthelmintics are applied at the 
appropriate dose rate (generally the manufacturer’s recommended dose rate but 
different dose rates may be used in original efficacy trials), based on the weight of 
the individual animal, at a time after parasitic inoculation, which is dependent on the 
species and developmental stage to be examined.  In the case of trichostrongyle 
nematodes that infect cattle, such as Ostertagia ostertagi and Cooperia oncophora, a 
period of 28 to 35 days following infection is deemed optimal for determining 
efficacy against adult nematodes (Wood et al., 1995).  Necropsy is conducted five to 
seven days following anthelmintic administration, which is of sufficient time to 
allow the expulsion of paralysed worms but not so long as to allow any unaffected 
immature stages to develop to adult worms  (Powers et al., 1982; Wood et al., 1995).  
This time period can be used for all classes of anthelmintic where examination of 
efficacy and not persistence are being examined, unlike the FECRT where the timing 
of faecal samples collected following anthelmintic administration are dependent on 
the anthelmintic class used (Coles et al., 1992).  Whilst recommendations for 
statistical analysis are not provided in the guidelines, resistance is proposed as an 
arithmetic mean reduction in adult worm burden of less than 95%, with a lower 95% 
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confidence interval of less than 90% (Coles et al., 1992); however, this guideline 
needs to be clarified depending on which class of anthelmintic is being applied, as 
some of the earlier classes  had a lower observed efficacy when tested in licensing 
trials (Rubin et al., 1965; Callinan and Cummins, 1979).  
Whilst the use of experimental animals and the associated time and labour costs 
precludes the use of the CET on a frequent basis (Johansen, 1989), it can be utilised 
to confirm the results of previously conducted FECRTs; a method proposed as the 
simplest test to perform in the field, but which is not without issue, as described in 
Chapter 3.  As demonstrated with the FECRTs conducted in Chapter 3, and in 
previously published studies, low FECs at the time of anthelmintic application can 
lead to difficulties in interpretation of the results (Sutherland and Leathwick, 2011).  
Furthermore, the usefulness of the FECRT is limited, as it has been indicated that, in 
the ovine nematodes Trichostrongylus colubriformis and Ostertagia spp., 
benzimidazole resistance cannot be reliably detected at levels below 25% (Martin et 
al., 1989).  In addition, anthelmintic administration is known to suppress production 
and release of eggs from female nematodes for a number of days after administration 
in a variety of nematode species (Scott et al., 1991; McKenna, 1997).  As a result, it 
can be impossible to determine if a reduction in FEC is a result of the removal of 
adult nematodes or due a temporary suppression of egg development or oviposition 
(Vermunt et al., 1996; McKenna, 1997).   
The first case of anthelmintic resistance in cattle nematodes to be confirmed by CET 
was published in 1986 (Eagleson and Bowie, 1986), when an isolate of 
Trichostrongylus axei was confirmed to be resistant to oxfendazole (OXF), following 
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worm burden analysis of calves 14 days after anthelmintic administration.  
Compared to the geometric mean worm burden of an untreated control group, a 13% 
reduction in adult T. axei worm burden was observed following oral administration 
of OXF  (Eagleson and Bowie, 1986).  In a second group of calves, 100% reduction 
in adult worm burden was recorded following application with subcutaneously 
administered ivermectin (IVM, 0.2mg kg
-1
 body weight; BW) (Eagleson and Bowie, 
1986).  The CET has subsequently been used to confirm cases of IVM and 
moxidectin (MOX) resistance observed in cattle nematodes in the field and following 
artificial infections (Vermunt et al., 1995; Gasbarre et al., 2009; Edmonds et al., 
2010; de Graef et al., 2012).  In the UK, a CET was used to confirm the findings of a 
FECRT study where IVM resistance was suspected (Coles et al., 1998; Stafford and 
Coles, 1999). There, ten calves were infected with a suspected IVM resistant 
Cooperia spp. isolate, and five were administered with an IVM injectable 
formulation (0.2mg kg
-1
 BW) at 28 days following infection.  All calves were 
necropsied seven days after anthelmintic administration and adult Cooperia burdens 
were found to be reduced by 16% in treated animals compared to controls, 
confirming the presence of resistance in this isolate (Stafford and Coles, 1999).  To 
date, no CETs have been conducted in the UK to examine anthelmintic resistance 
against moxidectin (MOX) or IVM delivered by other application methods such as 
pour-on or oral formulations.  In Belgium, IVM and MOX resistance were confirmed 
in a field isolate of C. oncophora, with 38% and 31% reductions in adult worm 
burden recorded against injectable IVM and MOX, respectively (de Graef et al., 
2012).  In previously conducted FECRTs, FEC analysis conducted 14 days following 
administration of injectable IVM, showed reductions in C. oncophora FEC of 73%, 
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40% and 0% over successive years, from 2006 to 2008 (El-Abdellati et al., 2010b).  
Results of the FEC analysis from the CET, using the same IVM product, revealed a 
55% reduction in FEC and 38% reduction in adult C. oncophora worm burden, 
confirming the presence of IVM resistance (de Graef et al., 2012). 
 
The anthelmintic application method chosen to ascertain efficacy is of particular 
importance to studies concerning cattle nematodes as anthelmintic efficacy is 
considered to be closely linked to pharmacokinetic behaviour (Campbell and Benz, 
1984) and changes in anthelmintic formulation may influence uptake, 
biotransformation and/or presentation (Lanusse et al., 1997; Lifschitz et al., 1999b).  
Previous studies have shown that alteration of an anthelmintic formulation can affect 
the pharmacokinetics of the product (Lo et al., 1985).  For example, use of an 
aqueous vehicle for subcutaneously applied IVM was found to allow greater 
bioavailability than that of a non-aqueous vehicle, with plasma concentrations of 84 
ng ml
-1
 IVM compared to 25 ng ml
-1
 IVM two days after administration (Lo et al., 
1985).  Consequently, this alteration in formulation allowed the aqueous product to 
be more extensively absorbed and distributed (Lo et al., 1985).  With regard to ML 
products, there have been concerns as to the relative efficacy of ML products when 
administered as a topical pour-on formulation compared to anthelmintics 
administered orally or by subcutaneous injection (Leathwick and Miller, 2013).  
Previously, IVM was demonstrated to be similarly efficacious when administered 
orally compared to injected subcutaneously, with a mean 100% reduction in adult O. 
ostertagi reported compared to nematode burdens in control animals (Armour et al., 
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1980).  With adult C.oncophora, reductions of 99% and 100% were achieved using 
the injectable and oral IVM formulations, respectively (Armour et al., 1980).   
The premise of a pour-on method of application for anthelmintics was first 
developed for levamisole  (Guerrero et al., 1984).  When developed for IVM 
application, efficacy against both O. ostertagi and C. oncophora was found to be 
high (Alva-Valdes et al., 1986), with 100% reductions in adult burdens observed 
against both nematode species compared to burdens in challenged control aninals.  In 
other studies, variable results were recorded (Bisset et al., 1990; Eagleson and 
Allerton, 1992).  In one trial, considerable differences in efficacy were observed 
among species; notably, a 100% reduction in adult O. ostertagi burdens observed in 
the same trial in which a 23% reduction was observed in adult C. oncophora (Bisset 
et al., 1990).  As there was no history of IVM useage on the farm tested, the authors 
proposed this was not a case of resistance, but may be a result of C. oncophora being 
a proposed ‘dose-limiting species’ for IVM, requiring greater concentrations of the 
anthelmintic to achieve efficacy (Egerton et al., 1979).  It was also suggested that as 
the calves were necropsied 14 days after administration, the adult C. oncophora may 
have recovered from a temporary paralysis caused by IVM within this period, 
allowing the nematodes to become re-established further down the small intestine 
(Bisset et al., 1990), a finding which concurs with observations in  sheep infected 
with Cooperia curticei (Bogan and McKellar, 1988).   
In addition to the confirmation of anthelmintic resistance, material collected 
following necropsy in a CET can be used for phenotypic and genotypic analyses.  
The phenotypic characteristics of the surviving worms can be examined; for 
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example, nematode length and the number of eggs in utero in female worms 
(Kloosterman, 1971; Bairden et al., 1992; de Graef et al., 2012).  Work conducted 
with the ovine nematode, C. curticei, showed that female nematodes surviving IVM 
administration had reduced numbers of eggs present in utero compared to worms in 
untreated animals  (McKellar et al., 1988).  These results indicate that whilst adult 
nematodes survive anthelmintic administration, there may be ramifications for egg 
reproduction (McKellar et al., 1988) .   
Surviving worms can also be subjected to genotypic analyses; for example, to 
identify molecular mechanisms or markers for resistance.  MLs have been shown to 
bind to glutamate-gated chloride (GluCl) channels to exert a paralysing effect upon 
nematodes (Arena et al., 1991; Arena et al., 1992).  The channel is held open by ML 
binding, allowing an influx of chloride ions which irreversibly hyperpolarise the cell, 
leading to a rapid paralysis of nematode movement and reduction in pharyngeal 
pumping (Cleland, 1996; Wolstenholme, 2011)  The GluCl receptor is made up of 
five subunits, arranged around a central pore, as confirmed by X-ray crystallography 
(Hibbs and Gouaux, 2011).  The subunits composing the GluCl channel may be 
homomeric and comprised of five identical subunits, or heteromeric and comprised 
of different subunits, some of which may be parasite specific (i.e.  not found in the 
free-living nematode Caenorhabditis elegans, (Yates et al., 2003).  To date, work in 
this area has been primarily focused on C. elegans and the ovine parasitic nematode 
Haemonchus contortus; however, recent work using isolates of C. oncophora that 
were demonstrated to be IVM resistant in vivo has shown differences in the 
nucleotide sequence of a GluCl subunit (glc-6) after exposure to IVM administration 
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(de Graef et al., 2013a).  Genetic analysis was conducted on eight C.oncophora 
isolates for changes in nucleotide sequence in this subunit: three geographically 
distinct IVM-sensitive populations and two isolates shown to be IVM-resistant (El-
Abdellati et al., 2010b), (de Graef et al., 2012) and three populations of IVM-
resistant worms exposed to IVM or MOX in vitro (de Graef et al., 2013a).  
Differences in nucleotide sequence between resistant nematodes after anthelmintic 
exposure were identified near the N terminal extracellular domain of the gene, in the 
region of the signal peptide (de Graef et al., 2013a).      
In this chapter, a CET was performed, first, to confirm the results of the FECRT for 
two nematode isolates obtained in the studies described in Chapter 3.  These isolates 
were indicated to contain IVM resistant Cooperia spp. larvae based on the mean 
FECR observed following administration of an injectable IVM formulation.  Second, 
the CET was employed to compare the efficacy of IVM and MOX pour-on 
formulations against the two isolates and to compare the results to those observed 
with the injectable IVM formulation.  Adult C. oncophora nematodes recovered at 
necropsy from untreated control animals and those surviving anthelmintic 
administration were used for phenotypic and genotypic analyses.  The phenotype 
analysis comprised the measurement of female worm length and the enumeration of 
eggs in utero in female nematodes.  Genotype analysis was conducted after 
extraction of RNA from pools of C. oncophora adult worms, followed by PCR 
amplification and cloning of a region of the glutamate-gated chloride channel gene 
(glc-6) (Glendinning et al., 2011; de Graef et al., 2013a).  Sequence comparison was 
made using material from male and female C. oncophora that were recovered from 
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untreated control calves, and between male and female worms that had survived 
administration with an IVM injectable formulation.  The overall aims were to 
confirm the presence of IVM resistance in the two field isolates by CET, to 
investigate the impact application route had on efficacy and to examine mechanisms 
potentially associated with ML resistance.  




4.2 Materials and Methods 
4.2.1 Generation of nematode isolates for investigation 
 
 
In Chapter 3, the results of 21 FECRTs were reported following administration with 
IVM.  The presence of potentially IVM-resistant nematodes was identified on 13 
farms, with Cooperia spp. being the most prevalent nematode genus identified 
following treatment on all occasions.  Of the 13 farm isolates, two were selected for 
further research: one derived from Farm 001 and one from Farm 004, namely 004a 
(McArthur et al., 2011).  These isolates are referred to hereafter as field isolates 001 
and 004 (FI001 and FI004, respectively).  These isolates were selected as both 
appeared to be IVM resistant by FECRT (Chapter 3) and more than 50, 000 L3 were 
generated from the Day 0 coprocultures, producing sufficient larvae to infect a donor 
calf.  A summary of results from the FECRT are displayed in Table 21.  To generate 
sufficient third stage larvae (L3) to infect 20 calves with each isolate, two donor 
calves were experimentally infected, one per isolate.  To prevent the introduction of 
any additional anthelmintic selection pressure to these isolates, larvae used to infect 
the donor calves were derived from samples collected prior to the administration of 
IVM in the FECRT.  A male Holstein Friesian helminth-naïve calf was administered 
with 50, 000 L3 per os for each isolate and faecal egg count (FEC) analysis was 
conducted weekly to monitor egg excretion (Jackson, 1974), once infection was 
observed to be patent, 21 days after infection, calves were harnessed to collect faeces 
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and collection bags changed twice daily.  Larval culture was conducted as described 
previously in Chapter 3. 
 
Table 21 Provenance of nematode isolates examined in the CET.  FECRT calculation, is based 
on arithmetic mean reduction in FEC 14 days after IVM administration (Coles et al., 1992).  
Genus composition data is presented based on examination of L3 obtained prior to the 
conduction of the FECRT and following passage through a helminth-naïve calf.  On each 
occasion, 100 randomly selected L3 were morphologically identified to genus level.   









composition of larvae 






passage through a 




72 (15 – 91) 
85% Cooperia spp. 
15% Ostertagia spp. 
80% Cooperia spp. 
20% Ostertagia spp. 
FI004 
East Ayrshire,  
 Scotland 
87 (69 – 95) 
62% Cooperia spp. 
38% Ostertagia spp. 
60% Cooperia spp. 
40% Ostertagia spp. 
A test of equal proportions (Newcombe, 1998) was conducted on the larval genus 
results following nematode passage through the helminth-naïve calves to assess 
changes in genus proportions, which was not found to be statistically significant for 
either isolate (P > 0.45). 
 
4.2.2 Experimental design of controlled efficacy test (CET)  
Forty, helminth-free male dairy calves, housed under conditions to minimise 
parasitic nematode infection, were administered per os with 50,000 L3 from isolate 
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FI001 (80% Cooperia spp., 20% Ostertagia spp.) or FI004 (60% Cooperia spp., 40% 
Ostertagia spp.).  Calves ranged from four to seven months in age and weighed 
between 90 and 185 kg.  Prior to experimental infection, faecal samples were taken 
on two occasions to confirm that no patent helminth infections were present.  On day 
27 post-infection (PI), all calves were weighed, faecal sampled and allocated to one 
of four treatment groups per isolate.  Group allocation was based on weight, age and 
FEC, with five calves per treatment group, as described in Table 22.  A power 
calculation was used to determine group size and group sizes were deemed be to be 
appropriate by ethical review (Moredun Research Institute Experiments Committee).  
Calves were administered anthelmintic treatment at the manufacturers’ 
recommended dose rates on day 28 PI in the following treatment groups: IVM 
injectable (Ivomec Super®,
 
1% w/v IVM, 10% w/v clorsulon, 0.2 mg kg
-1
 body 
weight; BW; Merial Animal Health), IVM pour-on (Ivomec Pour-On®, 0.5% w/v 
IVM, 5 mg kg
-1
 BW; Merial Animal Health) and MOX pour-on (Cydectin Pour-On 
®,
 
0.5% w/v MOX, 5 mg kg
-1
 BW; Pfizer Animal Health Ltd).  Dose rates for 
injectable IVM administration were rounded up to the nearest 0.1 ml and applied 
subcutaneously with 17 ½ gauge needle as per manufacturer’s instructions.  All pour-
on administrations were rounded up to the nearest 1 ml and applied using a 20 ml 
syringe along the midline of the back, from withers to tail head.  For each isolate, one 
group was used as an anthelmintic untreated control group.  The eight groups were 
housed separately and the calves that had received a pour-on application were 
observed for 30 min following administration for any evidence of licking behaviour.  
All experimental procedures were approved by the Moredun Research Institute 
Experiments and Ethics Committee and conducted under the legislation of a UK 
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Home Office License (reference PPL 60/03899) in accordance with the Animals 
(Scientific Procedures) Act of 1986. 
 
 
Table 22: Anthelmintic treatment groups for calves on trial in the CET. Anthelmintic dosage 
rates are displayed as mg per kg bodyweight (BW). Injectable and pour-on applications are 
represented by “INJ” and “PO” respectively. Ivermectin and moxidectin are represented by 
“IVM” and “MOX” respectively. 
Anthelmintic application  (dosage) Designation 
 Field Isolate 
001 
Field Isolate 004 





Pour-on ivermectin (0.5 mg kg
-1
 BW) IVM-PO-01 IVM-PO-04 
Pour-on moxidectin (0.5 mg kg
-1
 BW) MOX-PO-01 MOX-PO-04 
None  (i.e. untreated control group) CONTROL-01 CONTROL-04 
  
4.2.3. Collection of parasitological material during controlled 
efficacy test 
4.2.3.1 Faecal egg count (FEC) samples 
Rectal faecal samples were collected throughout the CET experiment for FEC 
analysis; one day prior to treatment (day 27 PI) for purposes of treatment group 
allocation; and then daily until the end of the experiment (day 35 PI).  All samples 
were taken at the same time of day and two FEC methodologies were conducted in 
duplicate for each sample: a centrifugal flotation method (Jackson, 1974) and a 
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McMaster method (Gordon and Whitlock, 1939) as described in Chapter 3, Section 
3.2.2.1.    
 
4.2.3.2 Collection and processing of blood plasma samples 
Blood samples were collected from all calves prior to anthelmintic administration via 
jugular venepuncture into 10 ml heparinised Vacutainer® blood collection tubes 
(Becton, Dickinson and Company).  Blood samples were then taken from all treated 
calves at 4, 8, 24, 48, 120, 144 and 168 h after anthelmintic administration.  
Immediately after collection, the sample tubes were inverted several times and 
placed inside a lidded cool box to prevent ML degradation due to sunlight (Halley et 
al., 1989).  Blood samples were centrifuged within 1 h of collection at 1275 x g for 
15 min at 4 °C.  The separated plasma was then aliquoted into dark amber Eppendorf 
tubes and stored at -20 °C until analysis.  
 
4.2.3.3 Analysis of ML concentration in blood plasma 
Determination of ML concentrations in the plasma samples was conducted by Mr 
Jean-François Sutra and Dr Anne Lespine (INRA, Toulouse, France).  IVM and 
MOX concentrations were determined in plasma by high performance liquid 
chromatography (HPLC) with fluorescence detection according to previously 
described and validated methods (Alvinerie et al., 1995; Alvinerie et al., 1998).  Data 
were analysed using a non-compartmental approach with version 4.2 of the Kinetica 
Tm computer program (InnaPhase, Philadelphia, USA).  Data are expressed as 
arithmetic mean and standard error of the arithmetic mean (S.E.M.).  The partial area 
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under the plasma concentration–time curve (AUC) was calculated by the linear 
trapezoidal rule (Yeh and Kwan, 1978).  
 
4.2.3.4 Organ processing following calf necropsy  
At necropsy (35 days PI, 7 days following anthelmintic administration), the 
abomasum and entire length of the small intestine were removed from each calf.  The 
abomasum was opened along the greater curvature and deposited, together with the 
abomasal contents, into a labelled 10 L bucket.  The mucosa was gently washed with 
lukewarm physiological saline (0.85% NaCl; 85 g NaCl, 10 L tapwater) and added to 
the bucket of abomasal contents.  Additional physiological saline was added to the 
bucket to a volume of 10 L and incubated for 4 h at 37 °C (Powers et al., 1982; 
Patterson et al., 1996).  The small intestine was treated similarly, with the intestinal 
contents collected into a bucket, the full length of the intestine opened and added to 
the bucket; warm physiological saline added up to a volume of 10 L and incubated as 
per the abomasum.  After 4 h, the organs were removed from their respective buckets 
and the surface mucosa rubbed to remove any adhering worms, with particular 
attention paid to cut surfaces and tissue folds.  The contents and digest were 
replenished to 10 L with warm physiological saline.  Following thorough agitation, a 
10% subsample (1 L) was removed and fixed using 100 ml 100% formalin (40% v/v 
formaldehyde; Fisher Scientific).  From this 10% subsample, a 220 ml subsample, 
equivalent to 2% total volume, was removed and stained with 10 ml helminthological 
iodine (250 g potassium iodine, 50 g iodine, 500 ml distilled water; Sigma Aldrich).  
The remaining 9 L organ contents were left to sediment for 15 min, after which the 
supernatant was removed and the sedimented contents fixed with 100% molecular 
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grade ethanol (EtOH; Fisher Scientific) to a final concentration of greater than 70% 
EtOH.  Formalin-fixed subsamples were washed over a 38 µm sieve to remove 
excess iodine before all nematodes were removed and enumerated.  Nematodes were 
classified according to sex, stage of development and species using the Ministry of 
Agriculture, Fisheries and Food document guidelines (M.A.F.F., 1986).  EtOH fixed 
subsamples were treated similarly, with nematodes classified in accordance to sex 
and species and transferred to bijoux containing 100% EtOH.    
 
4.2.3.5 Examination of female Cooperia oncophora length and numbers 
of eggs in utero  
For each animal, up to 25 randomly selected formalin-fixed adult female C. 
oncophora were mounted on glass slides with lactophenol (Sigma Aldrich), 
photographed immediately under x 40 magnification (Nikon D90 camera), followed 
by enumeration of eggs in utero under x 100 magnification on a stereomicroscope.  
Digital images were downloaded into Image-Pro Express software (version 5.0.1.26, 
Media Cybernetics, Inc.).  This software was used to measure the length of each 
female nematode and calibrated after every 25 nematodes by measurement of a 1 mm 
graticule under x 40 magnification. 
 
4.2.3.6 Statistical analysis 
Small intestinal nematode burdens were checked for normality and differences 
between treatment groups compared using two-sample t-tests.  A one-way ANOVA 
test was used to assess if the daily fluctuations in FEC were statistically significant..  
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Percentage efficacy was calculated using mean values of (1-(T/C) x100) (where C is 
mean nematode burden of the control group and T is mean nematode burden of the 
anthelmintic treated group (Coles et al., 1992).  Data manipulation and graphs were 
drawn in Microsoft Excel 2007 and statistical analyses performed using R Statistical 
Environment (R Core Team, 2013).  Arithmetic mean estimates were calculated by 
adding the FEC values together and dividing by the number of samples present.  
Geometric means were also calculated by the anti-log of log-transformed counts 
(Dash et al., 1988).  In order to calculate geometric means, a nominal value of one 
was added to each EPG prior to analysis and subsequently removed following 
analysis, as is accepted practice (Fulford, 1994). Unless explicitly stated otherwise, 
all mean values are presented as arithmetic means.  
4.2.3 Molecular analysis 
4.2.3.1 Ribonucleic acid (RNA) extraction protocol 
Ribonucleic acid (RNA) was extracted from eight aliquots containing 10 adult C. 
oncophora nematodes, fixed in EtOH at post-mortem, as shown in Table 23.  The 
RNA samples were used for cloning and sequence analysis.  Two male C. oncophora 
were randomly selected from EtOH-fixed subsamples from each of the five calves in 
CONTROL-01, resulting in a pool of 10 worms in total.   
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Table 23: Provenance of nematodes used for RNA extraction and molecular sequence analysis. 
All nematodes were recovered 35 days post infection (PI). Nematodes selected from untreated 
control groups are denoted "CON", with nematodes surviving IVM administration, seven days 
after application are denoted "IVM".  Male and female nematodes are denoted "M" and "F" 
respectively, and field isolates 001 and 004 are denoted by "01" and "04", respectively.    
Treatment group Field Isolate 001 Field Isolate 004 
Untreated, control calves  
 
10 female C. oncophora 
(CON-F-01) 
10 female C. oncophora  
(CON-F-04) 
10 male C. oncophora  
(CON-M-01) 
10 male C. oncophora  
(CON-M-04) 
IVM injectable  
(day 7 following IVM 
administration) 
10 female C. oncophora  
(IVM-F-01) 
10 female C. oncophora 
(IVM-F-04) 
10 male C. oncophora 
(IVM-M-01) 
10 male C. oncophora 
(IVM-M-04) 
 
A pool of 10 female C. oncophora was selected in the same manner for CONTROL-
01, and the entire process repeated for CONTROL-04, and for groups IVM-INJ-01 
and IVM-INJ-04.  The adult nematodes were transferred from EtOH storage using a 
sterile pipette tip to a 2 ml ribolyser tube containing ceramic beads (Precellys
(R) 
soft-
tissue homogenising CK-14 tubes, Bertin Technologies), and chilled on ice.  To each 
tube, 1 ml TRIzol reagent (Invitrogen) was added and the nematodes homogenised 
using a Precellys
(R) 
24 machine (Bertin Technologies), utilising a programme 
consisting of two homogenisation cycles of 30 s at 6500 rpm, with 2 min on ice 
between cycles to prevent RNA degradation.  After this, the tubes were examined to 
ensure homogenisation was complete.  Tubes were incubated at room temperature 
for 5 min and the TRIzol (Invitrogen) protocol followed as per manufacturer’s 
instructions.  Following extraction, RNA was subjected to DNAse treatment 
(Promega) and the concentration of the RNA estimated by spectrophotometer 
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(Nanodrop, ThermoScientific).  The remaining RNA (~19 µl) was divided into four 5 
µl aliquots and stored at -80 °C.           
 
4.2.3.2 Amplification of partial glutamate-gated chloride channel gene 
(glc-6) 
Initial analysis focused on generating full-length complimentary DNA (cDNA) 
sequence for the GluCl gene, glc-6, using RNA from 10 C. oncophora; however, 
inconsistent amplification (data not shown) led to the design of a more targeted 
approach, which focussed on a region of the glc-6 cDNA, previously identified to 
show differences in sequence between IVM-resistant C. oncophora prior to 
anthelmintic administration and those surviving seven days after anthelmintic 
administration to calves (de Graef et al., 2013a).  Glyceraldehyde 3-phosphate 
dehydrogenase (gapdh) was selected as the positive control template (Van Zeveren et 
al., 2007b; El-Abdellati et al., 2011; de Graef et al., 2013b).  The primer sequences 
used in the PCR experiments are listed in Table 24.  All primers were generated by 
MWG Eurofins and internal primer selection verified by Primer3 software 
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Table 24: List of primer sequences used in the molecular analyses 
Gene name Amplification 
purpose 




















4.2.3.2.1 Optimised PCR protocol for partial glc-6 amplification 
A one step reverse transcriptase (RT)-PCR procedure was followed using the 
SuperScript™One-Step RT-PCR kit (Invitrogen) in combination with Platinum® 
Taq (Invitrogen) following manufacturer’s instructions.  PCR reaction mixes had 
final concentrations of 0.5 µl RNA template, 0.8 μM of both forward and reverse 
primers, 1 unit of RT/Platinum® Taq Mix, in a reaction buffer containing 0.2 mM of 
each dNTP and 1.2 mM MgCl2, in a total volume of 25 µl.  For the purposes of 
cDNA synthesis, the reactions were incubated for 30 min at 50°C followed by 2 min 
at 94°C.  The PCR reaction followed directly, with 40 cycles of denaturing (30 s at 
94 °C), annealing (30 s at 50 °C) and elongation (90 s at 72 °C), with a final 
elongation incubation for 10 min at 72 °C.  In all cases, positive and negative control 
reactions were included; with gapdh primers used for the positive control and ‘no 
template’ reactions for the negative controls.  Negative controls consisted of both 
glc-6 and gapdh reactions with 1 µl nuclease-free water in place of template.  
Following the PCR step, amplification products were visualized by gel 
electrophoresis on 1.5% agarose gels with GelRed™ nucleic acid stain (Cambridge 
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Bioscience).  To 1 µl blue-orange loading dye (Promega), 4 µl PCR products were 
added, loaded into a well and a voltage of 80 volts applied for 40 min.  A 100 base 
pair (bp) ladder (Promega) was included each time to estimate amplicon size.    
4.2.3.3 Cloning of partial glutamate-gated chloride channel gene (glc-6) 
PCR amplification products of an appropriate size (319 bp) were purified using the 
Qiaquick PCR purification kit (Qiagen), followed by overnight ligation in pGEM-T 
Easy vector (Promega) and transformed into JM109 Escherichia coli competent cells 
(Promega) according to the manufacturer’s instructions.  Transformed plasmids were 
incubated for 90 min at 37 °C in a shaking incubator in the presence of SOC medium 
(20 g L
-1
  Tryptone, 5 g L
-1
  Yeast Extract, 4.8 g L
-1
  MgSO4, 3.6 g L
-1
  dextrose, 500 
mg L
-1
  NaCl, 186 mg L
-1
  KCl; Bioline UK) after which, 20µl or 200 µl of each 
transformation were spread on LB medium (15 g L
-1
 agar, 10 g L
-1
 tryptone, 5 g L
-1
 
yeast extract, 5 g L
-1
 NaCl) plates containing ampicillin (100 µg ml
-1
; Sigma 
Aldrich),  IPTG (0.5 mM; Isopropyl β-D-1-thiogalactopyranoside; Promega) and X-
Gal (80 µg ml
-1
; 5-bromo-4-chloro-3-indolyl-β-D-galactoside; Promega).  Plates 
were incubated overnight at 37 °C, and colonies for sequencing were selected on a 
blue - white basis.  For each plate, five white colonies were picked, resulting in a 
total of 10 colonies per transformation.  Colony PCR was performed using T7 and 
SP6 primers, in a 50 µl reaction, with one unit Platinum Taq (Invitrogen), 1 mM 
MgCl2, 0.2 µM of each primer and 0.2 µM of each dNTP per reaction. The PCR 
conditions were an initial step of 94 °C for 5 min,  followed by 30 cycles of 
denaturing (30 sec at 94 °C), annealing (30 sec at 55 °C) and elongation (60 s at 72 
°C) with a final elongation incubation for 7 min at 72 °C.  The presence of an insert 
of the correct size was confirmed by gel electrophoresis as above.  Colonies that 
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contained an insert of the correct size were amplified in 10 ml LB+ampicillin (150 
µg ml
-1
) media, for 14 h at 37 °C in an orbital shaking incubator.  Plasmids were 
purified using the Wizard plus SV kit (Promega) and sequenced on both forward and 
reverse strands (Eurofins MWG) using SP6 and T7 primers (Table 4.2), resulting in 
the generation of 160 sequences.  The sequence data was analysed using Lasergene 
10 software (DNAstar) and searched against BLASTn database (NCBI – 
http://blast.ncbi.nlm.nih.gov/Blast.cgi) to confirm identity.  Phylogenetic and 
multiple pairwise alignments were conducted in Clustal Omega 
(http://www.ebi.ac.uk/Tools/msa/clustalo) and a neighbour-joining cladogram 
constructed in Clustal W2 
(https://www.ebi.ac.uk/Tools/phylogeny/clustalw2_phylogeny). 




4.3.1 Controlled efficacy test  
4.3.2 Analysis of blood plasma to determine macrocyclic 
lactone concentration 
For the duration of the observation period, none of the calves administered with a 
pour-on application were observed to lick either themselves or other calves within 
the same treatment group.  
There was no IVM detected in plasma samples obtained from one of the calves 
(animal number 302354) infected with FI001 and administered with IVM injectable 
formulation (group IVM-INJ-01).  As a result, all data from this animal were 
excluded from analysis.  The plasma profiles of the anthelmintic formulations are 
shown in Figure 20.  The observed peak concentration (Cmax) was seen to differ 
between treatment groups and between isolates.   




Figure 20: Concentration of ML plasma concentration (ng ml
-1
) for each treatment group over 
the duration of the trial, error bars represent the standard error of the mean.  Filled and open 
symbols represent calves infected with FI001 and FI004, respectively. The top pane comprises 
groups MOX-PO-01 and MOX-PO-04, the middle pane contains groups IVM-PO-01 and IVM-
PO-04, and the bottom pane, IVM-INJ-01 and IVM-INJ-04.  Groups administered injectable 
IVM are identified by square symbols (); IVM pour-on recipients by triangle symbols (∆) and 
MOX pour-on recipients by circles (○).  




The IVM concentrations present in plasma taken from calves in group IVM-INJ-01 
were seen to increase for up to two days following administration, when a mean peak 
of 39 ng ml
-1
 IVM was observed (± 7 standard error of mean, SEM; range 18 – 50 ng 
ml
-1
 IVM).  By necropsy, seven days after administration, IVM concentrations had 
decreased to a mean of 26 ng ml
-1 
IVM (± 7 SEM; range 10 – 42 ng ml
-1
).  IVM 
concentrations in plasma from calves in group IVM-PO-01 peaked at a mean 
concentration of 27 ng ml
-1
 IVM (± 7 SEM; range 19 – 35 ng ml
-1
) five days after 
administration.  The mean IVM concentration was found to have decreased slightly 
at six days after administration (25 ng ml
-1 
IVM, ± 3 SEM; range 19 – 35 ng ml
-1
), 
before increasing to a mean concentration of 27 ng ml
-1
 IVM (± 2 SEM; range 19 – 
34 ng ml
-1
) at necropsy.  Compared to the IVM plasma results, lower plasma 
concentrations were observed from the calves infected with FI001 and administered 
with MOX pour-on product (group MOX-PO-01).  The mean peak MOX values 
were observed five days after administration (8 ng ml
-1
 MOX ± 1 SEM; range 4 – 
11), with similar mean values obtained for the following two days (8 ng ml
-1
 MOX, ± 
2 SEM; range 3 – 12).   
Plasma taken from calves in group IVM-INJ-04 showed a lower mean Cmax 
concentration than in plasma from calves applied with the same product in group 
IVM-INJ-01.  IVM concentrations increased until two days following administration, 
when a Cmax of 20 ng ml
-1
 IVM was observed (± 4 SEM; range 9 – 31 ng ml
-1
 IVM).  
By necropsy at seven days after administration, Cmax had decreased to a mean of 18 
ng ml
-1 
IVM (± 2 SEM; range 11 – 24).  The Cmax in plasma from calves in group 
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IVM-PO-04 was observed seven days after administration, compared to five days as 
observed with group IVM-PO-01.  A mean peak IVM concentration of 25 ng ml
-1
 
IVM (± 4 SEM; range 10 – 35) was observed.  Similar values were observed over the 
preceding two days, with mean IVM concentrations of 22 ng ml
-1
 IVM (± 3 SEM; 
range 12 – 33) and 21 ng ml
-1
 IVM (± 4 SEM; range 9 – 30) observed five and six 
days after administration, respectively.  Finally, for plasma from calves in group 
MOX-PO-04, the mean Cmax value was observed five days after application (12 ng 
ml
-1
 MOX ± 1 SEM; range 9 – 16), an estimate which was maintained over the 
following two days, a pattern similar to that observed in plasma collected from 
calves in group MOX-PO-01.  
4.3.1.2. Faecal egg count analysis  
Faecal egg count results obtained using a centrifugal flotation method (Jackson, 
1974) are presented in Figure 21 and Table 25.  All FEC values presented here are 
the result of an arithmetic mean calculated from two FEC counts from each calf.  For 
calves infected with FI001, the mean FEC on day of treatment (day 0; day 28 post 
infection) across all four groups, was 1,008 EPG (± 173 SEM; range 252 – 2,624).  
The mean FEC from the untreated control group on this day was 1,425 EPG (± 471 
SEM; range 446 – 2,624).  The lowest mean FEC for the control group was recorded 
on day five following treatment, with 1,036 EPG (± 251 SEM; range 551 – 1,764).  
FECs then increased until necropsy when the mean FEC was 1,491 EPG (± 422 
SEM; range 675 – 2,741).  The daily fluctuations in FEC observed in this group for 
the duration of the CET were not found to be statistically significant, as measured by 
ANOVA analysis (P = 0.98). 
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On day 0, the mean FEC from calves in group IVM-INJ-01 was 597 EPG (± 91 
SEM; range 486 - 869).  This rose to a mean of 740 EPG (± 96 SEM; range 455 - 
851) one day after application.  The lowest mean FEC for this group was recorded 
five days after IVM administration (14 EPG ± 2 SEM; range 11 – 17), which 
increased to a mean of 30 EPG (± 9 SEM; range 4 - 44) at necropsy.  The mean FEC 
for calves in group IVM-PO-01 was 1,133 EPG (± 357 SEM; range 491 – 2,453).  
The mean FEC for this group decreased in the days following anthelmintic 
application, to a mean of 4 EPG (± 4 SEM; range 0 – 21) after five days, which 
increased to a mean of 13 EPG (± 11 SEM; range 2 - 57) at necropsy.  Calves in 
group MOX-PO-01 had a mean FEC of 795 (± 268, range 116 – 972) on day of 
application.  The mean FEC decreased following administration to 3 EPG (± 3 SEM; 
range 0 – 15) after six days, increasing to 4 EPG (± 3 SEM; range 0 - 12) after seven 
days.  
In general, the FECs observed in samples from the calves infected with FI004 were 
lower than those observed with calves infected with FI001.  For all calves infected 
with FI004, a mean FEC of 613 EPG (± 165 SEM; range 116 – 1,562) was observed 
on the day of treatment.  The untreated control calves had a mean FEC of 613 EPG 
(± 422 SEM; range 675 – 2,741) on day of treatment.  The highest FEC was 
observed on the third day following anthelmintic application, with a mean of 1,004 
EPG (± 182 SEM; range 401 – 1,440) and subsequently decreased to a mean FEC of 
515 EPG (± 249 SEM; range 126 – 1,458) by necropsy.  As observed with the 
untreated control calves from FI001, the fluctuations in FEC observed across the 
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duration of the CET for the FI004 untreated control calves were not found to be 
statistically significant (P = 0.7).  
Calves in group IVM-INJ-04 showed mean FEC values of 782 EPG (± 243 SEM; 
range 365 – 1,562) on day of administration.  The lowest mean FEC was observed 
four days after the application of anthelmintic (130 EPG ± 40 SEM; range 39 - 279).  
Seven days after anthelmintic application, the mean FEC had increased to 324 EPG 
(± 41 SEM; range 221 – 428) at necropsy.  FEC values estimates from calves in 
group IVM-PO-04 increased from a mean FEC of 579 EPG (± 173 SEM; range 116 - 
972) on day of treatment, to mean FEC value of 766 EPG (± 147 SEM; range 419 – 
1,170) one day after anthelmintic administration.  The mean FEC in this group was 
lowest at five days after treatment (231 EPG ± 51 SEM; range 98 - 392) before 
increasing to 412 EPG (± 208 SEM; range 113 – 1,215) two days later, at necropsy.  
Calves in group MOX-PO-04 displayed a mean FEC of 799 EPG (± 178 SEM; range 
347 – 1,305) on day of administration.  The FECs of this group began to decrease, 
with a mean of 1 EPG (± 1 SEM; range 0 - 3) by necropsy.  




Figure 21: Mean faecal egg count values for isolates FI001 (top pane) and FI004 (bottom pane) 
during the controlled efficacy test.  Error bars indicate the standard error of the mean (SEM).  
Untreated control groups are indicated with diamond symbols (◊); IVM injectable groups by 
square symbols (); IVM pour-on groups by triangle symbols (∆) and MOX pour-on groups by 
circles (○).  




Two calculations were made to ascertain the percentage reduction in FEC, the results 
displayed in Table 25.  In the first calculation, the mean day 7 FEC for a treatment 
group was divided by that of the mean day 7 FEC of the respective control group, as 
described by Coles et al., (1992).  In the second calculation, the mean day 0 FEC of 
each group was divided by the mean day 7 FEC of the same group (Kochapakdee et 
al., 1995).  For calves infected with FI001, reductions in FEC of 98, 99 and 100% 
were observed for groups IVM-INJ-01, IVM-PO-01 and MOX-PO-01, respectively, 
regardless of the calculation used.  For calves infected with FI004, 100% reduction in 
FEC was observed with the group MOX-PO-04.  With IMV-INJ-04 and IVM-PO-04 
groups, the percentage reduction in FEC differed dependent on the calculation used.  
By comparing the FECs on day 0 and seven days later, percentage reductions of 59% 
(IVM-INJ-04) and 29% (IVM-PO-04) were observed.  These values are higher than 
those obtained when FECs from the treatment groups were compared to the untreated 
control group (CONTROL-04), with reductions of 37% (IVM-INJ-04) and 20% 










Table 25: Faecal egg count values and percentage reduction estimates for isolates FI001 and 
FI004 treatment groups.  Mean FEC values for day of treatment samples and those taken seven 
days later are presented with the SEM with the range in brackets.  FECR values were calculated 
either by comparing the arithmetic mean Day 7 FEC of treated groups (T2) to the respective 
control group (C2; Treated versus Control) or calculated based on the observed reduction in 
FEC seven days after anthelmintic treatment compared to the arithmetic mean day of treatment 
FEC (Day 0 (T1) versus Day 7).  Estimates represent percentage reduction in egg number and 
95% confidence intervals are presented in square brackets 
 Mean Faecal Egg Count (EPG ± SEM (range))  Percentage reduction in FEC (%)           
[95% confidence interval] 
Treatment 
Group 
Day 0  Day 7  T2 versus C2 T1 versus T2 
CONTROL-01 1,425 ± 471  
(446 – 2,624) 
1,491 ± 421  
(675 – 2,741) 
- - 
IVM-INJ-01 597 ± 91  
(456 – 869) 
30 ± 9  
(4 – 44) 
98 [95 – 99] 98 [96 – 99] 
IVM-PO-01 1,133 ± 357  
(491 – 2,453) 
13 ± 11  
(2 – 57) 
99 [95 – 100] 99 [95 – 100] 
MOX-PO-01 795 ± 268  
(252 – 1,715) 
4 ± 3  
(0 – 12) 
100 [99 – 100] 100 [99 – 100] 
CONTROL-04 613 ± 165  
(189 – 1,184) 
515 ± 249  
(126 – 1,458) 
- - 
IVM-INJ-04 782 ± 243  
(365 – 1,562) 
324 ± 41  
(221 – 428) 
37 [0 – 77] 59 [0 – 69] 
IVM-PO-04 579 ± 172  
(116 – 972) 
412 ± 208  
(113 – 1,215) 
20 [0 – 81] 29 [0 – 76] 
MOX-PO-04 799 ± 178  
(347 – 1,305) 
1 ± 1  
(0 – 3) 
100 [99 – 100] 100 [100 – 100] 
 
There was no change in percentage reduction values when geometric mean FEC 
values were used in place of the arithmetic mean values presented here.  In light of 
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4.3.1.3. Adult worm burden analysis 
4.3.1.3.1 Worm burden analysis of calves infected with FI001 
An arithmetic mean total of 13,630 adult nematodes (ranging from 7,950 to 19,400 
nematodes) were observed in the abomasum and small intestine of the untreated 
control calves in group CONTROL-01, equivalent to a percentage establishment of 
27%, based on the initial inoculum of 50,000 L3.  All nematodes from the abomasal 
and small intestinal samples were identified as O. ostertagi and C. oncophora, 
respectively, Table 26.  The mean number of adult O. ostertagi recovered from the 
calves in CONTROL-01 was 8,280 (± 2,693 SEM; range 4,150 – 18,100).  No 
juvenile O. ostertagi worms were observed in any of the abomasal subsamples taken 
from calves infected with this isolate.  In the small intestine, a mean of 5,350 (± 
1,288 SEM; range 1,300 – 8,350) C. oncophora were detected.  Juvenile C. 
oncophora were found in small intestinal subsamples from three calves, with 
estimates of 50, 100 and 150 (calves 501007, 300948 and 102316, respectively).  
Subsamples from two calves in IVM-INJ-01 were observed to have adult O. 
ostertagi present in the abomasum (namely 501014 and 602321), each with 50 adult 
worms.  As a result, for this treatment group, there was 99.7% reduction in adult O. 
ostertagi worm burden compared to the calves in CONTROL-01.  Based on the 
small intestinal subsamples from all calves in IVM-INJ-01, a mean of 3,325 (± 1,175 
SEM; range 600 – 6,050) adult C. oncophora were found.  This equated to a 38% 
reduction in C. oncophora adult nematode burden in comparison to the mean C. 
oncophora burden of calves in CONTROL-01.   
There was 100% reduction in adult O. ostertagi from calves in group IVM-PO-01, 
with no nematodes observed in any of the abomasal samples.  For the small intestinal 
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worm burden, a mean of 1,930 (± 1,098 SEM; range 50 – 6,050) adult C. oncophora 
were enumerated.  As a result, a 64% reduction in adult C. oncophora worm burden 
was recorded, in comparison to the mean C. oncophora burden of CONTROL-01. 
For calves in group MOX-PO-01, a 100% reduction in O. ostertagi was observed, 
with no nematodes observed in any of the examined samples.  From the five calves 
in this treatment group, one calf (301106) was observed to have 100 juvenile C. 
oncophora present in the small intestinal subsample.  A mean of 3,700 (± 1,818 
SEM; range 0 – 8,550) adult C. oncophora were calculated in the small intestines of 
these calves after MOX pour-on administration.  Samples from one calf (401027) 
had no adult or juvenile C. oncophora present in the small intestinal subsample.  As a 
group, the calves in group MOX-PO-01 displayed 31% reduction in mean C. 
oncophora adult worm burden compared to that of CONTROL-01 group.   
Overall, for calves infected with FI001, the mean number of C. oncophora 
nematodes recovered from each treatment group were not found to be significantly 
different from the mean number of C. oncophora recovered from the untreated 
control calves (P > 0.05).  Similarly, there was no significant difference found when 
the mean C. oncophora burden of any group receiving an anthelmintic administration 
was compared to the other groups in receipt of an anthelmintic administration (P > 
0.05).    
 
4.3.1.3.2 Worm burden analysis of calves infected with FI004 
Based on the mean nematode burden of calves in group CONTROL-04, a mean 
establishment rate of 35% was observed, based on the initial inoculum of 50,000 L3, 
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with a mean of 17,560 adult nematodes being recovered, ranging from 8,200 to 
28,650 nematodes per calf.  For all calves infected with this isolate, no juvenile O. 
ostertagi were observed in abomasal samples, nor were any juvenile C. oncophora 
observed in small intestinal samples. 
The calves in group CONTROL-04 had a mean O. ostertagi burden of 15,120 (± 
3,549 SEM; range 7, 200 – 25,900).  The mean C. oncophora adult burden was 2,440 
(± 649 SEM; range 850 – 3,900).  Using the two-sampled t-test, these figures were 
not found to be significantly different from those derived from the calves in 
CONTROL-01 (p > 0.05).   
In group IVM-INJ-04, one calf (701009) was found to contain O. ostertagi in the 
abomasal sample, numbering 200 nematodes.  For this group, there was a mean 
99.7% reduction in adult O. ostertagi compared to the mean O. ostertagi burden 
from calves in CONTROL-04.  In the small intestine, a mean of 1,160 (± 73 SEM; 
range 1,000 – 1,350) C. oncophora were calculated.  Compared to the mean C. 
oncophora burden of the calves in CONTROL-04, this equated to 10% reduction in 
worm burden following injectable IVM administration.   
In four of the five calves in group IVM-PO-04, no O. ostertagi were present in the 
abomasum, with one calf (701006) containing 50 adult O. ostertagi.  As a result, the 
mean percentage reduction of O.ostertagi in this treatment group was 99.9%, 
compared to the mean O.ostertagi burden of CONTROL-04.  For the small intestinal 
worm burdens, a mean of 1, 430 (± 167 SEM; range 1, 100 – 1, 950) adult C. 
oncophora were calculated.  This equated to a zero percent reduction in mean 
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number of C. oncophora present, compared to the mean number of C. oncophora in 
the calves from CONTROL-04.  
No O.ostertagi were observed in abomasal samples from calves in group MOX-PO-
04, therefore 100% reduction in O. ostertagi was recorded.  The mean number of C. 
oncophora recorded was 290 (± 97 SEM; range 100 – 650).  When compared to the 
numbers of C. oncophora calculated in the untreated control calves, this equated to a 
74% reduction in C. oncophora worm burden.  This was the greatest reduction in C. 
oncophora worm burden observed in any of the six groups receiving an anthelmintic 
application.  
Overall, for calves infected with FI004, there were no significant differences in mean 
C. oncophora worm burdens between the untreated, control calves (CONTROL-04) 
and any of the groups administered anthelmintic (P > 0.05).  However, a significant 
difference was observed between the mean C.oncophora burden of the group MOX-
PO-04 and group IVM-INJ04 and IVM-PO-04 (P values < 0.008).  There was no 
significant difference between mean C. oncophora burdens of groups IVM-INJ-04 










Table 26: Small intestinal worm burden results for each isolate, shown as arithmetic mean, 
including S.E.M for each group and the range in nematode burden, in addition to the 
percentage efficacy of each group compared to the respective control group  The percentage of 
male to female C. oncophora (M:F) is also presented. 
 Mean small intestinal worm burden ± SEM [range]   




CONTROL-01 2,480 ± 
635 [400-
3,800] 
2,810 ± 633 
[900-4,400] 







IVM-INJ-01 1,425 ± 
429 [400-
2,600] 
1,900 ± 625 
[200-3,450] 






IVM-PO-01 920 ± 543 
[50-3,000] 
1,010 ± 557 
[0-3,050] 






MOX-PO-01 1,590 ± 
837 [0-
3,700] 
2,090 ± 983 
[0-5,000] 






CONTROL-04 1,170 ± 
326 [250-
2,050] 
1,270 ± 339 
[350-2,050] 
0 ± 0           
[0-0] 
2,440 ± 649 
[850-3,900] 
NA 48:52 
IVM-INJ-04 1,040 ± 
97 [850-
1,400] 
1,160 ± 73 
[1,000-
1,350] 
0 ± 0           
[0-0] 




IVM-PO-04 1,280 ± 
270 [750-
2,300] 
1,430 ± 167 
[1,100-
1,950] 
0 ± 0           
[0-0] 




MOX-PO-04 350 ± 183  
[0-1,000] 
290 ± 97 
[100-650] 
0 ± 0           
[0-0] 




In general, higher numbers of female C. oncophora were enumerated compared to 
male C. oncophora, with the exception of the group MOX-PO-04, where more male 
worms were present (55%).  Based on the results of a series of proportion tests 
(Newcombe, 1998), there was no statistically significant difference in the proportion 
of male and female C. oncophora in the treated groups compared to the untreated, 
control groups. There was also no statistically significant difference found when 
comparing the groups in receipt of anthelmintic administration (P > 0.05).   




4.3.2 Comparison of number of eggs in utero in female Cooperia 
oncophora  
From the 39 calves included in the FEC and worm burden analysis, 36 animals had 
adult female C. oncophora worms present in the 2% small intestinal subsample.  The 
three calves without any female C. oncophora in their samples were infected with the 
FI001 isolate.  Two of these had received the IVM pour-on preparation (IVM-PO-01, 
calves 400949 and 700690), the other, the MOX pour-on preparation (MOX-PO-01, 
calf 401027).  For the remaining animals, the mean number of C. oncophora females 
recovered from the 2% subsample was 30 (± 4 SEM; range 2 - 100).  However, as 
not all enumerated worms were intact, an average of 19 nematodes (± 1.3 SEM; 
range 2 - 25) were measured for each calf.  Figure 22 demonstrates the difference 
observed between a female C. oncophora with a uterus full of eggs, isolated from an 
untreated control calf, and a female C.oncophora worm with an egg-free uterus, 
seven days after having survived a MOX pour-on application.  The results detailing 
the length of the female worms and eggs in utero measurements are displayed in 
Table 27, together with the arithmetic mean FEC of each group at post-mortem.  In 
total, 679 female C. oncophora were examined, with an overall mean length of 12.3 
mm (± 0.05 SEM; range 7.6 – 15.4) and a mean numbers of eggs in utero of  30 (± 
13 SEM;  range 0 – 158). There were no significant differences found between the 
number of eggs enumerated or lengths of nematodes from CONTROL-01 and 
CONTROL-04 (P > 0.05). 
 




Figure 22: Comparison of differences in numbers of eggs in utero between adult female C. 
oncophora. The image on the left shows an adult C. oncophora from a control animal (arrows 
indicate location of eggs present in utero), whilst the image on the right is C. oncophora from a 
calf treated with MOX pour-on (no eggs observed).  Both images were taken under x 100 
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Table 27: Data from female worm measurements and eggs observed in utero. Data are 
expressed as arithmetic mean values (± S.E.M) and range of values observed. Groups 
administered with IVM injectable, IVM pour-on and MOX pour-on applications are referred to 





Arithmetic mean ± SEM [range] 
Female worm 
length (mm) 
Eggs counted in 
utero 
FEC 7 days after 
administration 
CONTROL-01 112 
12.5 ± 0.1 [9.2-
14.4] 
54 ± 3 [0 - 158] 1,491 ± 282 [657-2,844] 
IVM INJ-01 79 
11.9 ± 0.1 [8.9-
14.7] 
3 ± 1 [0-72] 30 ± 6 [3-48] 
IVM PO-01 66 
12.2 ± 0.1 [9.4-
14.7] 
3 ± 1 [0-34] 13 ± 7  [1-60] 
MOX PO-01 82 
12.2 ± 0.1 [8.9-
15.2] 
0 ± 0 [0-0] 4 ± 3  [0-13] 
CONTROL-04 88 12.7 ± 0.1 [10.2-15] 61 ± 3 [0-141] 515 ± 166  [135-1,476] 
IVM INJ-04 112 
12.2 ± 0.1 [6.8-
15.4] 
23 ± 3 [0-125] 323 ± 28  [216-450] 
IVM PO-04 112 12.5 ± 0.1 [7.6-15] 39 ± 3 [0-144] 411 ± 139  [108-1,278] 
MOX PO-04 28 11.5 ± 0.2 [10-15] 0 ± 0 [0-0] 1 ± 0.3  [0-3] 
 
The eggs in utero data was found to fit a normally distributed error model and so 
linear regression was used to compare the lengths of examined nematodes from 
different treatment groups.  For the FI001 isolate, there was a significant difference 
in length found between C. oncophora examined from the calves in CONTROL-01 
and C. oncophora from calves in IVM-INJ-01, IVM-PO-01 and MOX-PO-01 (P < 
0.05), as displayed in Figure 23.  There were no significant differences in worm 
length between nematodes from calves in IVM-INJ-01 and those from IVM-PO-01 
(P > 0.05).  Nematodes from calves in group MOX-PO-01 were found to be 
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significantly shorter than both nematodes from calves receiving IVM-INJ-01 and 
IVM-PO-01 (P < 0.05).   
For nematodes derived from calves infected with the FI004 isolate, significantly 
shorter nematodes were found from groups IVM-INJ-04 and MOX-PO-04 than those 
from the untreated, control group CONTROL-04 (P < 0.05).  Nematodes recovered 
from the small intestine of calves in MOX-PO-04 were found to be significantly 
shorter than those that were examined in samples derived from both IVM-INJ-01 and 




Analysis of the number of eggs in utero revealed that there were significant 
differences for both isolates between all treatment groups when each was compared 
                        *                 *                 *                                     *                                     *                  
Figure 23: The mean length of female C. oncophora nematodes from each anthelmintic group. Blue bars 
represent FI001, white bars represent FI004, with ‘INJ’ and ‘PO’ indicating injectable and pour-on 
formulations, respectively.  Error bars indicate standard error of the mean and asterisks indicate groups 
with a mean nematode length that is significantly different from that of the respective control group (P< 
0.05).   
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to the respective untreated control group (P < 0.05).  No significant difference in egg 
number was found when comparing IVM-INJ-01 to IVM-PO-01 or when comparing 
IVM-INJ-04 to IVM-PO-04.  However, a statistically significant difference in egg 
number was found when comparing group MOX-PO-01 to IVM-INJ-01 and IVM-
PO-01; a finding also observed when egg numbers from MOX-PO-04 were 
compared to IVM-INJ-04 and IVM-PO-04 (P < 0.05), as displayed in Figure 23.  
 
Figure 23: The mean number of eggs counted in utero per female C. oncophora, in each of the 
treatment groups. Blue bars represent FI001, white bars represent FI004, with ‘INJ’ and ‘PO’ 
indicating injectable and pour-on formulations, respectively.  Error bars indicate the standard 
error of the mean and asterisks indicate groups with a mean number of eggs that is significantly 
different from that of the respective control group (P< 0.05).    
 
Logistic regression performed to analyse the relationship between the length of 
female C. oncophora and the numbers of eggs counted in utero per female.  For 
nematodes from CONTROL-01, a statistically significant positive correlation was 
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observed (P < 0.05).  For this isolate, statistically significant positive correlations 
were also observed for data from both IVM-INJ-01 and IVM-PO-01 groups (P < 
0.05).  As no eggs were observed in the uteri of nematodes surviving MOX pour-on 
administration (MOX-PO-01), this analysis could not be conducted for these 
nematodes.  For nematodes from untreated control calves infected with FI004 
(CONTROL-04), a statistically significant positive correlation was observed (P < 
0.05).  This was also observed when the C. oncophora from IVM-INJ-04 were 
assessed (P < 0.05).  However, a statistically significant relationship was not 
observed when the data pertaining to the IVM-PO-04 was analysed (P > 0.05).  As 
previously stated for FI001, due to the absence of eggs observed in uteri in 
nematodes from MOX-PO-04, this analysis could not be conducted.    
 
4.3.3 Molecular analysis of an area of glutamate-gated 
chloride channel gene (glc-6) in Cooperia oncophora  
4.3.3.1 Comparative analysis of glc-6 nucleotide sequences derived 
from C. oncophora obtained from untreated control calves versus glc-6 
nucleotide sequences obtained from C. oncophora harvested from IVM 
treated calves 
Following the phenotypic analyses of adult female C. oncophora from isolates FI001 
and FI004, differences were seen between worms recovered from the untreated 
control calves and those nematodes that had survived an anthelmintic administration.  
To investigate if there were differences present at a genetic level in these groups of 
parasites, analysis of cDNA encoding for a gene (glc-6), for which mutations have 
been putatively associated with IVM resistance, and which has been upregulated in 
resistant parasites following anthelmintic exposure (de Graef et al., 2013a) was 
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conducted. As described in Section 4.2.3.1, RNA was extracted from eight pools of 
10 adult nematodes.  RNA was extracted from male and female nematodes from 
untreated control calves infected with FI001 (CON-M-01 and CON-F-01) and from 
calves infected with FI004 (CON-M-04 and CON-F-04).  RNA was also extracted 
from male and female nematodes surviving IVM injectable administration from 
FI001 (IVM-M-01 and IVM-F-01) and FI004 (IVM-M-04 and IVM-F-04).  For each 
of the eight pools of RNA, RT-PCR was performed to produce a 319 base pair (bp) 
cDNA fragment of glc-6, located at the 5’ end.  Ten clones for each amplicon were 
produced and sequenced along both forward and reverse strands, to yield 20 
sequences.  These 20 sequences were subsequently aligned to form a consensus 
sequence for each pool.  The consensus sequence was subjected to Blastn analysis to 
examine percentage identity of each consensus sequence to previously submitted 
nematode glc-6 sequences.  For each consensus, the sequence results with the three 
highest percentage identities were recorded.  The remaining results from the Blast 
search were universally less than 40 bp in length and were not derived from parasitic 
nematodes.     
 
4.3.3.2 Analysis of glc-6 nucleotide sequence derived from C. 
oncophora from FI001 
The consensus from clones amplified from CON-F-01 nematodes showed the highest 
identity to the full-length glc-6 sequence for IVM-susceptible C. oncophora 
(Genbank accession number: HF545675) with 100% identity over 319 base pairs 
(bp).  The next closest identity was to the O. ostertagi glc-6 orthologue (74% identity 
over 266 bp; HF545676), followed by identity to a messenger RNA sequence for a 
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putative GluCl subunit (Hco-glc-6) in Haemonchus contortus (74% identity, 200 
over 268 bp; EU006789; (Glendinning et al., 2011). For the consensus representing 
cDNA from CON-M-01 nematodes, the highest identity was found to the full-length 
glc-6 sequence for IVM-susceptible C. oncophora (99% identity, 316 over 319 bp; 
HF545675).  The next closest identity was to the O. ostertagi glc-6 orthologue (74% 
identity over 266 bp; HF545676), followed by the Hco-glc-6 orthologue in H. 
contortus (74% identity, 198 over 268 bp; EU006789).  The consensus from CON-
M-01 and the consensus from CON-F-01 showed similar percentage identities to 
those observed in the consensus sequence from IVM-M-01 and the consensus from 
IVM-F-01.  For the IVM-F-01 consensus, there was 100% identity to the C. 
oncophora glc-6 sequence (HF545675) over 319 bp.  This was followed by 75% 
identity to Hco-glc-6 (200 bp over 268; EU006789) and 74% identity to O. ostertagi 
glc-6 orthologue (74% identity over 266 bp; HF545676).  For IVM-M-01 consensus, 
99% identity was seen with regard to the C. oncophora glc-6 sequence (HF545675) 
with 315 over 319 bp.  Identical percentage identities of 74% were seen with O. 
ostertagi glc-6 (198 over 266 bp; HF545676) and Hco-glc-6 (199 bp over 268; 
EU006789).     
 
4.3.3.3. Analysis of glc-6 nucleotide sequence derived from C. 
oncophora from FI004 
The glc-6 nucleotide consensus from CON-F-04 showed 99% identity with the IVM 
susceptible C. oncophora glc-6 nucleotide sequence (316 over 319 bp; HF545675).  
The next highest identity was to the H. contortus Hco-glc-6 orthologue (74% over 
268 bp; EU006789), followed by the glc-6 orthologue from O. ostertagi (72% over 
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310 bp; HF545676).  For the glc-6 consensus derived from CON-M-04, the 
percentage identity to C. oncophora glc-6 nucleotide sequence was 100%, over 319 
bp (HF545675).  The O. ostertagi glc-6 orthologue had the next highest identity, 
with 75% identity over 280 bp (HF545676), followed by the Hco-glc-6 nucleotide 
sequence of H. contortus with 74% identity over 278 bp (EU006789). The consensus 
from CON-M-04 and the consensus from CON-F-04 showed similar percentage 
identities to those observed in the consensus sequence from IVM-F-04 and the 
consensus from IVM-M-04.  The glc-6 consensus generated from amplifying cDNA 
from IVM-F-04, showed 100% identity to C. oncophora glc-6 over 319 bp 
(HF545675).  The second highest identity was with H. contortus Hco-glc-6 (75% 
over 268 bp; EU006789), followed by O.ostertagi glc-6 (74% over 266 bp; 
HF545676).  When the glc-6 nucleotide consensus from cDNA generated from IVM-
M-04 examined, a 99% identity was found for the C. oncophora glc-6 nucleotide 
sequence (317 over 319 bp; HF545675).  Identities of 74% were observed for H. 
contortus Hco-glc-6 (199 over 268 bp; EU006789) and O.ostertagi glc-6 (196 over 
266 bp; HF545676).    
 
 
4.3.3.4 Comparative amino acid sequence analysis of glc-6 in C. 
oncophora generated from untreated control calves and C. oncophora 
surviving injectable IVM administration 
Each nucleotide consensus was translated to a peptide sequence and aligned in 
Clustal Omega, as displayed in Figure 24.  Pairwise alignments were conducted to 
test for similarity between consensus, as reported in Table 28. For comparative 
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purposes, pairwise alignments also included glc-6 amino acid sequences derived 
from an IVM-susceptible C. oncophora isolate (HF545675; de Graef et al., 2013a), a 
non-related IVM-resistant C. oncophora isolate (unpublished data (de Graef et al., 
2013a)) and an IVM-susceptible O. ostertagi isolate (HF545676; de Graef et al., 
2013a), all originating in Belgium. 
 
Figure 24: Peptide sequences of the glc-6 gene, generated from nucleotide consensus data from, 
derived from 20 sequences from C. oncophora from two isolates, having being exposed, or not, 
to IVM in vivo. Unexposed nematodes and those surviving IVM are denoted by “CON” and 
“IVM” respectively. Male and female nematodes are denoted by “M” and “F” and the isolate 
from which the nematodes originated is denoted by 01 or 04. For comparison purposes, peptide 
sequences derived from an IVM-resistant C. oncophora and IVM-susceptible C. oncophora and 
O. ostertagi isolates are also included (De Graef et al., 2012). The region of peptide suggested to 
show differences between resistant and susceptible C. oncophora isolates (De Graef et al., 2013a) 
is highlighted within the box.    
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In total, four differences in peptide sequence were noted, compared to the IVM-
susceptible C. oncophora (HF545675) peptide sequence.  For CON-M-01, at position 
50 on the peptide sequence, threonine (ACC) replaced serine (ACT) on six occasions 
within the 20 sequences.  At the same location, for IVM-M-01, threonine (ACT) 
replaced serine (ACT) on six occasions.  For isolate FI004, at location 11 on the 
peptide sequence for CON-F-04, tryptophan (TGG) and threonine (ACG) both 
replaced serine (TCG) on eight occasions.  At position 25 on the peptide sequence, 
for IVM-M-04, serine (AGC) was replaced by a cysteine residue (TGC) on 12 
occasions and by arginine (CGC) on eight occasions.  Similar differences in peptide 
sequence were not observed in IVM-resistant or susceptible C. oncophora isolates 
examined in the Belgian study (de Graef et al., 2012), where a difference in sequence  
between IVM-R and IVM-S isolates was seen at the N terminal end of the G:LC-6  
peptide sequence (indicated by the box in Figure 24).        
As expected a substantial degree of identity  was observed among the GLC-6 peptide 
sequences derived from FI001 and FI004 and that of the IVM-susceptible C. 
oncophora isolate, with percentage identity > 99% for all comparisons.  Percentage 
identity of the FI001 and FI004 peptide sequences compared the IVM-R C. 
oncophora isolate was >96% (Table 28).  For almost all isolates, including the IVM-
susceptible C. oncophora isolate (HF545675), the percentage identity was 69.81% to 
IVM-susceptible O. ostertagi glc-6 sequence (HF545676).  A percentage identity of 
70.1% was observed between the IVM-R C. oncophora isolate and the IVM-
susceptible O. ostertagi glc-6 sequence.     
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Table 28: Pairwise comparison analysis, presented as percentage identity, of peptide sequences 
derived from C. oncophora from two isolates, having being exposed, or unexposed, to IVM in 
vivo.  Unexposed nematodes and those surviving IVM are denoted by “CON” and “IVM”, 
respectively, with male (M) and female (F) nematodes from field isolates 001 (01) and 004 (04) 
denoted accordingly. For comparison with other isolates, IVM-susceptible C. oncophora (C.o 
(S)), IVM-resistant C. oncophora (C.o (R)) and O. ostertagi (O.o) isolates are also included (De 
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The aims of the CET were to ascertain if the findings of IVM resistant Cooperia spp. 
from the FECRTs conducted in Chapter 3 were reproducible under controlled 
conditions and to investigate the efficacy of an alternative application method 
(namely, a topical pour-on) and anthelmintic product (MOX).  The results have 
proven that both field isolates FI001 and FI004 contained C. oncophora nematodes 
that are resistant to the effects of IVM and MOX.  The CET in this study was 
conducted as far as possible in accordance with the recommended WAAVP 
guidelines (Wood et al., 1995).  However, from the results displayed here, there are 
clear differences displayed in the plasma, FEC and worm burden analyses from 
different treatment groups and between the two isolates.  Blood plasma was taken 
during the CET for two reasons.  First, to confirm that animals administered with 
anthelmintic had the product circulating in their bloodstream and second, to examine 
the differences in plasma levels between the anthelmintic classes and application 
methods, as anthelmintic levels in blood plasma have been associated with clinical 
efficacy (Lanusse et al., 1997).   Here, peak IVM and MOX plasma concentrations 
observed fell within previously published concentration ranges (Gayrard et al., 1999; 
Lifschitz et al., 1999a; Lifschitz et al., 1999b; Sallovitz et al., 2002).  The 
pharmacological pattern from MOX-PO-01 and MOX-PO-04 groups were very 
similar and were far lower than the plasma concentrations observed with IVM-PO-01 
and IVM-PO-04.  This result is to be expected, given that MOX is believed to have a 
faster clearance time from the plasma to adipose tissue, which is linked to longer 
persistence of the molecule within the host (Lanusse et al., 1997; Bousquet-Mélou et 
al., 2004).  The finding of lower IVM concentrations in the plasma from calves 
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administered with a pour-on IVM application, particularly in IVM-PO-01, is also to 
be expected.  For IVM pour-on formulations, whilst they have been shown to be 
efficacious against IVM-susceptible O. ostertagi and C. oncophora  (Herd et al., 
1996; Gayrard et al., 1999), the IVM is less easily absorbed through the skin than it 
is from a subcutaneous injection site (Bousquet-Mélou et al., 2004; Prichard et al., 
2012). The observation that no IVM was found in plasma samples from one calf after 
it was administered with the injectable formulation of IVM was unexpected.  The 
calf was believed to have been administered correctly and all calves were injected by 
the same operator.  Consequently, there were only four animals in this treatment 
group, which increases the risk of a Type II error (not rejecting the null hypothesis 
when an effect is present, but not detected in the analysis).  Collecting samples of 
blood plasma samples to determine anthelmintic concentrations is not a practice 
routinely described in publications reporting CET results, nor stipulated in the 
current WAAVP guidelines (Wood et al., 1995).  However, in situations such as 
confirming anthelmintic efficacy against a suspected resistant isolate, the findings 
from this CET suggest the use of plasma analysis should be considered to confirm 
that anthelmintic was received by all animals.  Failure to do so may lead to 
uncertainty regarding the results, as results cannot be differentiated between a case of 
anthelmintic misadministration, and one of ‘true’ anthelmintic resistance.  The 
comparison of plasma concentrations between published studies can be problematic 
as, even under controlled conditions, differences in pharmacokinetic data can be seen 
due to factors such as animal breed (Sallovitz et al., 2002), gender (Ndong et al., 
2007), age and diet quantity, quality and composition (Sanyal et al., 1995), as well as 
study design, i.e. different sampling periods, anthelmintic applications used and non-
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standardised methods of analysis (Lanusse et al., 1997).  Previous studies have also 
reported pharmacokinetic differences between male and female cattle (Lo et al., 
1985; Toutain et al., 1997) and differences have been reported among generic IVM 
products (Lifschitz et al., 2004).  In the latter study, comparison of four generic IVM 
products, following subcutaneous administration in cattle, displayed differences in 
time to reach peak IVM concentration in plasma (range: 1.1 to 4.3 days), with a 
difference of 11 ng ml
-1
 between mean peak IVM concentrations (range: 22 to 33 ng 
ml
-1
 IVM) (Lifschitz et al., 2004).  For this reason, here, the anthelmintic products 
that were used contained the original compounds, namely IVOMEC® (Merial 
Animal Health) and Cydectin® (Pfizer Animal Health).  Another common issue is 
the use of different cattle breeds, which may have inherent differences in metabolism 
or body composition, a particular importance with ML compounds as both IVM and 
MOX are lipophilic and are distributed within the body fat reserves (Bassissi et al., 
2004).  This means that data collected by one study, for example the use of 400 kg 
dairy cattle (Herd et al., 1996) may be different to one which uses 200 kg Hereford 
cattle (Lanusse et al., 1997).  A previous study designed to examine the effect of 
cattle breed on pharmacokinetic data was conducted by comparing Aberdeen Angus 
and Holstein cattle, where differences in Cmax values and time to reach Cmax 
following MOX pour-on administration were found.  Cmax values of 2.33 ± 0.28 ng 
ml
-1
 and 5.08 ± 0.94 ng ml
-1
 were observed for Holstein and Aberdeen Angus cattle,  
respectively (Sallovitz et al., 2002).  Time to reach the Cmax value also differed 
between groups, with peak seen later with the Aberdeen Angus cattle (five days 
following administration) than with the Holstein cattle (two days following 
administration;  (Sallovitz et al., 2002)).  Here, this potential issue was avoided by 
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using male dairy calves that were balanced for age and weight, and no statistically 
significant correlations were found when ML plasma concentrations were compared 
to age or weight of calves.  
From the FEC analysis conducted on day of anthelmintic administration, differences 
in FEC were observed between calves infected with FI001 and those infected with 
FI004.  For the calves infected with FI001, a mean of 1,008 EPG was observed, in 
contrast to the mean FEC of 613 EPG for calves infected with FI004.  This can be 
attributed to a greater proportion of O. ostertagi L3 present in FI004 (40%), 
compared to 20% O. ostertagi present in FI001.  O. ostertagi is known to be less 
fecund than C. oncophora, containing, on average, 30 eggs per uterus at any one 
time, compared to an average of 60 eggs in the uterus of a C. oncophora female 
(Kloosterman, 1971).  As all calves received approximately the same number of 
larvae, the difference in genus proportions between the two isolates could account for 
the higher FECs observed in calves infected with FI001 prior to anthelmintic 
administration, compared to the FEC data from calves infected with FI004. Although 
daily fluctuations in FEC were seen with both CONTROL-01 and CONTROL-04 
groups, these differences were not statistically significant, and FECs were far higher 
than the FECs observed under the natural infection conditions of the on-farm 
FECRT, where the mean day of treatment FECs were 74 and 86 EPG for FI001 and 
FI004, respectively.   
The change in FEC after anthelmintic application is negatively correlated with the 
increase in ML plasma concentrations, across all treatment groups.  Based solely on 
reduction in FEC, results from groups IVM-INJ-01, IVM-PO-01, MOX-PO-01 and 
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MOX-PO-04, would appear to indicate a high level of efficacy.  If taken in isolation 
from the rest of the results presented here, an erroneous assumption of ML sensitivity 
may have been made.  However, it must be noted that these FECs were not taken 14 
days after anthelmintic administration, as indicated by FECRT guidelines for ML 
products (Coles et al., 1992).   IVM has been previously shown to have a temporary, 
paralysing effect on nematode uterine musculature, as demonstrated by work with 
the ovine nematodes Trichostrongylus colubriformis (Bottjer and Bone, 1985) and 
Cooperia curticei (McKellar et al., 1988).  The FEC data from groups  IVM-INJ-04 
and IVM-PO-04 suggests that after sufficient time has elapsed, egg-laying can 
resume in resistant isolates, adding further credence to appropriate sampling times 
being adhered to when conducting FECRTs (Coles et al., 1992).    
Analysis of adult nematodes recovered at necropsy confirmed the presence of IVM 
and MOX resistant C. oncophora in both isolates, FI001 and FI004.  Conversely, 
IVM and MOX were found to be highly effective against O. ostertagi in both 
isolates, with percentage reductions in abomasal worm burdens in excess of 99%.  
Percentage reductions in adult C. oncophora burdens were 38%, 64% and 31% for 
groups IVM-INJ-01, IVM-PO-01 and MOX-PO-01, respectively, when compared to 
the numbers present in samples from CONTROL-01.  Similarly, percentage 
reductions in adult C. oncophora were 10%, 0% and 74% for groups IVM-INJ-04, 
IVM-PO-04 and MOX-PO-04, respectively, compared to C. oncophora present in 
samples from CONTROL-04.  The findings of IVM inefficacy confirm the suspected 
resistance in Cooperia spp. detected with the on-farm FECRTs described in Chapter 
3 (McArthur et al., 2011).  The discovery that these isolates are also MOX-resistant 
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means these are the first confirmed cases of MOX-resistant cattle nematodes in the 
UK (Bartley et al., 2012). The presence of ML-resistant C. oncophora surviving 
anthelmintic administration is not surprising, as this species has globally been 
implicated in almost all initial reports of AR in cattle and was identified during pre-
registration efficacy trials to be one of the dose-limiting helminth species for both 
IVM (Egerton 1979, Egerton et al 1981) and MOX (Scholl et al 1992).  Higher 
concentrations of both products were required to match efficacy obtained against 
adult nematodes of abomasal species such as O. ostertagi (Egerton et al 1981, Scholl 
et al 1992).  Although IVM resistance was confirmed in C. oncophora in both field 
isolates and observed when using IVM injectable and pour-on preparations, there are 
differences in observed efficacy levels, based on adult small intestinal worm burdens.  
With group IVM-PO-01, a higher percentage efficacy (64%) was observed than in 
group IVM-INJ-01 (38%), despite a higher Cmax value being obtained in plasma 
collected from calves in group IVM-INJ-01.  This is unexpected, as it is generally 
accepted that application of anthelmintics by subcutaneous injection is a more 
efficient route in cattle, allowing greater and more immediate bioavailability when 
compared to pour-on or oral applications (Gayrard et al., 1999; Laffont et al., 2001).  
Conversely, with groups IVM-INJ-04 and IVM-PO-04, a higher Cmax value was 
observed with IVM-PO-04 compared to IVM-INJ-04, but a zero percent reduction in 
C. oncophora was recorded in group IVM-PO-04, compared to 10% reduction seen 
with group IVM-INJ-04.  These findings may indicate that whilst pharmacokinetic 
data from ML administration may appear to reflect FEC data, it may not reflect the 
extent of the effect on adult nematode burden at 7 days post treatment.    
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 Application with the MOX pour-on in group MOX-PO-04 produced a greater 
reduction in small intestinal worm burden (74%) than that observed with either of the 
IVM applications (0% and 10% for IVM-PO-04 and IVM-INJ-04, respectively).  
However, with FI001, the lowest reduction in C. oncophora numbers was observed 
in calves administered with MOX (31%), compared with reductions observed with 
IVM-INJ-01 (38% reduction) and IVM-PO-01 (64% reduction).  It might have been 
expected that MOX would have been more effective in reducing small intestinal 
worm burdens than IVM, as it is believed to be more lipophilic and have a higher 
potency compared to IVM (Kieran, 1994).  The results from work conducted by 
Ranjan et al (1992) suggested MOX exerts selection pressure on female C. 
oncophora, as greater efficacy was achieved against female C. oncophora than adult 
male C. oncophora, with efficacies of 98.4% and 93.8% respectively.  The results are 
in contrast to those of the current study where the ratio of male to female C. 
oncophora was more biased to females (55% of population).  Our results correlate 
with previous work conducted examining two C. oncophora isolates unexposed to 
anthelmintics, where the average percentage of male nematodes was 47%, based on 
results from 10 calves (Bairden et al., 1992).  The one exception in this study was 
with group MOX-PO-04, where 10% more male C. oncophora were found than 
female (55% and 45%, respectively).  This result indicates that, as with Bairden et 
al., (1992), sex ratios may differ between isolates and anthelmintic selection may not 
be wholly responsible for any observed differences and may not be true for all C. 
oncophora isolates. 
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Efficacy based on comparison to control animal data clearly shows resistance to both 
IVM and MOX, regardless of application method, in both isolates.  As the controlled 
conditions of the CET restrict a number of confounding issues, discussed above, such 
as use of calves of a similar breed and age, reasons for differing efficacies could be 
attributable to the previous use of anthelmintics on Farms 001 and 004, prior to 
isolation of these isolates.  Data regarding parasite management regimes was 
collected (as described in Chapter 2) and revealed both farms generally employed 
similar practices.  First season grazing calves were administered with anthelmintics 
twice (Farm 001) or three times (Farm 004) per year.  Both farms had administered 
ML products for the previous five years and had used pour-on products.  Farm 001 
volunteered the information that eprinomectin had been used in the preceding year 
and other ML products were used prior to this.  Differences were observed in 
administration practices; as while Farm 004 administered anthelmintics to all calves 
and individually weighed animals to determine dose volumes, Farm 001 usually 
estimated the weight of the calves to determine dose rates.  While Farm 001 was a 
cattle-only enterprise, Farm 004 also farmed sheep, which were grazed with cattle.  
Depending on the anthelmintic regime employed with the sheep, additional selection 
pressure for ML resistant nematodes may have been provided, especially in Cooperia 
spp., which are proven to infect sheep, as well as cattle (Keith, 1953; Isentstein and 
Porter, 1964).   
The mean lengths of the female C. oncophora reported here are longer than those 
published previously, ranging between 11.5 – 12.7 mm.  Work conducted in 1963 
found female C. oncophora to measure on average 9.43 mm (Isentstein, 1963) and 
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veterinary textbooks commonly cite C. oncophora as being of similar size to O. 
ostertagi (Urquhart et al., 1996) or measuring 6 – 8 mm (Taylor et al., 2002).  In 
other published literature, however, mean measurements of adult C. oncophora 
females ranged from 8.32 - 11.45 mm (Smith 1970), 9.3 - 11.10 mm (Bairden et al., 
1992), and 11.5 - 13.3 mm (Albers et al., 1982).  In this study, the results relate most 
closely to that reported by Albers et al (1982), who reported a statistically significant 
correlation between female C. oncophora mean length and the time of calf necropsy 
following infection.  Nematodes recovered at 55 days PI were significantly larger 
than those recovered at 28 days PI, measuring on average 13.3 and 11.8 mm, 
respectively (P < 0.010) (Albers et al., 1982).  Conversely, the opposite was observed 
in O.  ostertagi worm length, where a decrease of 7 – 8 % in female length was 
detected over time (Michel et al., 1978b).  These findings may go some way to 
explaining why the measurements of C. oncophora, not exposed anthelmintic 
administration, are so variable between studies.  The two isolates characterised here 
also appear to show differences in nematode length, depending on the anthelmintic 
administered.  Outwith C. oncophora from CONTROL-01 and CONTROL-04, the 
shortest nematodes were seen in groups IVM-INJ-01 (mean 11.9 mm) and MOX-
PO-04 (mean 11.5 mm).  It has been previously hypothesised with the ovine 
nematode Teladorsagia circumcincta, that nematodes resistant to levamisole were 
larger and more fecund than susceptible nematodes (Leignel and Cabaret, 2001).  As 
with the small intestinal worm burden data, the differences observed between 
isolates, may be a result of prior anthelmintic selection pressure, resulting in different 
responses in the different treatment groups.    
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Whilst lengths of C. oncophora worms appear to be variable between studies, so too 
are reports of the numbers of eggs observed in utero, potentially attributable to a 
number of factors, such as provenance of C. oncophora isolate, host immunity and 
that the production of nematode eggs is not known to be a continuous process 
(Kloosterman, 1971; Albers et al., 1982; Kloosterman et al., 1984; Bairden et al., 
1992).  In one previous study examining the effect of isolate pathogenicity in four 
groups of three month-old calves infected with mixed isolates of C. oncophora and 
O. ostertagi, 10 female C. oncophora per group were examined and an average of 
25, 37, 40 and 46 eggs per nematode were found (Bairden et al., 1992).  Differences 
in the numbers of eggs per C. oncophora female have also been found to differ 
dependent on the age of calf infected, with average numbers of eggs found in C. 
oncophora infecting yearling cattle to be less than half of that found in C. oncophora 
from first season calves, with a mean of 30 and 78 eggs recorded, respectively 
(Smith, 1970).  Here, in female C. oncophora from groups CONTROL-01 and 
CONTROL-4, an average of 54 and 61 eggs were counted per nematode.  This 
finding is similar to a recent CET in Belgium, where female C. oncophora from 
untreated control calves were found to contain an average of 67 eggs per nematode 
(de Graef et al., 2012), with nematodes surviving 14 days after injectable IVM or 
MOX administration found to have an average of 57 and 38 eggs per nematode, 
respectively (de Graef et al., 2012). Overall, the findings from the analysis of the 
numbers of eggs in utero show that eggs present in the examined female nematodes 
from the control groups can reflect the FEC observed on day of necropsy, a finding 
which was also observed in the Belgian CET, 14 days after anthelmintic 
administration (de Graef et al., 2012).  Where this becomes more complex is when 
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ML administrations alter egg generation or oviposition in worms. The low numbers 
of eggs present in C. oncophora from groups receiving IVM or MOX administration 
would indicate that egg production had been suppressed.  It has been previously 
shown that in nematodes surviving therapeutic levels of MLs, the musculature of the 
uterus may be paralysed (McKellar et al., 1988; Scott et al., 1991; McKenna, 1997) 
which may result in egg production resuming after ML levels have dropped.  The 
fact that eggs were observed in the on-farm FECRT 14 days after IVM 
administration, as presented in Chapter 3 (McArthur et al., 2011), would indicate this 
is a likely scenario for these two C. oncophora isolates.             
The molecular analysis of the glc-6 gene fragment previously shown to contain 
mutations that were putatively associated with ML resistance (de Graef et al., 2012), 
did not reveal any of the same polymorpisms here that led to amino acid differences 
at the N terminus.  As a result, it does not appear that differences in this region of 
peptide sequence for the glc-6 gene are responsible for the ML resistance observed in 
the C. oncophora isolates studied here, (FI001 and FI004).  This is further 
compounded by the high levels of percentage identity (in excess of 99%) between the 
IVM-susceptible C. oncophora isolate from Belgium and the two IVM-resistant C. 
oncophora isolates from this CET.  This may mean that there are other mutations 
present on different subunit genes that encode the proteins that make up the GluCl 
channel (Wolstenholme, 2011).  As a result, for each subunit within the GluCl 
channel, there are many potential areas for mutations to arise that may affect the 
conformation of the pore, and limiting the potential for MLs to bind (Hibbs and 
Gouaux, 2011).   Furthermore, it seems increasing more likely that ML resistance in 
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ruminant nematodes has a multigenic origin, with multiple mechanisms involved.  
MLs are also known to act on receptors such as GABA (Prichard, 2007) and the 
dopamine-gated chloride channel (Rao et al., 2009).  In addition, considerable 
evidence for the involvement of ATP-binding-cassette transporters, such as the P-
glycoproteins, interfering with ML-transport, has been published for sheep 
nematodes, such as T. circumcincta (Dicker et al., 2011).  Overall, the genetic basis 
of ML resistance appears to be highly complex, and is unlikely to be attributable to a 
single molecular marker.  It so leads that whilst the mutation in glc-6 may confer 
some conformational abnormalities in the GluCl channel of a specific C. oncophora 
isolate, such as may have occurred in the IVM-resistant isolate from Belgium, it may 
not be present in all isolates, as the mutation does not appear to be present in either 
of the isolates studied here.       
In this chapter, the aims were to characterise two field isolates of nematodes, which 
were believed to be resistant to IVM administration.  The results from the CET 
confirmed that both isolates contain not only IVM-resistant C. oncophora, but also 
MOX-resistant C. oncophora.  Phenotypic analysis of the surviving female 
nematodes revealed differences in worm length and oviposition between treatment 
groups and between isolates, whereas genotypic analysis of a gene fragment 
previously associated with ML resistance in C. oncophora (de Graef et al., 2013a)   
revealed that the same single nucleotide polymorphism was not identified in the 
IVM/MOX resistant isolates here.  Given the time and labour costs associated with 
characterising these isolates, and the complicated nature of ML resistance and the 
lack of molecular markers for detection, it is imperative that other methods of 
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diagnosing resistance are developed. For example, in vitro assays could be validated 
for use between laboratories and could provide rapid, reliable screening tests for 
resistant, and potentially resistant field isolates of nematodes. This was the next 
objective of this work, which shall be described in the following chapter (Chapter 5), 
towards developing an optimised in vitro test for the detection of ivermectin 
resistance in mixed isolates of gastrointestinal nematodes.  
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Chapter 5: Evaluation of the Larval Migration 
Inhibition Test (LMIT) for use with mixed 
species cattle nematode isolates  
 
5.1 Introduction 
For field populations of parasitic nematodes, characterisation of macrocyclic lactone 
(ML) sensitivity currently relies on the use of in vivo tests, such as the controlled 
efficacy test (CET) and the faecal egg count reduction test (FECRT) (discussed in 
Chapters 3 and 4).  Clear guidelines for conducting FECRTs in cattle remain to be 
established and currently researchers follow guidelines primarily described for small 
ruminants.  In addition, faecal egg counts (FEC) in cattle populations are often low 
compared to those found in sheep and goats (for example, less than 100 eggs per 
gram (EPG)).  By basing tests on FEC alone, inaccurate evaluations of sensitivity are 
possible as considerable differences in efficacy can be observed due to slight changes 
in FEC (Boersema, 1983; Sutherland and Leathwick, 2011).  It must also be taken 
into account that faecal samples from naturally infected calves on farms are likely to 
contain eggs of more than one nematode species, which may inherently differ in 
response to anthelmintic treatment.  For example, there may be direct effects on adult 
nematodes such as suppression in egg production following anthelmintic 
administration, as previously found in nematode species such as Cooperia curticei  
(McKellar et al., 1988) and Trichostrongylus colubriformis (Bottjer and Bone, 1985), 
or indirect effects, such as those on female egg output responding to changes in adult 
worm density (Keymer, 1982)  
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Current in vivo methods for the detection of anthelmintic resistance have a number of 
issues, as previously described in Chapters 3 and 4.  The FECRT has been 
demonstrated to lack sensitivity in detecting emerging resistance; studies with ovine 
nematode isolates demonstrated that this test was unable to detect benzimidazole 
resistance at levels below 25% with Teladorsagia (Ostertagia) spp. and 
Trichostrongylus colubriformis (Martin et al., 1989).  These results were achieved 
through combining different proportions of larvae from isolates known to be either 
resistant or susceptible to benzimidazoles in ratios of 90:10, 75:25, 50:50, 25:75 and 
90:10, with susceptible and resistant larvae, respectively.  Lambs were 
experimentally infected with the isolate mixes and FECRTs conducted.  Resistance 
proportions of between 25% and 50% were required for an unequivocal declaration 
of resistance in both species using the FECRT (Martin et al., 1989).  The alternative 
in vivo test is the CET, but despite being the current gold standard for determining 
anthelmintic resistance in ruminant nematodes, it requires the use of experimental 
animals and is labour intensive (Coles et al., 2006).  Consequently, there is a clear 
need for simple robust diagnostic tests that can be performed across laboratories 
(Kotze et al., 2006).  
As there are currently three classes of anthelmintic licensed for use in cattle and 
identification of emerging resistance to a particular class will be beneficial for 
informing future control strategies based on best practice principles.  As 
demonstrated in Chapter 2, ML anthelmintics appear to be the most popular class 
administered to cattle in the UK, so the ability to detect emerging resistance to this 
class is of particular interest.  The availability of a technically straightforward and 
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robust in vitro diagnostic test able to identify relatively small quantitative changes in 
dose response to anthelmintics would be extremely useful (Martin and Le Jambre, 
1979).  The use of in vitro tests as a means to observe anthelmintic activity on 
parasitic nematodes has been reported for some time (Lamson and Brown, 1936).  
Early studies examined the effect of anthelmintics on adult nematodes collected at 
post-mortem, with the caveat that the worms were outside the host in an environment 
not normally experienced by adult stages and were in the process of dying (Leiper, 
1963, cited in Leland Jr, et al., 1971).  The first in vitro test to utilise Cooperia 
punctata third stage larvae (L3) was published in 1971 and examined the extent of 
entangling exhibited by C. punctata L3 when incubated with organophosphates (OP) 
(Leland Jr. et al., 1971).  Two tests were described: a presumptive and a confirmative 
test to identify a range of OP concentrations likely to kill 50% of L3.  The 
confirmatory test procedure was lengthy and required the L3 to be placed in OP 
medium, then observed at hourly intervals for 6 h, followed by daily examinations 
for a week.  The L3 were then scored by an observer who categorised L3 as belonging 
to one of four “dead or alive” categories (namely, 100% dead, >90% dead, >50% 
dead and <50% dead).  Live L3 from the latter three categories were subsequently 
scored as: sluggish; active, but not entangled; active and entangled.  The ratings were 
then used to form the basis of a presumptive LD50 concentration range; i.e. the 
concentration estimated to kill 50% of L3.  The confirmatory test was similar to the 
presumptive test; however, numbers of live and dead L3were counted and used to 
generate LD50 estimates, rather than a rating scheme (Leland Jr. et al., 1971).  This 
protocol was then used to measure the effectiveness of anthelmintics such as 
levamisole (LEV), pyrantel (PYR) and thiabendazole (TBZ) (Leland Jr. et al., 1975).  
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The presumptive test was deemed to be relatively rapid, in that observations of only a 
few seconds were required to make an evaluation.  The tests were expanded to 
evaluate if TBZ paralysis could be reversed by incubation in TBZ-free media, but the 
LD50 range was found to be unaltered, suggesting TBZ induced paralysis was not 
reversible (Leland Jr. et al., 1975).  However, this finding was challenged in later 
studies (Boersema, 1983) and paralysis was found to be reversible.  Further studies 
evaluated tests that measured the effects of anthelmintics on larval motility (Martin 
and Le Jambre, 1979).  In these studies, Teladorsagia spp. L3 were incubated in a 
range of LEV concentrations for 24 h, followed by a period of observation during 
which larval motility was scored by an observer as either “normal” (seen to be 
moving) or “paralysed” (no movement during a five second observation).  The 
percentage of paralysed L3 were subjected to probit analysis and plotted as a dose 
response curve (Le Jambre et al., 1976).  The L3 exhibited a spastic paralysis which 
was found to be reversible (Martin and Le Jambre, 1979), particularly at 
concentrations of between 400 – 1,000 µg ml
-1 
(Geerts et al., 1987),
 
which lead to 
claims that the test was unrepeatable (Boersema, 1983).  Geerts et al (1987, 1989) 
repeated this test with L3 from a field isolate of O. ostertagi believed to be resistant 
to LEV and morantel tartrate (MOR), but found the method to be too subjective and 
insensitive in detecting MOR resistance, which had been confirmed previously by 
CET.  Attempts to optimise the test further with the addition of 25 µm sieves to 
separate migrating worms produced inconsistent results; LD50 estimates varied 
within isolates and larvae from resistant isolates often exhibited lower LD50 
estimates than those from susceptible ones (Sangster et al., 1988).  A later study also 
concluded that this test was unsuitable for testing TBZ resistance as the action of 
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TBZ does not directly cause muscular paralysis of larvae and so it was deemed 
unlikely that sufficient paralysis could be consistently achieved for the purposes of 
the test (Sutherland and Lee, 1990).   
Bennett and Pax (1986) surmising that a reduction in larval motility is the action of 
most anthelmintics, devised a micromotility meter to objectively measure the effect 
of ivermectin (IVM) against L3 of Ascaris suum, Caenorhabditis elegans and 
Nippostrongylus brasiliensis.  Unlike LEV-treated L3, IVM treated L3 exhibit a 
flaccid paralysis, primarily at the midgut region, which extends throughout the body 
(Geary et al., 1993; Kotze et al., 2012).  The L3 were incubated for up to 1 week in 




 M, and tested at 24 h intervals in the 
motility meter.  A motility index was produced dependent on the rate of movement 
perceived in one of three motility channels, connected to a photodiode and 
microprocessor.  A constant signal from the photodiode (i.e. not interrupted by 
moving L3) would give a motility index of zero.  This test was the first to produce 
quantitative data regarding larval motility (Bennett and Pax, 1986).  The meter was 
then used to examine the effect of IVM, LEV and albendazole on Haemonchus 
contortus L3, and a significant reduction in motility was reported over concentrations 
of 10 - 100 µg ml
-1
 with all anthelmintics tested (Folz et al., 1987).  However, the 
authors conceded there was a major limitation in the use of the micromotility meter, 
in that the test was unable to differentiate between dead L3, paralysed L3 or L3 
displaying abnormal (non-sinusoidal) movement (Gill et al., 1991).  Additionally, 
significant differences were found between the three channels forming the meter and 
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so a strict randomisation process needed to be followed to avoid confounding results 
(Folz et al., 1987).    
Douch et al. (1983) replaced anthelmintics with abomasal mucus to determine 
immunomodulatory effects on migration of a variety of ovine nematode species 
(namely, H. contortus, Nematodirus spathiger, T. circumcincta and T. 
colubriformis).  Here, the L3 were exsheathed and incubated in mucus at 37°C for 3 
h.  Next, they were transferred to a migration apparatus consisting of agar blocks and 
a nylon mesh with pore size of 100 µm.  Larvae were left to migrate overnight and 
aliquots of migrated and non-migrated L3 counted to calculate mean percentage 
migration and subsequently, LD50 estimates calculated (Douch et al., 1983).  A 
similar method was also used to study migration of O. ostertagi and C. oncophora L3 
following incubation with abomasal or small intestinal mucus, respectively 
(Kimambo and MacRae, 1988).  Douch and Morum (1994) later developed this 
method for use with anthelmintics (IVM, LEV, MOR and TBZ) using a lower 
volume of agar to test a variety of ovine nematode isolates.  IVM, LEV and MOR 
were found to significantly inhibit larval migration over concentrations of 1 - 10 µg 
ml
-1
, and migration was inhibited at TBZ concentrations in excess of 10 µg ml
-1 
(Douch and Morum, 1994).  Sigmoidal dose response curves were generated by 
exposing T. colubriformis to a range of IVM, LEV and MOR concentrations, 
whereas migration following exposure to TBZ was erratic, attributed in part to the 
insolubility of TBZ.  This test was subsequently adopted to examine IVM resistance 
in H. contortus and identified significant differences in larval migration across a 
range of IVM resistant and susceptible isolates (d'Assonville et al., 1996).  Wagland 
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et al., (1992) sought to simplify the protocol published by Douch et al., (1983) due to 
the perceived inconsistencies of L3 migrating out of the agar blocks.  The simplified 
test contained a shorter anthelmintic incubation period using exsheathed L3 for 3 h at 
room temperature, before transferring to migration chambers fitted with 20 µm nylon 
mesh in a 48-well plate.  The larvae were left to migrate for 16 h at room temperature 
and the percentage migration at a particular concentration compared to those in a 
control well containing no anthelmintic (Figure 25).  Tests using T. colubriformis in 
combination with IVM indicated 8 - 80% migration inhibition across concentrations 




Figure 25: Diagram of migration apparatus as adapted from Wagland et al (1992).  Larvae 
paralysed by the test substance are unable to migrate through the mesh and so are retained in 
the migration chamber.  Larvae not paralysed by the test substance are able to migrate down 
through the mesh into the plate well below, in the direction indicated by the arrow.   
 
Rabel et al., (1994) also conducted a series of comparisons to investigate operational 
factors such as the optimum number of larvae per well, dispensing error, effect of 
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sieve blockage and the effect of solvent (DMSO; dimethyl sulfoxide) used to 
dissolve test substances.  The results generated were highly reproducible and showed 
operational advantages over previous studies (Rabel et al., 1994).  The migration 
method originally developed by Wagland et al., (1992) (as modified by Rabel et al., 
1994) has subsequently been used to investigate the effect of condensed tannins on T. 
colubriformis  (Molan et al., 2000) and that of LEV on Oesophagostomum 
denatatum (Martin et al., 2003).  It has also been used successfully in conjunction 
with abomasal mucus to ascertain the immunomodulatory effect of mucus from 
previously-infected calves on migration of O. ostertagi L3 (Claerebout et al., 1999).    
 Recently, a further adapted method was published by Demeler et al., (2010b) 
designed to test the effect of ML anthelmintics on the migration of O. ostertagi and 
C. oncophora L3.  This study focused on optimisation of three tests; namely, the 
larval migration inhibition test (LMIT), the larval development test (LDT) and, for 
use with adult worms, a motility meter test.  The LDT was considered to be a rather 
fragile system, requiring consideration of a number of confounding factors, and the 
use of fresh, anaerobically stored faeces, whilst the motility meter was considered 
not be sufficiently sensitive for use with larvae.  However, the LMIT results showed 
considerable promise as a potential diagnostic test, with scope for further 
development.  The LMIT method described by Demeler et al., (2010b) requires an 
initial incubation period of 24 h, followed by a migration period of 24 h utilising a 
mesh size (20 - 28 µm) that is dependent on the nematode species being examined: 
28 µm was selected for the test involving cattle nematode species.  A five-fold 
difference in LD50 estimates was observed between IVM-susceptible and IVM-
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resistant C. oncophora isolates, although an IVM-resistant O. ostertagi isolate was 
not available for comparison against an IVM susceptible isolate.  This LMIT method 
was then subjected to a ‘ring test’ across a number of laboratories; however, 
‘definitive’ LD50 thresholds for determining IVM resistance status of a particular 
monospecific isolate remained to be established (Demeler et al., 2010a).  This was 
due, in part, to the eight-fold difference in LD50 estimates observed during the ‘ring 
test’ using the same IVM-resistant and susceptible C. oncophora isolates that showed 
a five-fold difference in the original study (Demeler et al., 2010a; Demeler et al., 
2010b).     
This chapter describes optimisation experiments of the LMIT, based primarily on the 
principles established by Wagland et al. (1992), for the purpose of screening ML 
sensitivity of field populations of cattle nematodes.  As outlined above, various 
protocols have been developed for larval migration and paralysis tests for use with 
single nematode species, with the caveat that further investigation was required for 
mixed-species isolates, a likely consideration when assessing field samples.  As basic 
laboratory conditions for the test varied amongst published protocols (for example, 
the use of sheathed versus exsheathed L3, mesh pore diameter and anthelmintic 
solvent), the impact of these parameters were examined in detail here.  Single species 
nematode isolates (comprising O. ostertagi and C. oncophora L3), categorised as 
IVM resistant based on FECRT analysis and laboratory isolates never exposed to ML 
anthelmintics (Coop et al., 1979; Van Zeveren et al., 2007a), were used to establish 
the value of the LMIT in differentiating L3 of varying ML sensitivities.  In addition, 
L3 derived from two mixed-species isolates (FI001 and FI004), previously 
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characterised as IVM resistant by FECRT and CET (McArthur et al. 2011; Bartley et 
al., 2012), were examined to inform on the utility of the LMIT in the characterisation 
of IVM sensitivity of mixed-species field samples. 
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5.2 Materials and Methods       
5.2.1 Parasitic isolates 
Six nematode isolates were used to evaluate the LMIT for use with cattle nematode 
larvae.  Details of the provenance and sensitivity of these isolates is summarised in 
Table 29.  Two test populations comprised mixed-species field isolates, containing 
both O. ostertagi and C. oncophora spp.  The remaining four isolates comprised 
single nematode species; two isolates monospecific for O. ostertagi and the two 
isolates monospecific for C. oncophora.  The two field isolates (FI001 and FI004) 
were isolated from two Scottish cattle farms in 2010 (located in Dumfriesshire and 
Ayrshire, respectively).  When first assessed, FI001 comprised 15% O. ostertagi, 
85% C. oncophora, whereas FI004 comprised 38% O. ostertagi and 62% C. 
oncophora.  In a FECRT using subcutaneously administered IVM (0.2 mg kg
-1
 body 
weight, BW), the isolates exhibited FEC reductions at 14 days post administration of 
72.4% and 87.3%, respectively (McArthur et al., 2011).  Both isolates were subjected 
to a controlled efficacy test (described in Chapter 4; (Bartley et al., 2012)) where 
IVM was administered as a topical pour-on formulation and subcutaneously, and 
moxidectin (MOX) was administered as a pour-on preparation.  Based on 
enumeration of adult worm burdens, percentage efficacies for FI001 were 38%, 64% 
and 31% and for FI004 were 10%, 0% and 74%, for injectable IVM, pour-on IVM 
and pour-on MOX, respectively.  As a result, the presence of IVM and MOX 
resistant C. oncophora in both isolates was confirmed.  In the CET, O. ostertagi 
worms present in both isolates were confirmed as being ML-sensitive with the 
percentage mean reduction in adult worm burden greater than 99.5%.  
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 O. ostertagi isolates were kindly provided by Professors Edwin Claerebout and Peter 
Geldhof (Ghent University, Belgium): one isolate was previously shown to sensitive 
to IVM in vivo (Van Zeveren et al., 2007a) and the other isolate resistant to IVM 
treatment in vivo (Van Zeveren et al., 2007a).  Examination of larvae upon arrival at 
Moredun Research Institute revealed that both isolates contained 4% C. oncophora 
larvae and 96% O. ostertagi larvae.  The proportion of each species remained 
unchanged following passage through helminth-naïve calves as outlined below.  The 
IVM-sensitive isolate (Oo IVM-S) was originally isolated from a Belgian dairy farm 
in 1987 and stored in liquid nitrogen for the next six years.  Since 1993, the isolate 
had been maintained via passage of helminth-naïve calves (Van Zeveren et al., 
2007a).  The isolate was confirmed to be sensitive to IVM treatment following a 
FECRT in which IVM was administered subcutaneously at the manufacturer’s 
recommended dose rate (0.2 mg kg
-1
 body weight, BW).  No eggs were observed by 
FEC analysis conducted at seven and 14 days post treatment, confirming IVM 
sensitivity.  Calves tested in this FECRT were necropsied three days later (i.e. 17 
days after IVM treatment) and adult O.ostertagi worms were not recovered from the 
abomasum (Van Zeveren et al., 2007a).  The IVM-resistant O. ostertagi isolate (Oo 
IVM-R) was generated through repeated exposure of the IVM-sensitive isolate (Oo 
IVM-S) to increasing levels of IVM in vivo over ten successive generations (Van 
Zeveren et al., 2007a).  Following anthelmintic administration, eggs passed out in 
faeces were collected and cultured to L3.  These larvae were then used to infect more 
calves for the next round of selection.  For seven generations, the dose rate of IVM 
administered increased across sub-therapeutic levels of IVM, from 0.0125 mg kg
-1
 
BW, to 0.1 mg kg
1
 BW.  For the final three generations, infected calves were treated 
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at the manufacturer’s recommended dose rate (0.2 mg kg
-1
 BW).  After a total of ten 
generations, a FECRT was conducted to examine IVM sensitivity of the isolate.  
Based on FEC analysis at 14 days after IVM treatment, a percentage efficacy of 
65.4% (range 0 – 94%) was identified (Van Zeveren et al., 2007a).  A later FECRT 
and CET showed FEC reduction of 68% at 14 days after IVM administration and the 
percentage mean reduction in adult worm burden compared to untreated control 
animals was 84%, confirming resistance (de Graef et al., 2012).     
The IVM sensitive C. oncophora isolate (Co IVM-S) is a Moredun Research Institute 
laboratory isolate that was isolated locally prior to 1979 (thus never exposed to ML 
treatment).  This isolate had been stored in liquid nitrogen and annually passaged 
through helminth-naïve lambs and calves (Coop et al., 1979).  To provide a 
monospecific IVM-R C. oncophora isolate (Co IVM-R), 25,000 larvae from F.I.001 
isolate (15% O. ostertagi, 85% C. oncophora) were administered per os to a 4 
month-old helminth-naïve, Greyface male lamb.  Only the C. oncophora larvae were 
able to produce a patent infection, as previously reported by Keith (1953), and this 
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Table 29: Provenance and IVM sensitivity status of six nematode isolates used in LMIT analysis.  
Isolates comprised two O. ostertagi isolates (kindly provided by University of Ghent), two C. 
oncophora isolates and two mixed-species, field isolates.  A monospecific IVM-R C. oncophora 
isolate was generated by passaging field isolate FI001 L3 through a helminth-naïve lamb.  IVM 
sensitivity of each isolate was determined based on published efficacy data (with the exception of 
Co IVM-S).   In vivo efficacy data is based on reductions in adult worm burden following 
subcutaneous administration of IVM (0.2 mg kg-1 BW), compared to untreated control animals.  
IVM efficacy against O .ostertagi in the two field isolates was demonstrated to be >99.5%.     
Isolate 
code 
Species present Provenance of isolate In vivo efficacy of IVM References 
Oo IVM-R 
96% O. ostertagi 
4% C. oncophora 
Experimentally selected 
over 10 successive 




84% reduction in adult 






96% O. ostertagi 
4% C. oncophora 
Belgian dairy farm,  
isolated in 1987 
IVM- Sensitive; 
100% reduction in adult 









isolate, isolated prior to 
1979 
IVM-Sensitive; 









generated via passage of 
FI001, passaged in 2011 
IVM-Resistant; 
38% reduction in adult 






15% O. ostertagi 
85% C. 
oncophora 
Farm 001, Dumfries, 
Scotland; isolated in 
2010  
IVM-Resistant  
C. oncophora;   
38% reduction in adult 






38% O. ostertagi 
62% C. 
oncophora 
Farm 004, Ayrshire, 
Scotland; isolated in 
2010 
IVM-Resistant  
C. oncophora;   
10% reduction in adult 






5.2.2. Larval collection and maintenance 
O. ostertagi and mixed-field isolates (Oo IVM-S and IVM-R, FI001, FI004) were 
passaged through helminth-naïve male Holstein Friesian calves, aged 3-4 months.  
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Calves were administered with 50,000 L3 per os and FEC (Jackson, 1974) examined 
weekly to monitor infection.  Once infection was observed to be patent (usually 21 
days post infection, verified by the appearance of eggs in FEC analysis), calves were 
harnessed to collect faeces and collection bags changed twice daily.  Coprocultures 
of collected faeces were conducted as follows: faeces were mixed with an equal 
volume of vermiculite, formed into balls, approximately 5 cm in diameter, placed 
into plastic trays, covered with a perforated polythene bag to allow air circulation 
and incubated at 15 °C for 14 - 17 days.  
Cooperia isolates (Co IVM-S and IVM-R) were passaged through helminth-naïve 
male Greyface lambs, aged approximately 4 months.  The lambs were infected with 
25,000 L3 per os, and following confirmation of patent infection by FEC analysis (21 
days post-infection) were harnessed to collect faecal output and collection bags 
changed daily.  After collection, faecal pellets were transferred to polythene lined 
trays to a maximum depth of 5 cm, covered with a perforated polythene bag and 
incubated for 14 days at 15 °C.  
 Following coproculture, all larvae were extracted using Baermann apparatus as 
described in Chapter 3 (M.A.F.F., 1986).  Larvae were enumerated by removal of a 1 
ml aliquot, re-suspended with 9 ml tap water in a volumetric flask, from which ten to 
20 aliquots of 10 µl were taken and counted under x 100 magnification.  L3 were 
identified to species using morphological keys (M.A.F.F., 1986) and also with 
reference to Hansen and Shivnani (Hansen and Shivnani, 1956).  The presence of 
non-strongyle or rhabditoid free-living larvae was noted on each flask and was 
recorded as below 1% in all batches.  The number of L3 per ml was calculated for 
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each batch and the density of L3 per flask adjusted to a maximum of 4,000 L3 ml
-1
.  
Flasks were stored at 4 °C and examined regularly for fungal growth and the water 
replenished weekly.  In all cases, L3 were assessed in the LMIT within 3 months of 
extraction from faeces.  Unless otherwise stated, L3 were adjusted to a final 
concentration of 1,000 L3 ml
-1 
prior to incubation with IVM. 
 
5.2.3 Larval exsheathment protocol 
L3 were exsheathed in sodium hypochlorite solution immediately prior to use, using 
the following procedure.  After enumeration to determine the volume of required, an 
aliquot was removed from the L3 culture flask into a 15 ml pointed-end centrifuge 
tube (Fisher Scientific Ltd) and the volume adjusted using ultrapure water to 10 ml.  
To this, 800 µl of sodium hypochlorite solution (0.5% w/w, Milton
TM
, Ceuta 
Healthcare Ltd) were added, gently inverted three times and incubated for 3.5 min at 
room temperature.  Exsheathed L3 were centrifuged for 2 min at 203 x g, then 
washed and centrifuged three times in ultrapure water (H2O) to remove excess 
sodium hypochlorite solution.  Successful exsheathment was confirmed by 
observation of 10 µl of L3 solution under x 40 magnification.   
 
5.2.4. Baermannisation protocol 
Two millilitres ultrapure H2O were added to one well of a 6-well cell culture plate 
(Corning).  Sheathed or exsheathed L3 were pipetted into a moistened Baermann 
apparatus (Baermann, 1917) and the entire apparatus transferred to the 6-well plate.  
The L3 were incubated for 2 h at 22 °C before the device was removed from the plate 
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and the migrated L3 recovered.  The L3 were enumerated as before and concentration 




5.2.5 LMIT optimisation    
5.2.5.1 Determination of optimum mesh pore size 
The selection of mesh pore size needs to be considered carefully to avoid 
confounding test results as too small a pore size will result in a failure of viable L3 to 
migrate and too large a pore size may allow dead or paralysed L3 to simply fall 
through the mesh leading to false positive results.  Initially, filter equipment was 
kindly provided by Dr. Janina Demeler (Freie Universitat, Berlin).  Six Plexiglass 
tubes (Evonik Industries), each measuring 20 mm in length and 12 mm in diameter, 
were fitted with nylon mesh of either 25 µm or 28 µm pore diameter (HPC Gears 
Ltd) to form migration chambers and attached to plastic sticks with water-resistant 
Superglue™ (Loctite).  Figure 26 shows two of the completed migration sticks.  
 
Figure 26: Two complete migration sticks, each consisting of six Plexiglass chambers fitted with 
25 µm mesh.   




Prior to each use, sticks were examined under a microscope at x 40 magnification for 
any holes or yellowing of the glue binding to the mesh, which may indicate 
perishing.  Any sticks found to have chambers containing holes were removed from 
use, the mesh replaced with fresh material, fixed with Superglue ™ and left to dry 
for 24 h before being used.  As IVM has previously been shown to bind to glass and 
plasticware (Tway et al., 1981), for use in the optimised assays, sticks were colour 
coded so migration chambers used for negative control wells (H2O or DMSO only 
wells) were never exposed to IVM.  Findings by Demeler et al., (2010a) suggested 
that O. ostertagi L3 did not migrate as well in negative control wells as C. oncophora 
L3.  For this reason, O. ostertagi L3 were used for the majority of the optimisation 
tests, to ensure sufficient levels of migration were achieved in control wells.   
 
To select the most appropriate mesh pore size for use with O. ostertagi and C. 
oncophora L3, a heat-treatment experiment was conducted, using heat-treated L3 as a 
negative control.  An aliquot of 1,200 O. ostertagi (Oo IVM-R) L3 were removed 
from culture, exsheathed and adjusted to 1,000 L3 ml
-1
 with ultrapure H2O in a total 
volume of 1,200 µl.  From this, 800 µl L3 were pipetted into an Eppendorf, lidded 
and sealed with Parafilm® (Pechiney Plastic Packaging Company) and incubated in 
a pre-heated water bath at 70 °C for 20 min.  The remaining 400 µl was sealed in an 
Eppendorf with Parafilm® and incubated at room temperature for 20 min.  After this, 
2 ml ultrapure H2O were added to each of 6 wells in the first and third rows (rows A 
and C) of a 24-well cell culture plate (Corning), as shown in Figure 27.  To row A, a 
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migration stick consisting of 6 migration wells fitted with 25 µm nylon mesh was 
added, with a similar stick fitted with 28 µm mesh added to row C.  Next, 90 µl 
aliquots of heat killed or live L3 were taken from the appropriate Eppendorf and 
gently pipetted to the inside of an appropriate migration chamber.  The plates were 
then covered with foil and incubated in the dark for 2 h at 26
 
°C.   
 
Figure 27: Diagram of plate layout for heat-treatment experiment.  Migration sticks were 
placed in rows A and C. Live L3 were added to wells A1, A2, C1 and C2.  Heat-treated L3 were 
added to wells A3 – 6 and wells C3 – 6.  Following incubation, migration sticks were lifted, 
inverted over rows B and D and non-migrated larvae washed into the respective wells. 
Following incubation, the plates were removed and uncovered.  Starting with the 
stick in row C, the outside of each chamber was gently washed with 600 µl ultrapure 
H2O to wash any L3 that had potentially migrated, but adhered to the outside of the 
chamber, into the appropriate well.  The stick was then inverted over Row D and 
non-migrated L3 washed into the corresponding well with 2 ml ultrapure water.  This 
was then repeated with the stick in Row A, so every well containing migrated L3 (for 
example, A1) had a corresponding well containing non-migrated L3 (for example, 
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B1).  After washing, the mesh was checked under a microscope to ensure no L3 were 
adhering to the mesh.  The plates were transferred to an inverted stereomicroscope 
and L3 examined under x 100 magnification to ensure all heat-treated L3 were dead 
and live L3 were motile.  Once this had been established, and to aid counting, 200 µl 
molecular grade ethanol (EtOH; Sigma Aldrich) were added to each well containing 
live L3 and the numbers of migrated and non-migrated L3 enumerated.  The same 
protocol was repeated using sheathed L3 and the comparison repeated on two 
separate occasions.  
 
5.2.5.2. Determination of optimum DMSO concentration   
Due to the insolubility of IVM in water, a solvent, such as DMSO, must be used to 
sufficiently dissolve IVM in solution, and without adversely affecting the L3 being 
tested in the LMIT.  To ascertain the effect of DMSO concentration on L3 in the 
absence of IVM, the following experiment was conducted.  Approximately 1,400 O. 
ostertagi (IVM-S) L3 were removed from culture and re-suspended in ultrapure H2O 
in a total volume of 1,400 µl.  To dark amber Eppendorfs (Axygen), 2, 4, 6 and 8 µl 
DMSO (Sigma Aldrich) were added to 8, 6, 4, 2 µl ultrapure water, respectively, 
followed by 190 µl L3 culture, to produce a range of DMSO concentrations of 1, 2, 3 
and 4%.  For 5% DMSO concentration, 10 µl DMSO were added to 190 µl L3 
solution, and 10 µl ultrapure water added to an Eppendorf containing 190 µl L3, as a 
negative control.  All Eppendorfs were vortexed briefly to ensure mixing and 
incubated in the dark at 26 °C for 2 h.  To five darkened 30 ml universal containers 
(Sterilin), 40, 80, 120, 160 and 200 µl DMSO were added, followed by 3.96, 3.92, 
3.84 and 3.8 ml ultrapure water, respectively.  All universals were then vortexed 
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briefly to ensure mixing.  For two wells on a 24-well plate, 1,910 µl of a particular 
DMSO dilution were added, with two additional wells filled with 1,910 µl ultrapure 
water to serve as negative controls.  A migration stick, comprising six migration 
chambers fitted with 25 µm mesh was added to rows A and C as for the heat-
treatment experiment.  After brief mixing by pipette, two 90 µl aliquots of the 
incubated L3 and IVM solution were added gently down the inside of two migration 
chambers.  The plates were covered in tin foil and incubated for a 2 h at 26
 
°C.  Next, 
the plates were removed from the incubator and the non-migrated L3 washed into the 
corresponding well as described in Section 5.2.5.1.  The contents of each well were 
fixed with 200 µl 100% molecular grade ethanol.  All L3 in migrated and non-
migrated wells were counted under x 100 magnification on an inverted 
stereomicroscope.   
5.2.6. Range of ivermectin solutions tested in LMIT 
Table 30 summarises the range of IVM concentrations evaluated in this study.  All 
solutions were kept at room temperature in darkened containers to prevent ML 
degradation (Halley et al., 1993).  Under these conditions, the stock solution (3000 
µg ml
-1
 IVM) was kept for a maximum of 2 months before replacement, with fresh 
dilutions of the remaining concentrations made weekly.  Moreover, only dark amber 
Eppendorf tubes were used and plates covered in aluminium foil whilst the tests were 
conducted.  In addition to the IVM concentrations shown, L3 were also incubated in 
3% DMSO only and ultrapure water only as negative controls.  Molarity was 
calculated using a combination of molecular weights of ivermectin B1a and B1b 
(474 g and 466 g, respectively) as the data sheet supplied by Sigma Aldrich 
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displayed a composition of 91% B1a and 3% B1b.  Using these values, the molarity 
of the stock solution was calculated to be 6.73 x 10
-3
 M.   
 

















(M) in well 
3000 150 - 6.73 x 10
-3
 3.37 x 10
-4
 
1500 75 0.5 3.37 x 10
-3
 1.68 x 10
-4
 
600 30 0.4 1.35 x 10
-3
 6.73 x 10
-5
 
300 15 0.5 6.73 x 10
-4
 3.37 x 10
-5
 
60 3 0.2 1.35 x 10
-4
 6.73 x 10
-6
 
30 1.5 0.5 6.73 x 10
-5
 3.37 x 10
-6
 
20 1 0.67 4.49 x 10
-5
 2.24 x 10
-6
 
10 0.5 0.5 2.24 x 10
-5
 1.12 x 10
-6
 
5 0.25 0.5 1.12 x 10
-5
 5.61 x 10
-7
 
1 0.05 0.2 2.24 x 10
-6





5.2.7. Optimised LMIT protocol 
After analysis of the above optimisation steps, the finalised procedure was as 
follows: approximately 4,800 L3 were removed from culture and re-suspended in 
ultrapure water in a total volume of 2,800 µl.  To a dark amber Eppendorf tube 
containing 6 µl IVM+DMSO dilution, 194 µl L3 solution were added, mixing by 
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pipette each time to ensure an even distribution of L3 as possible.  In addition, L3 
were added to Eppendorf tubes containing 6 µl DMSO only (no IVM present, solvent 
control) and Eppendorf tubes containing 6 µl ultrapure water only (no IVM or 
DMSO control).  Final IVM concentrations used were 0.05, 0.25, 0.5, 1, 1.5, 3, 15, 
30, 75, 150 µg ml
-1
 IVM.  All Eppendorf tubes were vortexed briefly to ensure 
mixing and incubated in the dark for 2 h at 26 °C.  Prior to completion of the 
incubation, reagents for the migration plates were prepared by adding 300 µl IVM + 
DMSO dilution to 9,700 µl ultrapure water in a darkened universal and vortexed 
briefly.  To conduct the test in duplicate, 1,910 µl of IVM + DMSO dilution were 
added to two wells on a 24-well cell culture plate, repeated for each IVM 
concentration, along with two 3% DMSO only wells, and two ultrapure water only 
wells (Figure 28).  A migration stick, comprising six migration chambers fitted with 
25 µm mesh was immersed in the solution of rows A and C.  After brief mixing by 
pipette, two 90 µl aliquots of the incubated L3+IVM solution were gently pipetted 
down the inside of two migration chambers.  The plates were covered in aluminium 
foil and incubated for 2 h at 26 °C.  
 
 




Figure 28: Layout of LMIT concentrations (in µg ml-1 IVM) on a 24-well plate.  All IVM 
concentrations were conducted in duplicate and a set of control wells (either ultrapure water or 
3% DMSO) were included on each plate.  
 
After 2 h, the plates were removed from the incubator and uncovered.  The sticks 
were removed, L3 washed, fixed and counted as described in Section 5.2.5.1.  The 
susceptible C. oncophora isolate (Co IVM-S) was examined on 11 separate 
occasions in duplicate and both O. ostertagi isolates were examined 10 times in 
duplicate (Oo IVM-S and IVM-R).  FI004 was examined eight times in duplicate and 
the resistant C. oncophora isolate (Co IVM-R1) and FI001 were examined five times 
in duplicate.  This protocol was also conducted using both sheathed and exsheathed 
O. ostertagi L3 (Oo IVM-S and IVM-R) on two occasions in duplicate and with 
Baermannised and non-Baermannised L3 (Oo IVM-S and IVM-R).  Due to a 
previous published study indicating that differences in levels of O. ostertagi 
migration could be observed after a storage period of two months (Geerts et al., 
1989), Oo IVM-S was tested using L3 which had been stored for one week at 4
o
C and 
L3 which had been stored for two months at 4
o
C.  This comparison was also 
conducted using freshly extracted C. oncophora L3 (stored for one week at 4 °C) and 
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L3 stored for 6 months at 4 °C (Co IVM-S).  Both comparisons were conducted 
twice, in duplicate.  
 
5.2.8. Data analysis 
Percentage migration was calculated by ((T-(M/T) x 100, where T equals “Total 
number of L3 per well” (the number of L3 migrated plus number of L3 that failed to 
migrate) and M represents “Number of migrated L3 per well”.  A minimum threshold 
of 85% migration in both DMSO- and water-only control wells was established for 
inclusion in further data analysis and on this basis, no results were excluded.  This 
threshold had been previously used by Demeler et al (2010b) to account for the 
potentially lower migration of O. ostertagi L3 in comparison to C. oncophora L3 and 
was adopted for this study to aid comparison of results between studies.  Dose 
response curves were generated by averaging percentage migration across both wells 
at each concentration.  Two sample Kolmogorov-Smirnov tests (Chakravarti et al., 
1967) were conducted where appropriate to test for statistical differences in 
distributions between isolates. LD50 estimates were generated using probit analysis 
in R statistical environment (version 3.0.1), using packages ‘MASS’ (version 7.3-26) 
and ‘epicalc’ (version 2.15.1.0 ).  Graphs were drawn with Microsoft Excel 2007 and 








5.3.1. Determination of optimum mesh pore size 
Data derived from the experiments designed to determine optimum mesh pore size 
for use with O. ostertagi (Oo IVM-S) larvae are shown in Figure 29.  All L3 in the 
negative control wells (i.e. live L3 not killed by prior heat treatment) were observed 
to be motile.  The mean number of L3 per set of test wells was 125 L3 (± 6 standard 
error of mean; SEM).  L3 migration in the negative control wells ranged between 91.8 
and 97%.  With heat-treated L3, the percentage of L3 falling through the mesh was 
lowest when sheathed larvae were combined with a 25 µm pore mesh (mean 1% ± 
0.3 SEM), compared to the highest level of “fall through” (mean 5.1% ± 1.4 SEM) 
observed with exsheathed L3 tested with the 28 µm pore mesh.  Differences observed 
between groups of sheathed and exsheathed larvae exposed to different mesh sizes 
were not statistically significant (p > 0.05).  On the basis of these results, a 25µm 
mesh was selected for use in the optimised tests.   




Figure 29: Box plot displaying the percentage ‘fall through’ of heat-treated sheathed and 
exsheathed O. ostertagi L3 exposed to mesh sizes of 25µm and 28 µm.  Lines in the middle of the 
boxes indicate median percentage ‘fall through’ for each set of L3, with whiskers indicating 
maximum and minimum values for each group (n = 8).  
 
5.3.2 Determination of optimum DMSO concentration 
Data from the experiment performed to determine optimum DMSO concentration for 
use in the LMIT are shown in Figure 30.  Sheathed and exsheathed Oo IVM-S L3 
demonstrated high levels of migration at all concentrations of DMSO tested (1 - 5% 
v/v %), with mean percentage migrations of 97.8% (± 1.3 SEM) for sheathed L3 and 
96.6% (± 1.4 SEM) for exsheathed L3.  Percentage migration with sheathed and 
exsheathed L3 ranged from 89.5 - 100%.  The lowest percentage migration (89.5%) 























Exsheathed 25µm    Exsheathed 28 µm     Sheathed 25 µm      Sheathed 28 µm 
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Sheathed L3 samples migrated at levels of up to 100% at concentrations ranging from 
1 - 4% DMSO, whereas 100% migration was not observed with exsheathed L3 
beyond a concentration of 3% DMSO.  Based on these results, a DMSO 
concentration of 3% was selected for use in the optimised LMITs. 
 
Figure 30: Mean percentage migration of O. ostertagi L3 incubated in increasing concentrations 
of DMSO, conducted on two occasions, in duplicate.  Open and closed symbols represent 
sheathed L3 and exsheathed L3, respectively.  Error bars represent standard error of mean 
(SEM) for percentage migration at each concentration (n=4), dashed lines for sheathed L3 and 
solid lines for exsheathed L3.   
5.3.3. Comparison of sheathed and exsheathed L3, with or 
without a prior Baermannisation step 
An evaluation was made of the impact of IVM+DMSO on sheathed and exsheathed 
L3 from O. ostertagi isolates Oo IVM-R and Oo IVM-S, in addition to the impact of 
including a pre-LMIT Baermannisation step.  The mean number of L3 counted per set 
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of wells (i.e. migrated and non-migrated) was 137 (± 3 SEM) across all samples.  
LD50 estimates generated from this comparison are displayed in Figure 31.  
 
Figure 31: LD50 estimates from optimisation analysis. Bars A – D represent L3 from Oo IVM-S, 
and bars E – H represent L3 from Oo IVM-R.  Bars A, B and E, F indicate estimates from 
sheathed L3, and bars C, D and G, H indicate estimates from exsheathed L3.  Filled bars 
represent samples in which L3  were Baermannised prior to use, open bars represent L3 not 
Baermannised prior to use.  Error bars indicate the standard error of the LD50 estimates.   
 
The highest LD50 estimates were achieved using exsheathed L3 which were not 
Baermannised prior to use (3.5 and 4.5 µg ml
-1
 IVM; Oo IVM-S and Oo IVM-R, 
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respectively).  The lowest LD50 estimates were found with Baermannised, sheathed 
L3 (1.1 and 3.3 µg ml
-1
 IVM; Oo IVM-S and Oo IVM-R, respectively).  Migration in 
the H2O-only control wells ranged from 87 to 99%, with a mean migration of 94.4% 
(± 1% SEM) and 93.2% (± 0.6% SEM) for Oo IVM-S and Oo IVM-R, respectively.  
Migration was found to be higher in the DMSO-only control wells, ranging from 93 
to 99% with a mean migration of 97.14% (± 0.2% SEM) and 96.4% (± 0.4% SEM) 
for Oo IVM-S and Oo IVM-R, respectively.  In larval cultures where there are high 
proportions of dead L3 or free-living larvae, a Baermannisation step may prove 
helpful, but given the high levels of migration observed without a preceding 
Baermannisation step here, and the low levels of free living larvae present in cultures 
(<1%), it was decided not to include this step in the optimised test.  In addition, L3 
stimulated by the exsheathment process may be more likely to pass through the mesh 
due to the increase in activity compared to sheathed L3.  As a result, the effect of L3 
exsheathment may confound the LMIT results, as any observed migration cannot be 
wholly ascribed as being in response to IVM incubation.  Consequently, the decision 
was made to use sheathed L3 in the optimised test to avoid confounding.       
 
5.3.4. Effect of age on migration of Ostertagia ostertagi  and 
Cooperia oncophora larvae  
The effect of prior length of time of storage of L3 on migration was tested using Oo 
IVM-S and Co IVM-S (Figure 32).  The mean number of L3 counted across each set 
of wells was 146 (± 3 SEM).  For Oo IVM-S L3
 
stored for one week, mean 
percentage migration in the H2O-only control wells was 97.7%, compared to 95.5% 
migration observed in DMSO-only control wells.  With Oo IVM-S L3 stored for two 
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months, mean percentage migrations of 97.4% and 96% were observed in H2O-only 
and DMSO-only wells, respectively.  LD50 estimates of 1.2 and 1.1 µg ml
-1
 IVM 
were generated for one week-old and two month-old L3, respectively.   
C. oncophora (Co IVM-S) L3 stored for one week gave a mean percentage migration 
of 95.9% (± 0.96% SD) in H2O-only wells and 97.3% (± 1.55% SD) migration in 
DMSO-only control wells.  The mean number of L3 counted across each set of wells 
was 217 L3 (± 69).  Larvae  previously stored for six months at 4 °C showed a mean 
migration of 95% (± 0.82% SD) in H2O-only wells and 93.8% (± 1.75% SD) mean 
migration in the DMSO-only wells.  LD50 estimates were 3.2 and 3.3 µg ml
-1
 IVM 
for one week-old and six-month old L3, respectively.  For these studies, the age of L3 
was not considered a concern because all L3 tested subsequently had been stored for 
less than three months following collection. 





Figure 32: Dose response curves displaying the effect of storage on migration of O.ostertagi and 
C. oncophora L3 across a range of IVM concentrations.  Blue symbols represent Oo IVM-S L3, 
with red symbols representing Co IVM-S L3. Open symbols represent L3 stored for one week at 
4
o
C prior to LMIT, closed symbols indicate L3 stored for two or six months prior to testing, for 
Oo IVM-S and Co IVM-S, respectively. Comparison completed on two occasions (four times in 
total).   
   
5.3.5 Use of the optimised LMIT protocol to test parasite 
isolates 
5.3.5.1 Optimised LMIT conducted with Ostertagia ostertagi  
Dose response curves derived from the LMIT using the O. ostertagi isolates (Oo 
IVM-S and Oo IVM-R) are displayed in Figure 33.  For Oo IVM-S, the mean 
number of L3 per set of wells was 159 (± 40 SD), ranging from 81 to 337 L3.  With 
Oo IVM-R, the mean was 116 L3 ( ± 22 SD).  For both isolates, all control wells (i.e. 
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wells containing water only or DMSO only) showed migration in excess of the 85% 
threshold.  For Oo IVM-S, the mean percentage migration for water-only control 
wells was 93.9%, with 95.2% mean migration achieved in wells containing DMSO 
only.  In LMIT experiments with Oo IVM-R, mean percentage migrations of 94.2% 
and 95.3% were achieved in wells containing H2O-only and DMSO-only, 
respectively.    
 
Figure 33: Mean percentage migration of two O. ostertagi isolates incubated in a range of IVM 
concentrations, conducted on ten occasions, in duplicate.  Open and closed symbols represent 
IVM-sensitive isolate (Oo IVM-S) and IVM-resistant isolate (Oo IVM-R), respectively.   
5.3.5.2 Optimised LMIT conducted with Cooperia oncophora isolates 
The dose response curves derived from the LMIT using the two C. oncophora 
isolates (Co IVM-S and Co IVM-R) are displayed in Figure 34.  With Co IVM-S, the 
mean number of L3 per set of wells was 195 (± 64 SD) and was 193 (± 71 SD) with 
Co IVM-R.  L3 in all control wells for both isolates exhibited migration in excess of 
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the 85% threshold.  With isolate Co IVM-S, mean percentage migrations of 92.8% 
and 91.8% were observed in wells containing water or DMSO, respectively.  For Co 
IVM-R, a mean percentage migration of 93.9% was observed in wells containing 
water only and 92.8% migration observed in wells containing only DMSO. 
 
Figure 34: Mean percentage migration of two C. oncophora isolates incubated in a range of IVM 
concentrations.  Open and closed symbols represent IVM-sensitive isolate (Co IVM-S) and 
IVM-resistant isolate (Co IVM-R), respectively.  LMIT was conducted 11 times in duplicate 
with Co IVM-S (n=22) and five times in duplicate for Co.IVM-R (n=10)    
 
5.3.5.3 Optimised LMIT conducted with two field isolates 
The dose response curves derived using L3 from the two mixed species field isolates 
(FI001 and FI004) are displayed in Figure 35.  With this comparison, the number of 
L3 per set of wells was 147 (± 38 SD) for FI004 and for to FI001, mean 108 (± 23 
SD).  Larval migration in all control wells for both isolates was in excess of the 85% 
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threshold set.  For FI001, the mean percentage L3 migration in the control wells was 
92.6% and 88.9% for H2O-only and DMSO-only wells, respectively.  For FI004, 
mean percentage L3 migration achieved in control wells was 91.3% and 93.6% for 
H2O-only and DMSO-only wells, respectively.  
 
 
Figure 35: Mean percentage migration of two mixed species field isolates incubated in a range of 
IVM concentrations.  Open and closed symbols represent data derived from FI001 and FI004, 
respectively.  For FI001, the test was conducted five times in duplicate (n=10), and was 
conducted eight times in duplicate for FI004 (n=16).  
 




Figure 36: Dose response curves displaying mean percentage L3  migration observed for all isolates examined in the optimised LMIT, across a range of IVM 
concentrations.  Results from Oo IVM-S and Oo IVM-R isolates are represented by blue and red, respectively. Results from Co IVM-S and Co IVM-R are shown 
in green and purple, respectively, and F001 and FI004 by grey and orange symbols, respectively. All isolates tested a minimum of five times in duplicate.  
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As shown in Figure 36, migration levels in L3 derived from all isolates were above 
80% migration until exposed to a concentration of 0.25 µg ml
-1
 IVM, when the mean 
percentage migration began to decrease.  As IVM concentration increased, 
percentage migration of FI001 and both C. oncophora isolates (Co IVM-S and IVM-
R1) was observed to decrease at a greater rate compared to the O. ostertagi isolates 
and FI004.   
Percentage migration values for each isolate were subjected to probit analysis and the 
resulting LD50 estimates presented in Table 31.  The highest LD50 estimate was 
observed with field isolate FI004 (1.71 µg ml
-1
 IVM), followed by the two O. 
ostertagi isolates (Oo IVM-S, then Oo IVM-R).  The other field isolate FI001 
provided the next highest LD50 estimate, followed by the IVM-S C. oncophora 
isolate.  The lowest LD50 estimate was observed with IVM-R C. oncophora L3 (0.76 
µg ml
-1
 IVM).  Isolates Oo IVM-S, Oo IVM-R and FI004 were all found to have 
significantly larger LD50 estimates than each of isolates Co IVM-S, Co IVM-R and 
FI001, but between these two groups there was no significant difference in LD50 
estimates.    
Table 31: LD50 estimates generated from probit analysis from all data produced for each isolate 
Isolate 





Oo IVM-S 1.53  0.06 
Oo IVM-R 1.36  0.08 
Co IVM-S 0.78  0.05 
Co IVM-R 0.76  0.07 
FI001 0.81  0.02 
FI004 1.71  0.09 




There is a clear need for an in vitro test capable of detecting anthelmintic resistance 
with a high degree of sensitivity and repeatability for field populations of ruminant 
nematodes (Taylor et al., 2002). With the increase in the number of reports of 
anthelmintic resistance in cattle nematodes, particularly with regard to ML, such a 
test could prove to be a useful tool (Sutherland and Leathwick, 2011).  Use of a 
motility test, such as that described by (Martin and Le Jambre, 1979) or a motility 
meter as used by (Bennett and Pax, 1986; Folz et al., 1987) are not suitable for this 
purpose due to issues with operator subjectivity or mechanical variability.  The ideal 
in vitro test to detect anthelmintic resistance would be: relatively inexpensive; simple 
to perform; reproducible between laboratories and operators; able to objectively 
discriminate between resistant and susceptible worm populations regardless of 
species composition; utilise a life cycle stage that is easily accessible/maintained and 
be used for an anthelmintic class of relevance and interest to the researcher.  The 
aims here were two-fold; first, to optimise a quantitative LMIT for use with IVM to 
investigate O. ostertagi and C. oncophora L3 ML sensitivity in an adaptation of 
previously published protocols and second, to utilise the optimised test to compare 
monospecific and mixed-species field isolates of known anthelmintic sensitivity 
status.  
The first objective was to optimise a protocol using IVM with bovine nematode 
species L3 in an adaptation of previously published protocols (Wagland et al., 1992; 
Rabel et al., 1994; Demeler et al., 2010b).  The first evaluation concerned the mesh 
pore size used to separate live and paralysed L3.  The use of mesh sizes ranging from 
20 µm to 100 µm have been published for use with L3 of various nematode species 
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(Douch et al., 1983; Sangster et al., 1988; Rabel et al., 1994; Claerebout et al., 1999); 
however it was decided to focus on 25 µm and 28 µm mesh for bovine L3 as 
recommended by (Demeler et al., 2010a).  The results from the heat-treatment 
experiment showed that, with O. ostertagi L3, fewer L3 ‘fell through’ a 25 µm mesh 
compared to a 28 µm mesh, and fewer sheathed L3 ‘fell through’ compared to 
exsheathed L3.  The width of sheathed O. ostertagi L3 has previously been reported 
to average 24.8 µm (range 22.5 – 27.5 µm) (Bisset et al., 1984), which correlates 
well with the report that T. colubriformis L3 have an average width of 25 µm (± 2.1 
µm) (Rabel et al., 1994).  The width of C. oncophora has been published to be 0.03 
mm (Isentstein, 1963), although given the larger units used to determine this 
measurement, this result may not be directly comparable to those observed with O. 
ostertagi or T. colubriformis.  In addition, the sheaths of T. colubriformis and H. 
contortus L3 have been reported to be 0.55 µm and 0.56 - 0.7 µm thick, respectively 
(Davey and Rogers, 1982; Wharton, 1986), so it can be supposed that removal of the 
sheath could decrease larval diameter by 1.1 -1.4 µm in total.  If it assumed that 
sheath thickness is approximately equal across other nematode species, this may 
account for the slightly higher (although still low) levels of “fall through” observed 
here with exsheathed L3.  The use of a heat-treatment protocol, rather than killing the 
L3 by fixing with ethanol or iodine, prevented any potential shrinkage of fixed 
worms (as observed whilst enumerating fixed L3 here), which may have 
subsequently increased levels of fall through.  The high levels of migration observed 
across all control wells (in excess of 95% migration) suggests that a mesh pore size 
of 25 µm is not too small to prevent viable larvae from migrating.  Even with C. 
oncophora, previously determined to be slightly larger than O. ostertagi, mean 
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percentage migration was still in excess of 91% and 92% in DMSO-only and H2O-
only wells, respectively.  It should also be considered that if the pore size was too 
small to allow C. oncophora to fully migrate, there may have been evidence of L3 
becoming caught in the mesh.  The migration chamber mesh was examined 
microscopically after each use and no adhering L3 were ever observed.  As a result of 
the high levels of migration observed in this optimisation step with O. ostertagi and 
the subsequent migration of C. oncophora in the optimised test, a mesh pore size of 
25µm was deemed appropriate for use with both O. ostertagi and C. oncophora L3.   
The next step evaluated was the use of DMSO as a solvent.  A previous study 
highlighted that a major disadvantage of an in vitro test compared to an in vivo test is 
the water insolubility of the anthelmintic test substances (Boisvenue et al., 1983).  To 
overcome this, a variety of solvents have been used to dissolve anthelmintic 
compounds including acetone, ethanol and DMSO (Folz et al., 1987).  DMSO has 
been used in several studies to successfully solubilise IVM (Rothwell and Sangster, 
1993; Rabel et al., 1994; Demeler et al., 2010a; Demeler et al., 2010b).  To achieve a 
solubilised solution of IVM, varying levels of DMSO concentration have been tested, 
ranging from less than 1% total volume (Bennett and Pax, 1986; Sangster et al., 
1988) to 5% total volume DMSO (Rabel et al., 1994). Here, high levels of 
percentage migration (in excess of 90%) were observed across all DMSO 
concentrations tested, with both sheathed and exsheathed L3.  At 3% DMSO, the 
mean percentage migration for sheathed L3 was 99.25% with a mean percentage 
migration of 97.4% for exsheathed L3, which was the highest observed with 
exsheathed L3 across all concentrations tested.  The results presented here with O. 
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ostertagi L3 suggest that a concentration of 3% v/v DMSO can be used as a solvent, 
without adversely affecting the migration of sheathed or exsheathed L3.  
Furthermore, a concentration of 3% v/v DMSO was also found to dissolve the 
highest concentration of IVM completely, with no sediment visible after agitation or 
following incubation, whereas flocculation was observed when DMSO+IVM 
concentrations (1% v/v) were prepared as described by (Demeler et al., 2010a).  
Futhermore, the use of 1% v/v DMSO has been reported to give poor solubility of 
IVM at concentrations greater than 20 µM (17.5 µg ml
-1
) (Evans et al., 2013).  The 
results presented in this study are also in agreement with those of Rabel et al., 
(1994), who reported that the use of DMSO up to a concentration of 5% v/v had no 
adverse effect on L3 migration.  As such, a DMSO concentration of 3% v/v was 
determined to be the most suitable for the purposes of sufficiently solubilising IVM 
without consequently affecting the migration of the L3.  As with the mesh pore size 
evaluation, the consistently high levels of C. oncophora migration observed in the 
DMSO-only control wells of the optimised LMIT confirm that this was an 
appropriate decision.   
Having established appropriate DMSO concentrations and mesh pore size, the next 
step was to evaluate the difference in migration between sheathed and exsheathed L3 
and if there was any confounding effect of including a Baermannisation step 
immediately prior to the test.  Previous studies have predominantly used exsheathed 
L3 in the LMIT (Wagland et al., 1992; Rabel et al., 1994; Claerebout et al., 1999; van 
Doorn et al., 2010).  Some studies, such as those described by Douch et al., (1983), 
used exsheathed L3 immediately after exsheathment, whereas other studies 
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exsheathed larvae the night before LMIT testing (van Doorn et al., 2010).  Wagland 
et al., (1992) claimed exsheathed larvae were able to be stored, if maintained at 4 °C.  
Sodium hypochlorite has been shown to be lethal to nematodes after prolonged 
incubation (Rabel et al., 1994).  It has also been stated that exsheathed L3 have a 
tendency to be more sensitive in vitro to anthelmintics compared to sheathed larvae, 
with (Douch and Morum, 1994) suggesting that differences in cuticle permeability 
may alter depending on the nematode species being evaluated.  The results here 
would suggest that sheathed O. ostertagi L3 were more susceptible to the effects of 
IVM, compared to the exsheathed O. ostertagi   L3, as shown by the lower LD50 
estimate.  Larvae observed during the exsheathment process here were visibly more 
active compared to sheathed larvae and this observation was true for both IVM-S and 
IVM-R O. ostertagi isolates.  To ensure that the subsequent LMIT results were not 
unduly compromised by this observed increase in activity, sheathed larvae were used 
for all the optimised tests.  
Inclusion of a Baermannisation step immediately prior to conducting the LMIT was 
found to give slightly higher LD50 estimates in L3 that had been Baermannised 
compared to those L3 which had not; however, the difference was not found to be 
statistically significant.  Baermannisation of L3 prior to use in the LMIT was 
routinely conducted in studies by Demeler et al (2010a, b).  However, previous work 
has raised concerns about the use of a pre-test Baermannisation step, due to the 
potential for pre-selecting active L3 (Glazer and Lewis, 2000), resulting in L3 having 
to migrate twice in the course of the test.  As a result, it was decided not to include a 
Baermannisation step in the optimised test here.   
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In previous studies, the length of time that L3 are stored for prior to use in the LMIT 
is widely variable.  For example, Geerts et al., (1989) used L3 that had been stored 
for less than one month, whereas Demeler et al., (2010a) did not use L3 that had been 
stored for more than three months.  Results from a study with T. colubriformis 
(Molan et al., 2000) found L3 previously stored for seven months prior to use were 
more sensitive to the effect of condensed tannins, compared with L3 that had been 
stored for only one month.  In an attempt to address the reported inconsistencies of 
the larval paralysis test (Martin and Le Jambre, 1979), a study by Geerts et al (1989) 
explored the effect of storage on L3 stored for one or two months prior to use.  MOR-
resistant and sensitive O. ostertagi isolates were exposed to concentrations of LEV 
and MOR.  When testing the effect of MOR incubation on MOR-resistant O. 
ostertagi, a statistically significant difference in LD50 estimates was observed when 
comparing LD50 estimates from one month-old L3 (73.8 µg ml
-1
 MOR) with LD50 
estimates generated with two month-old L3 (27.9 µg ml
-1
 MOR).  When a MOR-
sensitive O. ostertagi isolate was tested with MOR, a similar (albeit non-significant) 
decrease in LD50 estimates was observed between larvae of different ages: an LD50 
estimate of 95.6 µg ml
-1
 MOR was seen with one month-old L3, compared to the 
LD50 estimate of 56.1 µg ml
-1
 MOR seen with two month-old L3 (Geerts et al., 
1989).  The data from this study where LD50 estimates from C. oncophora L3 stored 
for six months were compared to LD50 estimates from C. oncophora L3 extracted 
the previous week showed that there were no significantly differences between the 
batches of larvae tested (P=0.89).  Similarly, with O. ostertagi L3 there was no 
significant difference between L3 stored for two months compared to L3 stored for 
one week (P=0.39).  However, in order to maintain continuity with other studies, and 
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acknowledging the previous observation that O. ostertagi L3 have the potential to 
migrate less consistently than other species (Demeler et al., 2010b), L3were not 
stored for longer than three months prior to use in the LMIT. 
In summary, based on the results generated from the optimisation steps, a final 
protocol was established using sheathed L3 that were not Baermannised prior to 
assessing in the LMIT; a DMSO concentration of 3% was selected to solubilise IVM 
without having an adverse effect on migration; a mesh pore size of 25 µm and larvae 
used within three months of being stored at 4 °C.   
The second objective here was to evaluate the LMIT for use in determining the IVM 
sensitivity of a selection of nematode isolates.  These isolates had been previously 
shown to exhibit varying levels of IVM sensitivity in vivo and comprised four 
monospecific isolates and two field (i.e. mixed-species) isolates.  For a diagnostic 
test, capable of detecting the presence of IVM resistance in vitro, it can be 
hypothesised that IVM resistant isolates would exhibit higher LD50 estimates, 
compared to IVM-sensitive isolates.  This would indicate that higher concentrations 
of IVM are required to paralyse 50% of the resistant population compared to the 
sensitive population.  This hypothesis was not confirmed here.  
With the exception of FI004, an inverse relationship was found between in vitro 
LD50 estimates and in vivo IVM efficacy data for each isolate.  C. oncophora 
present in FI004 had previously been confirmed as IVM-resistant, as described in 
Chapter 4 and Bartley et al., (2012).  Following administration with subcutaneous 
and pour-on IVM, percentage reductions in small intestinal adult worm burdens 
(compared with untreated control animals) were 10% and 0% for each treatment, 
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respectively.  In the LMIT, the highest LD50 estimate of all isolates tested was 
observed when testing L3 from FI004 (1.71 µg ml
-1
 IVM).  If this nematode 
population was being examined in isolation, the results of the in vitro LMIT would 
appear to correlate well with the in vivo CET results.  In contrast, the LD50 estimate 
observed with field isolate FI001 did not reflect the in vivo status of the isolate.  As 
previously stated, when a CET was conducted with subcutaneously and topically 
applied IVM, C. oncophora adult worm burdens in comparison to untreated control 
animals, were reduced by 38% and 64%, respectively, confirming the presence of 
IVM resistant C. oncophora (Bartley et al., 2012).  As a result, it could be expected 
that if the LMIT were capable of detecting IVM resistance, the LD50 estimate of this 
isolate would be lower than that which was generated with FI004, given the slightly 
greater efficacy of IVM against FI001.  However, the LD50 estimate generated for 
FI001 was 0.81 µg ml
-1
 IVM; nearly 50% lower than the estimate generated for 
FI004 and was statistically significant (P < 0.05).  When L3 from FI001 were 
passaged through a lamb to remove O. ostertagi L3 and retain only C. oncophora L3, 
the LD50 for this isolate (Co IVM-R) was lower still (0.76 µg ml
-1
 IVM).  
Furthermore, it was lower than the LD50 estimate achieved using Co IVM-S L3 (0.78 
µg ml
-1
 IVM) which had never been exposed to ML compounds (Coop et al., 1979).  
Similarly, with the two O. ostertagi isolates, L3 from the susceptible isolate (Oo 
IVM-S) exhibited a slightly higher LD50 estimate (1.53 µg ml
-1 
IVM) than that 
observed for the laboratory-selected IVM resistant isolate (Oo IVM-R, 1.36 µg ml
-1
 
IVM), although this was not a statistically significant difference.   
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For a diagnostic test capable of detecting IVM resistance in vitro, it would be 
desirable for the ML-resistant isolates to have higher LD50 estimates than the 
sensitive isolates.  With the exception of FI004, this hypothesis does not reflect the 
findings of this study.  Furthermore, C. oncophora has been identified as a dose-
limiting species for ML anthelmintics, with higher levels of anthelmintic needing to 
be administered to achieve the efficacy required for product licensing, compared to 
other nematode species including O. ostertagi (Benz and Ernst, 1979; Egerton et al., 
1979; Benz and Ernst, 1981; Egerton et al., 1981).  Consequently, it could be 
expected that C. oncophora isolates would demonstrate higher LD50 estimates than 
O. ostertagi isolates when tested against IVM in vitro, but this was not reflected in 
the findings here.  The results from the ring test described by Demeler et al., (2010a) 
are in agreement with the findings here, in that an IVM-S O. ostertagi isolate was 
shown to exhibit higher LD50 estimates in the LMIT than those obtained using an 
IVM-S C. oncophora (308 nM IVM, 107 nM IVM, respectively).  No IVM-R O. 
ostertagi isolate was available for testing in the previous studies; however, two 
isolates of H. contortus were used (IVM-S and IVM-R) and LD50 estimates from 
IVM-S H. contortus (914 nM IVM) were found to be higher than those exhibited by 
IVM-R C. oncophora (886 nM IVM).  When the same protocol was conducted with 
field isolates (Almeida et al., 2013), the test was able to distinguish between a 
susceptible Cooperia spp. isolate (LD50 estimate 1.2 nmol IVM) and ML-resistant 
Cooperia isolates (LD50 estimates 2.5 - 11.4 nmol IVM).  However, the LD50 
estimates did not reflect the results of an in vivo FECRT, as an isolate where IVM 
had an efficacy of 52%, showed an LD50 estimate of 6 nmol IVM, whereas an 
isolate where IVM had 23% efficacy in vivo, showed a lower LD50 estimate in the 
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LMIT (2.5 nmol IVM) and was not found to be significantly different from an IVM 
susceptible reference isolate (Almeida et al., 2013).   
The inverse relationship between in vivo and in vitro results observed here, and that 
of (Almeida et al., 2013) has also been reported with other classes of anthelmintics.  
When LEV-resistant T. colubriformis L3 were assessed in a migration test, the LD50 
estimate was often found to be lower than that of LEV-sensitive isolate and LD50 
estimates varied from 40 – 300 µM LEV.  At the time, the authors considered the test 
to be too subjective for use in such studies and hypothesised that although adult 
worms from these isolates were deemed to be LEV-resistant in vivo, resistance in L3 
may not be observed phenotypically in vitro (Sangster et al., 1988).  Similarly, in a 
study with MOR-resistant O. ostertagi, as defined in vivo, a higher LC50 estimate 
was recorded with a MOR sensitive isolate (95.6 µg ml
-1
 MOR) compared to the 
MOR resistant isolate (73.8 µg ml
-1 
MOR) (Geerts et al., 1989).  The authors 
ventured that this may be due to relatively low levels of MOR-resistance in the 
‘resistant’ isolate; however, a CET reported MOR efficacy of 77% against this 
isolate, compared to adult worm burdens in untreated animals (Borgsteede, 1988).   
For the reasons detailed above, it would appear the LMIT may not be a sufficiently 
sensitive test for determining levels of ML resistance with mixed-species nematode 
isolates.  There have been few attempts to determine the reasons (or potential 
mechanisms) responsible for this, either by exploring the differences between in vitro 
and in vivo tests or by examining the differences between nematode species and 
stages being examined.  The provenance and species composition of the isolates 
tested in the LMIT should be considered.  Here, the O. ostertagi isolates shared a 
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genetic background, with the IVM-R isolate experimentally selected from the IVM-S 
isolate (Van Zeveren et al., 2007a).  The resulting IVM-R isolate may not necessarily 
reflect the phenotype or genotype of resistance that may be found in the field as 
different selection protocols have been  shown to produce differing genotypes (Gill 
et al., 1998; Le Jambre et al., 1999); however at least the close relatedness of the two 
O. ostertagi isolates here allows a reasonable comparison for analysing LMIT data 
against FECRT results.  Likewise, in a study by Gill et al., (1998), H. contortus 
isolates selected using sub-therapeutic IVM treatments in sheep did not display 
‘resistance’ in a number of in vitro tests.  In contrast, a field isolate of H. contortus 
selected using the recommended dose rate of IVM, did display similar findings in 
vitro compared to in vivo (Gill et al., 1998).   If this is true for O. ostertagi, the 
phenotype (in this case, the levels of migration) exhibited by the IVM-R isolate may 
not be necessarily representative of the phenotype of every O. ostertagi IVM-R 
isolate.      
Although the IVM-S C. oncophora used here was isolated prior to the release of 
IVM (Coop et al., 1979), the genetic background of this isolate has not been studied.  
It is supposed that genes conferring for resistance are at very low, levels the first time 
selection pressure is applied through the use of anthelmintic administration, and that 
these will increase in frequency with continued treatments (Prichard, 1990).  
Therefore, it is not known if there are genotypic differences between this unexposed 
C. oncophora isolate and a C. oncophora isolate that has been exposed to IVM, but 
still displays sensitivity to IVM in vivo.  As with the O. ostertagi isolates, this may 
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mean that the phenotype displayed by Co IVM-S is not representative of all IVM-
sensitive C. oncophora isolates.    
C. oncophora differs from O. ostertagi in that it is able to produce a patent infection 
in both sheep and cattle (Keith, 1953).  The IVM-R C. oncophora isolate was 
produced by passaging L3 from mixed field isolate FI001 through a helminth-naïve 
lamb, successfully removing the O. ostertagi from the isolate.  However, previous 
findings have suggested there are differences within a host species which may give 
rise to differences between C. oncophora L3
 
cultured from faeces produced by a lamb 
and C. oncophora L3 cultured from faeces produced by a calf, when cultured under 
identical conditions (Isentstein and Porter, 1964).  Average measurements of L3 
generated using calves in the Isentstein and Porter (1964) study were found to be 
slightly longer (909 µm) than L3 derived from ovine infections (893 µm) but the 
differences were not found to be statistically significant.  The authors proposed that 
differences in larval length may be a consequence of differences in the host animal’s 
utilisation of diet or differences in the microbiota present in the faeces (Isentstein and 
Porter, 1964).  With these findings in mind, the choice of donor animal species may 
affect the larvae generated, and so may explain why the LD50 estimate for IVM-R C. 
oncophora isolate (passaged through a lamb) was marginally lower than that of the 
original FI001.  It should be noted that the FI001 isolate contained O. ostertagi, 
which appears to be less sensitive to IVM in vitro and so may contribute to this 
difference between the FI001 and the C. oncohora L3 harvested via sheep infections.   
FI001 was isolated from a farm which did not farm sheep, and so prior to isolation, 
was maintained solely through cattle and only passaged through calves once isolated.  
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FI004 was isolated from a farm which also reared sheep that were co-grazed with 
cattle.  As a result, C. oncophora present in FI004 may have been exposed to greater 
selection pressures for IVM resistance than that of FI001.  From the CET data 
(Bartley et al., 2012), FI004 showed the lowest reduction in adult worm burden with 
IVM, but was more sensitive to MOX treatment than FI001. Both farms were known 
to have consistently used ML treatments in calves for the five years prior to 
performing the FECRT; however, the exact brands used are unknown.  Theoretically, 
use of different anthelmintic products could have resulted in differing selection 
pressures on each isolate, and as previously demonstrated for C. elegans¸ with 
differences exhibited in response to IVM and MOX treatment (Ardelli et al., 2009).         
Results from a recent LMIT study using filarial nematode L3 also indicated a 
disparity between in vivo and in vitro data (Evans et al., 2013).  In this study, 30% of 
ML-sensitive L3 continued to migrate in IVM concentrations 6000 times greater than 
that required for 100% efficacy against L3 in vivo.  The authors postulated that IVM 
may be acting on more than one mechanism, which may be responsible for this 
observed difference and that the host immune system may also contribute to the 
larval phenotype.  The effect of host immunity on parasite behaviour has also been 
discussed with gastrointestinal nematodes.  For example, a study examining egg 
hatch tests with H. contortus found that there were differences in levels of egg hatch 
dependent on the length of infection (Borgsteede and Couwenberg, 1987). LD50 
estimates increased to a peak between 40-60 days post infection, and subsequently 
decreased after this time.  Similarly,  Scott et al., (1989) found variation in LD50 
estimates when conducting egg hatch tests with T. circumcincta eggs, concluding 
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that differences within host animals may contribute to changes in the LD50 estimates 
generated (Scott et al., 1989). Consequently, the timing of nematode isolate 
collection (for example, from newly infected animals or those developing immunity) 
may also have an effect on the in vitro behaviour of L3.         
In vivo and in vitro tests examine different life cycle stages and targets may differ 
between developmental stages.  Adult nematodes tested in vivo are known to be more 
sensitive to anthelmintics than the immature stages (Leland Jr. et al., 1975).  With 
respect to IVM, data published from the original efficacy trials showed greater IVM 
concentrations were required to remove immature stages of C. oncophora and O. 
ostertagi compared to adult worms of both species (Egerton et al., 1981).   The high 
levels of IVM efficacy against adult nematodes may be partially attributed to its 
mode of action, due to the paralysis of the somatic musculature and pharangeal 
pumping associated with feeding (Kotze et al, 2006).  Not all target sites of IVM 
have been determined; this anthelmintic has been shown to irreversibly bind to 
glutamate gated chloride channels (GluCl), which increases membrane permeability 
to chloride ions, resulting in hyperpolarisation of motor neurons and flaccid paralysis 
of the parasite (Wolstenholme and Rogers, 2005).  There are a number of different 
genes that code for GluCl channels, silencing combinations of these in C. elegans 
can lead to greater tolerance of IVM (Dent et al., 2000).  In addition to paralysis of 
somatic muscle, IVM has also been found to paralyse the pharynx of adult H. 
contortus, the pharynx being the sole muscle of the nematode digestive tract (Geary 
et al., 1993), and uterine musculature, thus affecting reproductive capabilities 
(McKellar et al., 1988). It has been hypothesised that a combination of pharyngeal 
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and somatic paralysis may be responsible for the expulsion of adult worms (Kotze et 
al., 2012).  At lower IVM concentrations, the worms are unable to feed (and so 
starve) and as IVM concentrations increase, somatic paralysis occurs and worms are 
unable to maintain their position in the host (Geary et al., 1993; Kotze et al., 2012).  
As L3 do not feed, loss of pharyngeal function is unlikely to cause phenotypic 
response as seen with adult worms and so if both are required to effectively kill adult 
nematodes, it may partially explain why L3 appear able to survive higher 
concentrations of IVM.    
GluCl channels are not the only identified targets of IVM in nematodes.  Work 
conducted with C. elegans showed IVM can activate gamma amino butyric acid 
(GABA) activated chloride channel to induced paralysis of nematode musculature 
(Fisher and Mrozik, 1992).  There may be differences between nematode species as 
the same receptor has been found to be up-regulated in C. elegans and down-
regulated in H. contortus, implying that although receptors may be common between 
species, they may display different functions (Accardi et al., 2012).  There may also 
be further mechanisms which are unexplored in parasitic nematodes, such as 
mutations found in the amphid sensory endings of C. elegans, associated with cuticle 
permeability to IVM (Dent et al., 2000).  These targets may all differ in expression 
between species and developmental stages of parasitic nematodes. 
Studies of multidrug ABC transporters (predominantly P-glycoproteins, Pgps) in 
parasitic nematodes have shown that they may play a significant role in ML 
resistance, as they are cell efflux pumps, and are implicated with limiting drug entry 
to cells within the parasite (Zhao et al., 2004). Recently, work has been published on 
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the role of P-gps in ML-resistant C. oncophora (de Graef et al., 2013a; Demeler et 
al., 2013).  Differing levels of P-gp expression were found in eggs, L3 and adult 
stages.  Levels in P-gp expression were also found to differ in adult worms 
unexposed to MLs and those that survived IVM and MOX treatment, indicating 
different treatments may also affect P-gp expression.  To date, no work has been 
published on the levels of P-gp expression in O. ostertagi, with work in C. elegans 
suggesting P-gp expression is highly diverse and may involve several transporters 
acting in combination (Lespine et al., 2012).   
The complicated nature of IVM resistance, potentially involving a number of 
mechanisms, means that the use of an in vitro test to detect anthelmintic resistance in 
field populations may not be feasible.  However, given the excellent migration in 
control wells and small standard errors, there could be scope for it to be developed 
further, in order to examine some of the mechanisms associated with resistance.  For 
example, P-gp inhibitors have been used in a larval feeding inhibition test to restore 
IVM sensitivity in resistant ovine nematode isolates (Bartley et al., 2009).  Use of P-
gp inhibitors with IVM-R O. ostertagi and C. oncophora could give vital information 
about the mechanisms behind ML resistance in these two species and phenotype 
within an isolate could be tested in the LMIT.  
Based on a variety of parameters, the LMIT was optimised here with a view to being 
able to be utilised as a diagnostic test for screening mixed-species field isolates for 
IVM resistance.  The results suggest that even an optimised test lacks the 
characteristic essential for a robust diagnostic test; this was due to incompatibility of 
the LMIT data with previous in vivo results and incompatibility with expected IVM 
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sensitivities amongst different nematode species.  These factors make confirming 
anthelmintic resistance in populations comprising of a variety of nematode species 
populations difficult, and possibly beyond the scope of a laboratory-based diagnostic 
LMIT, as found by a number of other researchers (Demeler et al., 2012; Almeida et 
al., 2013).  However, as mechanisms for ML resistance are still unclear, the LMIT 
may yet prove to be a useful tool for investigating specific populations of interest to 
examine the action of particular anthelmintics (Rothwell and Sangster, 1993), or to 
further investigate unerlying mechanisms associated with resistance (Kotze et al., 
2006).  
  Chapter 6 
277 
 
Chapter 6: General Discussion   
Anthelmintics are medicinal products, for which, high efficacy is vital to ensure the 
continued health and welfare of ruminant livestock worldwide.  The studies 
presented in the preceding chapters have considerably added to the knowledge base 
on gastrointestinal nematode infections in UK cattle and usage of the anthelmintics 
employed to prevent and control these infections.  Exploration of the questionnaire 
data (Chapter 2) provided an insight into the intense reliance of cattle farmers on 
macrocyclic lactone (ML) anthelmintics, with the faecal egg count reduction test 
(FECRT) data (Chapter 3) revealing a predominance of Cooperia spp. larvae present 
following administration of ivermectin on a number of the farms.  The examination 
of different formulae used to determine percentage reduction in FEC was also 
conducted in Chapter 3.  A controlled efficacy test (CET; Chapter 4) confirmed the 
presence of ivermectin in two of the C. oncophora isolates obtained in the field 
study.  This work extended to the further characterisation of these isolates to 
demonstrate that they were also moxidectin resistant.  This was followed by 
examination of female C. oncophora length and oviposition and molecular analysis 
of a section of glutamate-gated chloride channel (GluCl) gene, (glc-6) which had 
been proposed previously to be down-regulated in ivermectin resistant nematodes 
following in vivo exposure to MLs (de Graef et al., 2013a).  Chapter 5 described 
attempts to develop an in vitro diagnostic test for utility in detecting emerging ML 
resistance in mixed species isolates.  
A major finding in this thesis was the presence of ML resistant C. oncophora in field 
populations in combination with ML sensitive Ostertagia ostertagi.  The observation 
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of C. oncophora surviving ML administration is a now a relatively common finding 
(Sutherland and Leathwick, 2011). In the field, when the first case of ML resistance 
is reported in cattle nematodes, the species most commonly implicated is C. 
oncophora; this has been the observation in New Zealand (West et al., 1994); the EU 
(Coles et al., 1998, Stafford and Coles, 1999); South America (Fiel et al., 2001) and 
North America (Edmonds et al., 2010).  In these studies, ivermectin resistance was 
defined by FECRT, and, with the exception of the New Zealand study in which 
species was confirmed by faecal culture, ivermectin resistance in C. oncophora was 
confirmed via controlled efficacy trials in housed cattle.  As discussed in Chapter 3, 
C. oncophora is one of the dose-limiting parasites for ivermectin, and so the results 
here were not surprising (West et al., 1994).  Although sensitivity of the Cooperia 
isolates to other anthelmintic classes were not tested here,  studies in New Zealand, 
where all 56 farms tested were found to have ML resistant Cooperia spp., also 
identified that 74% of these farms also had albendazole resistant Cooperia (Waghorn 
et al, 2006).  The finding of resistance in more than one nematode species has been 
observed in the USA, where ML- and benzimidazole-resistant Cooperia spp. were 
identified together with ML-resistant Haemonchus spp. (Gasbarre et al., 2009).  
Worryingly, a controlled efficacy test in the USA confirmed a 0% reduction in adult 
C. oncophora at 14 days after IVM administration and a 90% reduction in adult O. 
ostertagi, the first confirmed case of ML-resistant O. ostertagi in the world 
(Edmonds et al. 2010).  As a result, it could be proposed that the observation of ML 
resistance in Cooperia spp. can be considered as a precursor to anthelmintic 
resistance being detected in other nematode species.  Thus, steps need to be taken to 
reduce further selection for resistance by altering farm practices. 
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Currently, there are no therapeutic alternatives to using one of the three anthelmintic 
classes licensed for use in cattle in the UK.  Two anthelmintic products launched for 
use in sheep in the last 5 years, monepantel, an amino-acetonitrile derivative 
(Kaminsky et al., 2008), and a combination product, comprising abamectin and 
derquantel (Leathwick and Hosking, 2009) have not been registered for use in cattle. 
This may be, in part, due to relatively low efficacy of monepantel (78%) observed 
against adult Dictyocaulus filaria, the ovine lungworm (Hosking, 2010).  It has also 
been proposed that other factors, such as the costs required for product synthesis or 
compliance with safety guidelines, may be a barrier to development of products for 
species other than sheep (Epe and Kaminsky, 2013).  Even if these products were to 
be released immediately for use in cattle, the issue of anthelmintic resistance will 
remain.  Resistance to monepantel has already been recorded in goats in New 
Zealand, where resistant Teladorsagia circumcincta and Trichostrongylus 
colubriformis have been identified (Scott et al., 2013).  As a result, the emphasis 
must be to preserve the anthelmintics that are currently available for cattle.   
The findings from the research described in Chapters 2 and 3 indicated that farmers 
are often constrained by availability of land, stocking densities, lack of time/handling 
facilities, and weather conditions.  Prior to this research, little was known about 
which anthelmintic classes were used and the application methods applied on UK 
cattle farms.  A small scale survey (72 questionnaires) had been conducted 
previously on beef cattle farms to examine anthelmintic products usage (Barton et 
al., 2006), but did not enquire about quarantine or management procedures, or use of 
faecal egg count (FEC) analysis.  Similarly, few details had been published detailing 
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FECRT analyses in cattle, with the majority of reports regarding reduced efficacy 
limited to case reports (Coles et al., 1998; Sargison et al., 2009; Orpin, 2010; 
Sargison et al., 2010).  To date, no analysis had been conducted to examine the 
relationship of management practices to anthelmintic efficacy across farms.  In 
Chapters 2 and 3, the questionnaire data revealed that beef and dairy farmers used 
similar numbers of anthelmintic treatments as first season grazing calves were 
administered with anthelmintics, on average, twice per year, with over 80% of 
farmers using ML products.  In terms of differences identified between the two 
sectors, dairy cattle farmers were significantly less likely to isolate new stock 
following quarantine treatment and were less likely to attend farmers meetings 
relating to parasitology or utilise FEC analysis.  Only one respondent had conducted 
a FECRT prior to this study, demonstrating a clear need for promoting further testing 
and monitoring of FEC.  The benefit of making use of regular FEC analysis is that 
farmers can gain an understanding about levels of nematode contamination on their 
pastures, and so could use this knowledge in pasture management strategies, perhaps 
by grazing other animals, such as sheep on heavily infected pastures, and in 
combination with FECRT to ensure that the anthelmintics they are using are actually 
effective.  Farmers also tended to apply long-acting anthelmintics to first season 
grazing calves at turn-out and again at housing, but due to a lack of FEC monitoring, 
were potentially unaware of levels of pasture contamination from nematodes passed 
out during the course of grazing season.  By promoting FEC analysis in determining 
treatments, applications may be targeted, particularly in older calves and cows who 
may have developed immunity to reinfection, and so may only require a single 
treatment at housing to target inhibited O. ostertagi larvae.  First season grazing 
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calves from the dairy sector, which are not grazed with their dams, are more likely be 
exposed to higher levels of worms on pasture over the grazing season and so closer 
monitoring of FECs in these calves throughout the season could track levels of 
pasture contamination, allowing for intervention with anthelmintics when FEC levels 
are high.  
Given the lack of appropriate quarantine activities across the dairy sector farms here, 
this should be promoted more within the industry (Brennan and Christley, 2012). 
Current UK quarantine guidelines recommended in the Control of Cattle Parasites 
Sustainably (COWS) publication suggest that sequential administration of an oral 
benzimidazole product and a product containing levamisole (LEV) should be used 
when new cattle are brought onto farm.  However, given conflicting data regarding 
efficacy of fenbendazole against inhibited O. ostertagi larvae and lack of an efficacy 
claim for LEV against these stages, it is possible that inhibited larvae may survive 
treatment.  A further complication is that in the UK, there are few anthelmintics with 
a short withdrawal period licensed for use in milking dairy cattle.  There are no LEV 
products licensed for use in dairy cattle and withdrawal periods for BZ products vary 
between 60 hours and 120 days (VMD database, accessed August 2014).  Both 
factors may go some way to explain the limited implementation of quarantine 
procedures in dairy cattle and the predominance of ML products used in the cattle 
industry, both as quarantine administrations and for general control.   
The questionnaire analysis demonstrated a general lack of accordance with the 
COWS guidelines, which include: adopting quarantine measures, selecting an 
appropriate product and ensuring it is applied correctly, devising a parasite control 
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plan with an advisor, using anthelmintics only when necessary, testing anthelmintic 
efficacy, reducing dependency on anthelmintics and using methods to preserve 
susceptible nematodes (COWS, 2010).  The questions that arise from these findings 
are; first, are farmers aware of these guidelines and, second, as veterinary surgeons 
were deemed to be the most important source of advice, are they making sufficient 
efforts to promote responsible anthelmintic use?  For example, veterinary practices 
or prescribing premises could arrange meetings for farmers or promote best practice 
through newsletters.  Another factor that could affect uptake of best practice 
guidelines is the practicality of the COWS recommendations, as shown in the 
example of quarantine treatments above.  It should also be noted that the currently 
available COWS manual is a large document, spanning 64 pages, which could be off-
putting for farmers and advisors seeking clear and accessible advice.  Further 
consultations with farmers may be helpful to ascertain the feasibility of following the 
current guidelines on farm.        
Of the 20 IVM FECRTs performed (Chapter 3), IVM resistant Cooperia were 
identified in samples from over 50% of the farms.  These results are similar to those 
reported previously (Waghorn et al., 2006; Soutello et al., 2007; El-Abdellati et al., 
2010a).  The FECRT outputs were subsequently analysed with respect to the 
questionnaire survey responses to explore risk factors for resistance, and a number of 
differences were found between farms with IVM-sensitive Cooperia spp., and those 
with IVM-resistant Cooperia spp.  The most striking observations were differences 
in the management of adult cows.  On 40% of farms where IVM-resistant Cooperia 
were detected, adult cattle were given anthelmintics at housing; however, this 
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practice was highlighted by only 16% of farmers where IVM-sensitive nematodes 
were identified.  In addition, on 46% of farms where IVM resistance was detected, 
farmers did not treat adult cattle on a selective basis and administered anthelmintic to 
all adult cows, a practice conducted on only 16% of farms where IVM sensitive 
nematodes were identified.  Although the type of farm could not predict the presence 
or absence of anthelmintic resistant nematodes, beef cattle farmers were found to be 
more likely to follow specific recommendations highlighted in the current best 
practice control guidelines, for example, administering anthelmintic according to the 
heaviest animal in the herd and isolating new cattle brought onto farm.  This may be 
because in this study, the beef farmers were more likely to farm sheep, with 69% of 
respondents also farming sheep, a sector in which the Sustainable Control of 
Parasites in Sheep (SCOPS) guidelines (National Sheep Association) have been 
disseminated for many years (Abbott et al., 2005).  These results highlight that there 
is need for a greater awareness of evidence-based helminth control in the cattle 
industry, particularly in the dairy sector.  It could be argued that the relatively low 
numbers of respondents here may have skewed the results of the odds ratios; 
however, conservative precautions were taken during this analysis as odds ratios with 
confidence limits spanning 1 were discarded from the analysis (Chapter 2).  An 
interesting follow-up to this study may be to repeat the questionnaire after the 
FECRT analysis had been conducted and the results disseminated, to see if attitudes 
have changed in the intervening years.   
The finding that only one of the questionnaire respondents had previously undertaken 
a FECRT is indicative of a general lack of engagement regarding the threat of 
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anthelmintic resistance.  This is further hindered by lack of a clear, standardised 
method for FECRTs in cattle, and this might act as a disincentive to veterinary 
surgeons to offer these tests.  FECRT guidelines for cattle are undergoing required 
development (Sutherland and Leathwick, 2011).  The work in Chapter 3 
demonstrated that a robust FECRT method requires sensitive FEC methodology.  
When conducting FECRT in the field it is impossible to know if there is ‘true’ 
inefficacy or if this is an artefact of misadministration.  Confirmation of two of the 
FECRT results here using the CET substantiated that the FECRT method employed 
in Chapter 3 was robust.  This was further confirmed by analysis of the farms 
identified as having IVM sensitive nematodes using one calculation method, in the 
most part, being classified as IVM sensitive using other analytical methodologies.  
Regardless of the formulae used in calculating thresholds for efficacy, FECRT 
analysis must be underpinned by good practice in terms of administering the 
products, handling and storing the samples and using a FEC method of the 
appropriate sensitivity, as made apparent here by the comparison between the 
McMaster method (Gordon and Whitlock, 1939) and the double centrifugation 
method (Jackson, 1974) in estimating FECs.  Areas for further work could include 
testing further anthelmintic classes at these sites, particularly to test if there is 
insensitivity to BZ or LEV products.  WAAVP recommendations (Coles et al, 1992,) 
suggest a non-treated control group per test; however, on many of the farms here, the 
first grazing season group sizes were too small and splitting of the groups would 
have rendered the results statistically less meaningful.  Also, a main objective of 
anthelmintic administration at housing time, when the studies here were performed, 
is to kill inhibited O. ostertagi larvae, thus preventing Type II ostertagiosis, so there 
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would have been ethical considerations regarding withholding this treatment.  As 
most samples were taken just prior to winter housing, samples taken earlier in the 
year may have had different nematode genus compositions (Michel, 1969), which 
may have affected the efficacy observed.  As the majority of farms participating here 
did not handle their first season grazing calves over the summer grazing season, 
faecal samples could not be taken prior to the autumn.   
This study provided this first report of MOX resistant C. oncophora in UK cattle.  
The direct comparison between ML application methods (injectable and pour-on) in 
UK cattle was also novel.  Monitoring FEC through a longer period of the CET may 
have shown if the observed suppression in egg production was a temporary effect, 
and would have allowed direct comparison to the on-farm FECRT data; however, the 
decision was taken to necropsy seven days after anthelmintic administration, exactly 
as recommended by the WAAVP guidelines (Wood et al., 1995).  Examination of 
nematode length and numbers of eggs in utero was examined here to analyse the 
phenotype of the parasites surviving ML treatment in comparison to nematodes from 
the untreated control calves.  Few studies have been published to compare worm 
length and eggs in utero in cattle nematodes in anthelmintic treated animals, but 
these phenotypic markers have been compared more often through the course of 
natural or experimental infections designed to monitor the development of immunity 
in cattle (Kloosterman, 1971; Albers et al., 1982; Kloosterman et al., 1991).  
Recently, a study in Belgium examined C. oncophora eggs in female worms 
unexposed to anthelmintic administration and identified an average of 68 eggs per 
nematode (de Graef et al., 2012).  This finding is similar to the findings of here and 
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earlier studies in untreated animals (Albers et al, 1982, Kloosterman 1971.  The 
difference in number of eggs in utero here was seen to differ between ML products, 
and between application methods.  The absence of any eggs in nematodes from either 
isolate following MOX administration indicates a longer egg suppression effect with 
this product compared to IVM, indicating that the anti-parasite effects of ML 
anthelmintics vary between compounds.     
Whilst the FECRT and CET analyses provided vital data regarding anthelmintic 
sensitivity of the isolates examined here, time, cost and labour resource that needs to 
be invested in these types of experiments indicates that the development of in vitro 
tests would be beneficial.  With regard to further analysis of the isolates (FI001 and 
FI004) characterised here, the larval migration inhibition test (LMIT) analysis 
indicated discrepancies between in vitro and in vivo ML sensitivity classification, an 
observation similar to other recent studies (Whitney et al., 2011; Demeler et al., 
2012; Almeida et al., 2013).  Earlier studies with the LMIT using single nematode 
isolates yielded reproducible dose-response curves which appeared to be in 
agreement with anthelmintic sensitivity classification derived from in vivo studies 
(Wagland et al 1992, Rabel et al 1994).  Even with single species populations here, 
the relative degree of ML sensitivity did not concur with the observed in vivo 
sensitivity of the isolates; for example, ML-sensitive O. ostertagi isolates displayed 
higher resistance ratios than ML-resistant isolates of C. oncophora.  The latter 
observation is in agreement with those of Demeler et al (2012).  
To underpin the results of the in vivo testing and to aid further development of in 
vitro tools, an understanding of the mechanism(s) of ML resistance at the molecular 
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level would be beneficial, particularly for screening nematode populations in the 
early stages of resistance.  A glutamate-gated chloride channel subunit (glc-6) gene 
was previously been shown to have a SNP in the signal peptide region of the gene in 
a ML-exposed, ML-resistant C. oncophora isolate (De Graef, 2013).  The peptide 
sequence associated with this spanned an aspartic acid (D) change to glycine (G).  
However, this SNP was not identified in any of the peptide sequences analysed from 
male and female nematodes from isolates FI001 and FI004; either from nematodes 
recovered from untreated control animals or from nematodes that had survived 
injectable IVM administration.  There were no differences in amino acid sequence 
observed between ML resistant isolates here and a previously generated sequence 
from a Belgian ML-sensitive isolate (de Graef et al., 2013a), indicating this SNP may 
not be involved in ML-resistance in all C. oncophora isolates.  It would have been 
beneficial to have access to a ML-naïve parental isolate of both ML-resistant C. 
oncophora isolates, and to examine sequences in nematodes surviving MOX 
administration.  Future studies to investigate this further could include the 
examination of genome sequences from single worms, through the exploration of 
next generation sequencing or deep-sequencing, as the capability of these 
technologies increase.  For example, in a recent study on Dictyocaulus viviparus, 
(Cantacessi et al., 2011) a large-scale examination of transcriptome data across 
several life-cycle stages using 454 sequencing yielded 8-fold greater coverage than a 
study conducted in 2007, which utilised a conventional sequencing approach 
(Ranganathan et al., 2007).  Previously, studies detailing the transcriptome of O. 
ostertagi, (Abuker et al., 2009) and C. oncophora (De Graef, 2013) have been 
published, compiling thousands of expressed sequence tags (ESTs) (Abuker et al., 
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2009).  However, with the use of 454 sequencing, greater coverage of both 
transcriptomes have recently been published (Heizer et al., 2013).  This knowledge 
could be vital in identifying genes which are associated with resistance developing 
across all anthelmintic classes..  
Whilst the phenotypic and genotypic analyses here did not reveal a diagnostic tool or 
marker for ML resistance in cattle nematodes, the information could be exploited to 
explore a narrower range of anthelmintic concentrations in the LMIT across the 
range where the biggest change in migration occurred (around at 1 µg ml
-1
 IVM), 
and larvae that migrate or not could be subjected to analysis to examine changes in 
gene expression proposed to have a role in ML resistance, such as the P-
glycoproteins (de Graef et al., 2013b; Demeler et al., 2013).  There is also scope to 
use P-gp inhibitors to examine the potential for these compounds to reverse ML 
resistance in vitro  (Bartley et al., 2009).  For example, in Haemonchus placei, P-gp 
inhibitors were successful in improving in vitro IVM efficacy against IVM-resistant 
worms and were able to reduce the effective concentration (EC50) estimate with a 
number of inhibitors, compared to IVM alone (Heckler et al., 2014).  To explore this 
work further, a molecular test could be added to the end of the in-vitro test to 
examine larvae which either migrated or fed, or failed to do so and the genetic 
differences between these populations, for example in the up- or down-regulation of 
different Glu-Cl subunits or P-gps.  
Taking the entire work of this thesis into account, the most important areas requiring 
further research are clear.  Whilst the most straightforward approach would be to 
conduct more FECRT, using different anthelmintic classes and gather more data 
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from farmers to identify their parasite control practices, there is a general lack of 
information regarding the epidemiology of these parasites and the impact of 
anthelmintic selection.  The majority of epidemiological data in the UK was 
published in the 1960s and 1970s, i.e. before registration of most broad spectrum 
anthelmintics currently in use (Michel, 1963, 1968, 1969a, b,; 1970, 1976; Armour et 
al., 1969a, b; Michel and Sinclair, 1969, Michel and Lancaster, 1970; Michel et al., 
1970, Armour, 1970, 1974; Michel et al, 1978; Michel et al., 1978b) and so there is 
little information regarding the changes in nematode populations that may have 
occurred due to extensive use of broad spectrum anthelmintic products, in particular 
the MLs.  With the likely shift in nematode genus composition following ML 
administration, Cooperia spp. could dominate cattle nematode populations.  
Worryingly, in the course of a small-scale CET, it was previously reported that an 
ML-resistant C. oncophora isolate was more pathogenic than a non-related 
susceptible isolate (Njue and Prichard, 2004c).  Two calves infected with the 
resistant isolate suffered from ill-thrift and signs of parasitic gastroenteritis, which 
was not observed in two calves infected with the same number of larvae from the 
ML-susceptible isolate (Coles et al., 2001; Njue and Prichard, 2004c).  Due to the 
small numbers of calves used, there is a need for further work in this area, especially 
with isolates that are more closely related, to prevent other population differences 
confounding the results.  This is not only pertinent to cattle farmers, but those who 
co-graze sheep with cattle, given the ability of C. oncophora to infect both species 
(Isenstein, 1963; Isenstein and Porter, 1964).  Further work on such farms could 
investigate the effect of ML applications given to sheep as this, in theory, would 
provide additional ML selection upon C. oncophora or Trichostrongylus axei 
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nematodes present.  Future work should take the whole herd into account to ensure 
confounding variables can be accounted for.  Such an example, would be additional 
ML applications to treat psoroptic mange (Mitchell et al., 2012), which will add 
additional selection pressure to nematodes, as has been reported in the sheep industry 
in relation to long acting ML treatments for Psoroptes ovis (Taylor, 2012). Again, to 
spread awareness about this issue in the cattle industry, veterinary surgeons and 
advisors must collaborate with their clients to ensure anthelmintic applications are 
justified.   
 
6.1 Summary 
By combining parasitological knowledge with knowledge of current farming systems 
optimum anthelmintic use can be achieved, whilst maintaining productivity and 
preserving efficacy of the current anthelmintic classes for as long as possible.  
Knowledge regarding the epidemiology of the parasites in the current management 
strategies and climatic conditions is vital, and encouragement to adopt “best 
practice” principles must be continued through efforts of veterinary professionals and 
industry advisors through a variety of accessible media.  Strategies need to be 
feasible to encourage uptake of advice and to aid farmer compliance, but they must 
also be underpinned by strong empirical evidence, which is currently lacking in the 
dairy and beef cattle sectors.  With no new classes of anthelmintic likely to appear on 
the market in the short to medium term for cattle, there is an urgent need to 
understand the mechanisms behind anthelmintic resistance, (Sutherland and 
Leathwick, 2011).  If, or when, these mechanisms are discovered, new tests (for 
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example, cheap molecular screening tests) could be used to support advice and 
deployment of strategies aimed at reducing dependence on anthelmintics.  Changes 
in marker frequency could be indicative of resistance developing before any 
phenotypic effect could be discerned (Ellis et al., 2011; Jackson, 2013).  As a result, 
the early detection of anthelmintic resistance could be dramatically improved and 
this information integrated into evidence-based decision support systems for farmers 
and livestock producers.     
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Appendix 1: Questionnaire Survey  
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Results from Farms 001 - 004 presented in Chapter 3 have previously been published 
in a peer-reviewed short communication: McArthur, C.L., Bartley, D.J., Shaw, D.J., 
Matthews, J.B. (2011) “Assessment of ivermectin efficacy against gastrointestinal 
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The results from the controlled efficacy study in Chapter 4 have been previously 
reported in a peer-reviewed publication: Bartley, D. J.*, McArthur, C. L.*, Devin, L. 
M., Sutra, J-F., Morrison, A. A., Lespine, A., Matthews, J. B. (2012) 
“Characterisation of macrocyclic lactone resistance in two field-derived 
isolates of Cooperia oncophora.” Veterinary Parasitology 190: 454 – 460 
* denotes joint first-authorship 
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